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SUMMARY 
The relationship between nutrition and HIV infection/AIDS is well recognised. HIV 
infection compromises the nutritional status of infected persons and in turn, poor nutritional 
status affects the progression of HIV infection. 
Nutritional supplementation has been shown to be associated with a significant slowing of 
disease progression, assists in maintaining and· optimising the nutritional status and the 
immune function of HIV-infected persons. The value of nutritional supplementation on the 
immune function of HIV-positive/AIDS patients from low socio-economic communities in 
the Free State is not yet known. Hence, the main purpose of this study was to determine 
the influence of a nutritional supplement (Africa's Solution) on the immune status of HIV-
positive/AIDS patients from the low socio-economic communities of Bloemfontein in the 
Free State Province. 
The study entailed a clinical trial that consisted of one screening visit and three monthly 
visits . A total of 35 respondents were selected according to specific inclusion criteria. 
Food frequency questionnaires were completed during the screening visit. Haematological 
parameters, CD4+T-cell counts and CD8+T-cell counts were determined at the screening 
visit, monthly visits and by the end of nutrient supplementation (final visit). 
The patients studied, demonstrated energy and dietary intake of major macronutrients, 
higher than the RDNAI and higher (P<O.05) in the male than in the female subjects. It 
was also observed that the mineral and trace element intakes exceeded the RDNAI, 
except for iodine and selenium. A majority of the patients reported adequate intake of 
most vitamins with the exception of folate and vitamin D. It is envisaged that the high 
dietary intake of major macronutrients and micronutrients would help in maintaining the 
nutritional status and in curtailing wasting in the patients. 
The anthropometric profiles and the viral load were determined at baseline (n= 35) and at 
the end of study (n=28). There was no significant difference (P>O.05) in the fat percentage 
and body weight before and after nutrient supplementation; however, fat percentage 
differed significantly (P<O.05) between genders. The body mass index (BMI) and the lean 
body mass (LBM) produced a trend towards an improvement. There was a positive 
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correlation between BMI and fat percentage. The CD4+T-cell count showed no correlation 
with the anthropometric profiles, while the viral load showed a negative correlation with the 
LBM, the fat percentage and the BMI. 
Results of the influence of the supplement on the immune status, haematological and 
clinical conditions showed that the viral load decreased significantly (P<0.002) with time 
following supplementation . The mean cell volume (MCV) and the mean cell haemoglobin 
concentration (MCHC) increased significantly (P<0.002, P<0.0002 respectively), reflecting 
the positive effect of the supplement on a few of the haematological parameters. The 
supplement demonstrated no effect on the CD4+T-cell count and the CD4+T-cell count 
decreased significantly (P<0.05) with HIV disease progression. The non-positive effect of 
the supplement on the CD4+T-cell count may be related to the already low CD4+T-cell 
counts before supplementation (lower than 200 cells/mm3 in the majority of patients); short 
duration; inter-assay variation; changes due to inter-current illness; impaired production of 
CD4+T -cells; red istribution within the intravascular spaces and drug-nutrient interactions. 
The supplement showed observable positive effects on the general well-being (clinical 
conditions) of the patients. 
Although, the nutritional supplement did not indicate a positive effect on the CD4+T-cell 
counts, the reduction in the viral load is very important, since median survival time is 
known to increase with reduction in HIV viral load. Because of certain limitations (small 
sample size, short duration , late stage of the infection and inter-assay variation), further 
study is needed to confirm the efficacy of the supplement. 
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SUMMARY 
The relationship between nutrition and HIV infection/AIDS is well recognised. HIV 
infection compromises the nutritional status of infected persons and in turn, poor nutritional 
status affects the progression of HIV infection. 
Nutritional supplementation has been shown to be associated with a significant slowing of 
disease progression, assists in maintaining and optimising the nutritional status and the 
immune function of HIV-infected persons. The value of nutritional supplementation on the 
immune function of HIV-positive/AIDS patients from low socio-economic communities in 
the Free State is not yet known. Hence, the main purpose of this study was to determine 
the influence of a nutritional supplement (Africa's Solution) on the immune status of HIV-
positive/AIDS patients from the low socio-economic communities of Bloemfontein in the 
Free State Province. 
The study entailed a clinical trial that consisted of one screening visit and three monthly 
visits. A total of 35 respondents were selected according to specific inclusion criteria. 
Food frequency questionnaires were completed during the screening visit. Haematological 
parameters, CD4+T-cell counts and CD8+T-cell counts were determined at the screening 
visit, monthly visits and by the end of nutrient supplementation (final visit). 
The patients studied, demonstrated energy and dietary intake of major macronutrients, 
higher than the RDAIAI and higher (P<O.05) in the male than in the female subjects. It 
was also observed that the mineral and trace element intakes exceeded the RDAlAI, 
except for iodine and selenium. A majority of the patients reported adequate intake of 
most vitamins with the exception of folate and vitamin D. It is envisaged that the high 
dietary intake of major macronutrients and micronutrients would help in maintaining the 
nutritional status and in curtailing wasting in the patients. 
The anthropometric profiles and the viral load were determined at baseline (n= 35) and at 
the end of study (n=28). There was no significant difference (P>O.05) in the fat percentage 
and body weight before and after nutrient supplementation; however, fat percentage 
differed significantly (P<O.05) between genders. The body mass index (BMI) and the lean 
body mass (LBM) produced a trend towards an improvement. There was a positive 
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correlation between BMI and fat percentage. The CD4+T-cell count showed no correlation 
with the anthropometric profiles, while the viral load showed a negative correlation with the 
LBM, the fat percentage and the BM!. 
Results of the influence of the supplement on the immune status, haematological and 
clinical conditions showed that the viral load decreased significantly (P<0.002) with time 
following supplementation. The mean cell volume (MeV) and the mean cell haemoglobin 
concentration (MCHC) increased significantly (P<0.002, P<0.0002 respectively), reflecting 
the positive effect of the supplement on a few of the haematological parameters. The 
supplement demonstrated no effect on the CD4+T-cell count and the CD4+T-cell count 
decreased significantly (P<0.05) with HIV disease progression. The non-positive effect of 
the supplement on the CD4+T-cell count may be related to the already low CD4+T-cell 
counts before supplementation (lower than 200 cells/mm3 in the majority of patients); short 
duration; inter-assay variation; changes due to inter-current illness; impaired production of 
CD4+T-cells; redistribution within the intravascular spaces and drug-nutrient interactions. 
The supplement showed observable positive effects on the general well-being (clinical 
conditions) of the patients. 
Although, the nutritional supplement did not indicate a positive effect on the CD4+T-cell 
counts, the reduction in the viral load is very important, since median survival time is 
known to increase with reduction in HIV viral load. Because of certain limitations (small 
sample size, short duration, late stage of the infection and inter-assay variation), further 
study is needed to confirm the efficacy of the supplement. 
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OPSOMMING 
Die verwantskap tussen voeding en MIV infeksieNIGS is welbekend. MIV-infeksie 
kompromiteer die voedingstatus van ge·infekteerde persone, en op sy beurt, bern vi oed 
swak voedingstatus die progressiewe toename van MIV-infeksie. 
Dit is reeds bewys dat die inneem van 'n voedingsupplement die gang van die siekte 
vertraag, en daartoe bydra om die voedingstatus en die immuunfunksie van MIV-besmette 
persone te handhaaf en optimaliseer. Die waarde van voedingsupplementasie teenoor die 
immuunfunksie van MIV-positieweNIGS pasiente, vanuit die lae sosio-ekonomiese 
gemeenskappe in die Vrystaat, is nog onbekend. Derhalwe was die hoofdoel van hierdie 
studie om die invloed van voedingsupplementasie op die immuunstatus van MIV-
positieweNIGS pasiente, vanuit die lae sosio-ekonomiese gemeenskappe van 
Bloemfontein, in die Vrystaat, te bepaal. 
Die studie het 'n kliniese toets behels wat bestaan het uit een siftingsbesoek en drie 
maandelikse besoeke. 'n Totaal van 35 respondente is gekies volgens bepaalde 
insluitingskriteria. Voedselfrekwensievraelyste is voltooi tydens die siftingsbesoek. 
Hematologiese parameters, CD4+T-seltellings en CD8+T-seltellings is gedoen tydens die 
siftingsbesoek, die maandelikse besoeke en aan die einde van die toediening van die 
voedingsupplement (Iaaste besoek). 
Die pasiente wat bestudeer is he! energie en dieetinames van die belangriks!e 
makrovoedingstowwe getoon wat hoer was as die ADT/AI en die innames was ook hoer 
(P<O.05) in manlike as in vroulike pasiente. Dit is ook waargeneem dat die minerale- en 
spoorelementinname die ADT/AI oorskry he!, behalwe wat betref jodium en selenium. 'n 
Meerderheid pasiente he! voldoende innames van die meeste vi!amienes gerapporteer, 
met uitsondering van folaat en vitamien D. Dit word in die vooruitsig gestel dat die hoe 
inname van makro- en mikrovoedinstowwe sal bydrae om die voedingstatus van pasiente 
te handhaaf en om uittering te beperk. 
Die antropometriese profiele en die viruslading van die pasiente is aan die begin van die 
studie (n=35) en aan die einde van die studie (n=28) bepaal. Daar was geen sta!isties 
beduidende verskil (P>O.05) in die vetpersentasie en liggaamsmassa voor en na die 
toediening van die voedingsupplement nie; alhoewel die vetpersentasie aansienlik verskil 
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(p<0.05) het tussen geslagte. Die liggaamsmassa-indeks, die middllyf-heup-verhouding 
en die maerligaamsmassa het 'n neiging tot verbetering getoon. Daar was 'n positiewe 
korrelasie tussen liggaamsmassa-indeks en vetpersentasies. Die CD4+T-seltelling het 
geen korrelasie met die antropometriese profiele getoon nie, terwyl die viruslading 'n 
negatiewe korrelasie met die maerliggaamsmassa, die vetpersentasie en die 
liggaamsmassa-indeks getoon het, maar wei 'n positiewe korrelasie met die middellyf-
heup verhouding. 
Resultate van die invloed van die voedingsupplement op die immuunstatus, die 
hematologiese en kliniese toestande, het getoon dat die viruslading aansienlik gedaal het 
(P<0.002) met verloop van tyd na die toediening van die supplement. Die gemiddelde 
korpuskulere volume en die gemiddelde korpuskulere hemoglobienkonsentrasie het 
aansienlik vermeerder (P< 0.002, P<0.0002 respektiewelik), wat die positiewe effek van 
die voedingsupplement op sommige van die hemoglobienparameters aantoon. Die 
voedingsupplement het geen effek op die CD4+ T-seltelling gehad nie en die CD4+T-
seltelling het aansienlik verminder (P<0.05) 5005 wat die MIV-siekte toegeneem het. Die 
nie-positiewe effek van die voedingsupplement op die CD4+ T-seltelling kan moontlik 
verband hou met die reeds lae CD4+ T-seltellings voor die toediening van die supplement 
(Iaer as 200 selle/mm3 in die meeste pasiente), kort tydsduur; inter-toets variasie; 
verandering as gevolg van bykomende siektetoestande; verswakte selproduksie; 
herverdeling binne die intravaskulere ruimtes en medikasie-voedingstof-interaksie. Die 
voedingsupplement het waarneembare positiewe gevolge getoon op die algemene 
welstand (kliniese toestand) van die pasiente. 
Alhoewel die voedingsupplement nie 'n positiewe effek op die CD4+ T-seltelling gehad het 
nie, was die afname van die viruslading baie belangrik, omdat dit bekend is dat die 
mediaan-oorleweringstyd vermeerder 5005 wat die virus lading verminder. As gevolg van 
sekere beperkings (klein steekproefgrootte, kort tydsduur, gevorderde fase van die 
infeksie en inter-toets variasie), is verdere navorsing benodig om die effektiwiteit van die 
voedingsupplement te bevestig. 
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CHAPTER 1 
1. INTRODUCTION 
1.1 General Background and Problem Statement 
The HIV/AIDS epidemic continues to have a devastating effect on people in Sub-
Saharan Africa. By the end of 1998 (Piwoz & Preble, 2000), at least 34 million people 
living in Sub-Saharan Africa had become infected with HIV and some 11.5 million of 
these have already died. In 1998 alone, about 2 million Africans died from HIV/AIDS 
(Piwoz & Preble, 2000). In global terms, South Africa is known to have one of the 
fastest growing AIDS epidemics. Approximately 1700 persons are believed to be 
infected with the HIV each day. It is also estimated that nearly 12% of adults are 
assumed to be HIV positive and 2.5 million will have died of AIDS, or an AIDS-related 
illness by 2005 (Dhianraj, 2000). 
Malnutrition has been an endemic problem in Africa for decades, caused by a 
combination of factors, and more recently magnified by the impact of HIV/AIDS. HIV 
infection exacerbates malnutrition through its attack on the immune system and its 
impact on nutrient intake, absorption and utilization (Friis & Michaelsen, 1998). 
Nutritional deficiencies affect immune functions in ways that may influence viral 
expression and replication, further affecting HIV progression and mortality (Semba & 
Tang, 1999). 
However, HIV-positive patients have demonstrated improved quality of life (increased 
activity, increased ability to perform activities of daily living and prolonged employment) 
after adequate provision of nutritional support (Futures Group, 1999). The impact of 
nutritional interventions mostly depend on the underlying nutritional and immune status 
of the individuals being studied (Watson, 1994) and many of the studies conducted on 
supplementation or nutritional support are In industrialised countries and may not be 
directly relevant to African settings. 
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Research is therefore urgently needed on the nutritional management of HIV/AIDS in 
Africa, where HIV infection is spreading very fast; where malnutrition is endemic, and 
where resources for management of both HIV and malnutrition are extremely limited. 
Studies are needed to determine the efficacy of multiple micronutrient supplements for 
improving nutritional status, slowing down HIV disease progression and delaying AIDS-
related mortality in populations that are endemically deficient and may also experience 
chronic food insecurity. The quality of life and the prospects for millions of African adults 
and children living with HIV and AIDS today and those who are likely to be infected in 
the future may remain bleak if research into the nutritional management of HIV/AIDS 
patients is neglected. 
Available scientific evidence has revealed that several vitamins and minerals are critical 
for fighting HIV infection, because they are required by the immune system and major 
organs to attack infectious pathogens (Tang et al., 1996; Chandra, 1997). Previous 
studies indicate that in the early period of HIV infection, weight gain or maintenance 
might be achieved through good nutrition and has helped to reduce the consequences 
of wasting in people living with HIV/AIDS (Watson, 1994; Semba & Tang, 1999; Piwoz 
and Preble, 2000). 
Micronutrients have helped to strengthen the immune system and reduce the severity 
and impact of opportunistic infections in people living with HIV/AIDS (Watson, 1994; 
Semba & Tang, 1999; Piwoz & Preble, 2000). According to Piwoz & Preble (2000), the 
relationship between HIV/AIDS and malnutrition represents a classical instance of a 
well-recognised vicious circle of immune dysfunction, infectious disease and 
malnutrition. It is known that any immune dysfunction as a result of HIV/AIDS leads to 
malnutrition and this in turn leads to further immune dysfunction. This worsens the 
impact of HIV and may contribute to faster progression to AIDS. Various research 
studies have confirmed that nutrient deficiencies are associated with immune 
dysfunction and accelerated progression to AIDS (Baum & Shor-Posner, 1998; Fawzi & 
Hunter, 1998; Macallan, 1999; Bijlsma, 2001). For instance, deficiencies of vitamin A 
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and B12 have been associated with a reduction in CD4+T-cell count in HIV infected 
patients (Baum et al., 1995). 
Studies on nutritional supplementation in HIV positive patients are limited ; while some 
targeted specific groups, others are more retrospective in nature or survey (Allard et al., 
1998; Nimmagadda, 1998; Muslimatun et al., 2001). Furthermore, there have been 
some controversial reports on the benefits and/or role of nutritional supplementation in 
HIV/AIDS patients in general. Few studies (Vella et al. , 1995; Van Staden et al., 1998; 
Tang & Smit, 1998) show a weak correlation between the dietary intake and blood levels 
of nutrients, which could lead to the conclusion that increasing intake of recommended 
macro-or micronutrients might not improve nutrient status. However, the weak 
correlation may be due to poor reliability or inaccuracy of intake measurement. In 
addition, studies have used a variety of different variables to characterize HIV status, 
making comparison between studies complicated. Research studies vary in their length 
of follow-up and may have biased conclusions. Other studies only measure changes in 
body weight following nutritional interventions whereas some measured body cell or lean 
body mass. Measuring changes in body weight and using this to measure the nutritional 
status of HIV infected subjects is less than optimal and may be misleading, because 
weight gain or stabilization can occur in the presence of muscle wasting when nutritional 
interventions increase body fat and water only. The differences in the study populations, 
study design and methodology have made it difficult to extrapolate findings from one 
population to another and to draw practical lessons for a specific and for different 
community settings. These reasons are a strong motivation for one to examine the role 
of nutritional intervention in HIV-infected patients in the African community of 
Bloemfontein. 
Researchers have expressed the view that further and urgent community-based 
research studies are needed on nutritional supplementation among HIV positive patients 
(Fawzi & Hunter, 1998; Macallan, 1999; Kennedy et al., 2001). Van Staden et al. (1998) 
reported a deficiency in several micronutrients in HIV-1 sero-positive patients in the Free 
State and suggested a multi-vitamin/anti-oxidant supplementation to improve the 
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immune status of these patients. It is in line with his recommendations that the product 
Africa's Solution was devised. Observations by clinicians from preliminary results 
indicated that the product . Africa's Solution increases the CD4+T-cell count in HIV-
infected patients. The viral load decreases over a period of time and the capacity for 
work of such people retums to normal. However, the product needs to be studied under 
research conditions. 
1.2 Justification of the Study 
Data on the prevalence of malnutrition, dietary intake and/or supplementation in HIV-
infected persons in industrialised countries are widely available. However, this is often 
scarce in Africa, therefore, a study to evaluate the role of nutritional supplementation in 
HIV-positive patients becomes necessary, especially in a developing country such as 
South Africa. A study concerned with nutritional supplementation of HIV positive 
patients could be considered as very important due to the points enumerated below: 
• HIV infection frequently results in nutritional deficiencies and growth failure. The 
specific mechanism related to HIV infection, nutritional status and its role in 
human health is not well known. 
• Benefits from nutritional supplementation include not only the improved health 
and well-being of individuals and families, but also improves the chances of 
prolonged survival for those infected. 
• The knowledge acquired from this study would be vital in setting up nutrition 
intervention strategies for this group and other groups regarding various 
nutritional problems associated with HIV/AIDS. 
1.3 The Aim of the Study 
The aim of this study was to investigate the influence of a multiple combination liquid 
supplement on the CD4+T-cell count and viral load of HIV-positive/AIDS patients with a 
depressed immune system, and to examine the change in the anthropometric status, 
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haematological parameters and clinical conditions following supplementation for a given 
period. 
1.3.1 Sub-aims 
• To determine the dietary intake of the patients. 
• To determine the effects of the supplement on anthropometric, haematological 
and immune parameters. 
• To determine any correlation between the measured parameters at baseline and 
at the end of nutrient supplementation 
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CHAPTER 2 
2 LITERATURE REVIEW 
2.1 Introduction 
The human immunodeficiency virus (HIV) is seen as one of the most severe 
infections ever known to have attacked the human population, especially the 
economically productive age group of between 15-49 years (UNAIDS, 2001). HIV is 
also seen as an infection of attitude and behaviour, as it is closely associated with 
sexual behaviour, especially where a person has more than one sexual partner 
(UNAIDS, 2001; Oguntibeju & Fabode, 2002). Scientific evidence has shown that 
HIV infection is caused by a retrovirus named the HIV. HIV is a ribonucleic acid 
(RNA) retrovirus, so designated because of its genome that encodes an unusual 
enzyme called reverse transcriptase. This enzyme allows deoxyribonucleic acid 
(DNA) to be transcribed from RNA. Thus HIV can make copies of its own genome as 
DNA in the host's cells, such as human T 4-helper lymphocytes, and this leads to the 
elaboration of vast numbers of viral particles (Weiss, 1996; Denny et al., 1998; 
Oguntibeju & Banjoko, 2003). There has been a drastic increase in the number of 
people infected with HIV, in spite of various efforts made to combat this infection. 
This increase is not peculiar to a particular racial group, country and community. It is 
a worldwide problem. However, according to reports, the greatest incidence of HIV 
infection is found in Sub-Saharan Africa (UNAIDS, 2001; SAHIVCS, 2001). 
2.2 Definition of AIDS 
The acquired immunodeficiency syndrome (AIDS) is caused by a retrovirus named 
the H IV which selectively attacks and depletes T -lymphocytes bearing the CD4 
receptor (T-helper cells), causing a predisposition to opportunistic infections and 
malignancies (Sabatier, 1987; Weiss, 1996; Wong et al., 1997). In its definition, the 
World Health Organization (WHO) gave a provisional clinical case definition for AIDS 
in places where diagnostic resources are limited, and stated thus: 
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2.2.1 AIDS in Adults 
This is defined by the existence of at least two of the major clinical signs associated 
with at least one minor clinical sign in the absence of known causes of immuno-
suppression such as cancer or severe malnutrition, or other recognised aetiologies. 
The major clinical signs include weight loss of more than 10% of the body weight, 
chronic diarrhoea for more than one month and prolonged fever for longer than one 
month. The minor signs are generalised lymph-adenopathy, a persistent cough for 
longer than one month and oropharyngeal candidiasis. It also stated that the 
presence of generalized Kaposi's sarcoma or cryptococcal meningitis are sufficient 
cl inical signs by themselves for the diagnosis of AIDS in the adult group (WHO, 1993; 
Barnhart et a/., 1996; SAHIVCS, 2001). 
2.2.2 AIDS in Children 
Paediatric AIDS should be suspected in an infant or a child presenting with at least 
two major clinical signs associated with at least two minor signs in the absence of 
known causes of immuno-suppression. The major clinical signs include weight loss 
or abnormally slow growth and chronic diarrhoea for longer than one month. The 
minor clinical signs include generalised lymph-adenopathy and oropharyngeal 
candidiasis (WHO, 1993; Barnhart et a/., 1996; SAHIVCS, 2001). 
2.3 Natural History of HIV Infection 
Observations have shown that from the natural history of the disease, it is usually 
lethal to those who are infected by HIV. Furthermore, every person infected is an 
active carrier of the virus to an unsuspecting contact, even before the infected carrier 
presents with AIDS. The mean time from infection with HIV to the development of 
AIDS is about nine to ten years in industrialized countries (Weiss, 1996; Liu et a/., 
2000). Factors that are suggested to affect the duration of clinical latency include 
genetic susceptibility, viral load, concurrent infections as well as the pre-existing 
immune status at the time of HIV infection (Royce et a/. , 1997). Based on available 
data, the survival time of HIV infected persons is much shorter in Africa than in 
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industrialised countries (Enwonwu, 1992; Gilks, 1993; Piwoz & Preble, 2000; 
SAHIVCS, 2001). 
Studies suggest a rapid transition from asymptomatic HIV infection to AIDS 
(Enwonwu, 1992; Bentwich et al., 1999; Hazenberg et al., 2000). Many of the 
patients in Africa have poor access to health care systems, therefore infections due 
to endemic pathogens such as Mycobacterium tuberculosis, Streptococcus 
pneumonia and non-typhoid salmonellae coupled with malnutrition seem to be 
playing a significant role in the cause of death (Gilks, 1993; Tindall & Copper, 1991; 
SAHIVCS, 2001). 
2.3.1 Classification of HIV Infection 
In 1986, the United States Centers for Disease Control and Prevention (CDC) 
developed the first classification system for HIV infection with the focus on AIDS-
defining opportunistic infections and malignancies (CDC, 1987). The CDC 
classification system was revised in 1987 to reflect clinical practice more practically 
and included in it the "HIV wasting syndrome" along with other HIV related diseases. 
The former classification refers to the presence of involuntary weight loss of greater 
than 10%, accompanied by chronic diarrhoea (> 30 days) or documented fever (> 30 
days). In 1991, the classification of AIDS included all HIV-infected individuals with 
CD4+ T-cell counts < 200 x 106 (Buehler et al., 1993; SAHIVCS, 2001). In 1993, the 
WHO staging system for HIV infection and disease was formulated as universal 
staging system for HIV infection with some flexibility for international use, including 
countries with limited access to technology. The WHO did not include pulmonary 
tuberculosis as an AIDS defining illness within this staging system, since it occurs as 
an endemic disease in many developing countries. Involuntary weight loss of greater 
than 10% of normal weight in clinical stage 3 and the HIV wasting syndrome in stage 
4 were included (WHO, 1993; SAHIVCS, 2001). This staging is currently in use in 
South Africa (Martin 2000, SAHIVCS, 2001). 
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2.4 The Epidemiology of HIV/AIDS 
2.4.1 Origin and History of HIV/AIDS Epidemic 
The first reported cases of AIDS were recorded in the morbidity and mortality weekly 
report of June 5 1981, in the United States of America and concerned five young 
men, all active homosexuals who had been treated in Los Angeles hospital for a rare 
infection called Pneumocystis carinii pneumonia (PCP). All five men had evidence of 
other infections and a defective immune system. About the same period, physicians 
in the United States of America diagnosed Kaposi's sarcoma (an uncommon 
malignancy) in twenty-six homosexual men whose ages ranged from 26-51 years 
(Cahill, 1994; UNAIDS, 2000; 2001). 
2.4.2 Global Epidemiology of HIV Infection and AIDS 
The HIV/AIDS pandemic is perhaps the most serious disease threat to this 
generation. There is, however, inadequate information on the extent of its spread 
(UNAIDS, 2002). Reports show that global statistics are collated by WHO, but these 
statistics are usually incomplete because, for a number of reasons, many authorities 
do not/are unable or are unwilling to give an accurate figure regarding the number of 
cases occurring in their countries (Sabatier, 1987; SAHIVCS, 2001). The 
epidemiological data available on the distribution of HIV/AIDS cases throughout the 
world point to distinct patterns, each of which is characterized by the time the 
infection or disease was diagnosed and the predominant modes of transmission 
(Martin, 2000; UNAIDS, 2002). 
At the end of 2001, an estimated 40 million people globally were documented to be 
living with HIV. In many parts of the developing world, the majority of new infections 
occur in young adults, with young women especially being more vulnerable. About 
one-third of those currently living with HIV/AIDS are between 15 and 49 years of age. 
Most of them do not know that they are carrying the virus. Many people in Africa 
especially those living in the rural areas, know nothing or too little about HIV to 
protect themselves against the virus (UNAIDS, 2001 ; Oguntibeju et al., 2002). 
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The pattern of HIV/AIDS distribution has implications for the type of prevention and 
nutritional support needed and for the priority that needs to be given to different 
aspects of the activities that would reduce its spread and improve the health status of 
those already infected with HIV (UNAIDS, 2000). 
2.4.2.1 Pattern 1 
In pattern 1 areas, most cases of HIV infection and AIDS occur in homosexual or 
bisexual males and in intravenous drug users. Heterosexual transmission is also 
increasing, but it is responsible for only a small percentage of cases. This pattern is 
typical of North America. The male to female ratio of HIV/AIDS reported cases range 
from 10:1 to 15:1 (Royce eta/., 1997; UNAIDS, 2001). 
2.4.2.2 Pattern 2 
This is typical of most Sub-Saharan Africa and parts of the Carribbean. Most of the 
reported cases in these regions occur through sexual transmission among 
heterosexuals with the male to female ratio of documented cases put at ratio 1 :1. 
Transmission from intravenous drug users and homosexual relationship occurs at a 
lower rate than heterosexual transmission (Royce et al. , 1997; UNAIDS, 2000). 
2.4.2.3 Pattern 3 
This pattern is found in North Africa, Eastern Europe, Asia and most parts of the 
Pacific. In these areas, HIV appears to have been introduced in the early to mid 
1980s and only a small number of HIV/AIDS cases have been documented as of 
1989. However, the prevalence rate of HIV/AIDS in the different regions has 
increased significantly in the last few years (Royce et a/., 1997; UNAIDS, 2000). 
2.5 HIV Epidemics in Sub-Saharan Africa 
Africa is believed to be home to at least 70% of the total adults and 80% of the total 
children globally living with HIV (Piwoz & Preble, 2000; UNAIDS, 2002). About 75% 
of all AIDS deaths have occurred in sub-Saharan Africa since the epidemic began 
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two decades ago. At the end of 2001 , it was reported that of the 40 million people 
estimated to be living with HIV/AIDS, 28.5 million live in Sub-Saharan Africa. Of 
approximately 13.2 million children who have lost both parents due to HIV infection, 
12. 1 million live in Sub-Saharan Africa (UNAIDS, 2001; WHO, 2002). Available data 
showed that countries in southern Africa now have prevalence rates higher than 
20%: Botswana (38.8%), Lesotho (31 %), Namibia (22.5%), South Africa (20.1%), 
Swaziland (33.4%), Zambia (21.5%), and Zimbabwe (33.7%) (Maw, 2000; WHO, 
2001). 
In West and Central Africa, new data confirm an increased rate. In Cameroon's 
urban areas, the HIV prevalence rate increased from 2% in 1988 to 4.7% in 1996. 
Nigeria's national prevalence rate rose from 1.9% in 1993 to 5.8% in 2001 . Already 
about 3.5 million Nigerians are estimated to be living with HIV/AIDS (UNAIDS, 2001; 
2002). The rise of HIV prevalence in conflict countries such as Angola, Burundi, the 
Democratic Republic of Congo and Rwanda is considered a serious concern as the 
extensive displacement of people and the disruption of social systems increase the 
vulnerability of the people to HIV infection (UNAIDS, 2001; 2002). Table 2.1 reveals 
a global summary of the HIV/AIDS epidemic. 
Table 2.1: Global Summary of HIV/AIDS Epidemic, December 2001 (UNAIDS 
2001) 
Number of people living Adults 37.2 million 
with HIV/AIDS Men 16.9 million 
Women 17.6 million 
Children under 15 years 2.7 million 
People newly infected with Adults 4.3 million 
HIV in 2001 Men 1.7 million 
Women 1.8 million 
Children under 15 800, 000 
AIDS deaths in 2001 Adults 2.4 million 
Men 720000 
Women 1.1 million 
Children under 15 years 580, 000 
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2.5.1 Prevalence of HIV/AIDS in South Africa 
In global terms, South Africa is known to have one of the fastest growing AIDS 
epidemics. Approximately 1700 people are believed to be infected with HIV each 
day (Dhianraj, 2000). The HIV-1 epidemic in South Africa started in the white 
homosexual population in the mid-1980s. However, by 1990 it was clear that 
heterosexual contact was becoming the predominant mode of transmission in the 
country, with a subsequent explosive epidemic occurring in the heterosexual 
population (ADSA, 1996; Dannhauser et al., 1999). 
The HIV/AIDS epidemic in South Africa continues to grow at a rapid rate. UNAIDS 
estimates that in 2000, 19.9% of adults South Africans were infected, exceeding the 
12.9% recorded in 1998 (UNAIDS, 2000). Reliable empirical data on the HIV 
epidemic in South Africa as in other African countries are, however, difficult to obtain 
(Dorrington et al., 2001). According to Dorrington et al. (2001), the death rates 
increased from 9% in 1995 to 40% in 2000. 
2.6 Modes of Transmission of HIV 
HIV is present in peripheral blood , cell free plasma, semen, cervical and vaginal 
secretions, Iymphnodes, brain cells , liver cells, cerebrospinal fluid (CSF) and saliva 
(Sabatier, 1987; DeGruchy, 1990; Soderlund et al. ,1999; SAHIVCS, 2001). HIV can 
be transmitted via 
• Sexual acts (horizontal transmission). 
• Blood or blood products from an infected person transfused to another 
individual. 
• Intravenous d rug abuse 
Needle stick injury and other parenteral modes of innoculation of the virus as well as 
ear piercing, tribal marks and scarifications are other methods of transmission 
(DeGruchy, 1990; SAHIVCS, 2001). In addition , Royce et al. (1997), reported that 
HIV can still be transmitted by people receiving highly active anti-retroviral therapy 
(HAART) and/or by those who have undetectable viral loads. HIV-1 and HIV-2 are 
transmitted in the same ways, although there is evidence that HIV-2 is less easily 
transmitted through the sexual route and mother to child route than HIV-1 subtypes. 
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Epidemiological evidence showed that HIV-1 subtypes seem to be predominant in 
certain epidemics (for example, the rapid heterosexual spread of subtype E strains in 
Thailand). However, there is no clear evidence to link particular subtypes with a 
specific mode of transmission (DeVicenzi , 1994; Bartlett, 1998; Gallant, 1999). 
2.6.1 Sexual Transmission 
As Royce et a/. (1997) stated , unprotected sexual intercourse (defined as penetrative 
oral , vaginal or anal sex) without the use of a condom between a male and a female 
or between males, accounts for 75-85% of HIV infection in adults. One of the most 
complex factors affecting the pathogenesis of HIV infection is that of sexual 
transmission. Sexual transmission of H IV is dependent on a number of factors that 
are involved in both the person transmitting the virus and the uninfected partner 
(Darby et al. , 1996; Denny et al., 1998; Oguntibeju & Fabode, 2002; Oguntibeju et 
al., 2002). Sexual transmission of HIV may occur when a sufficient amount of the 
infectious virus penetrates the mucosa of an individual during sexual relations 
(Denny et al., 1998). 
It has been suggested that factors that increase the amount and virulence of the 
immunodeficiency virus; weaken the integrity of the localised tissue barriers, or 
interrupt with the production of an effective local and systemic immunological 
response, may increase the chances of transmission of HIV (Denny et al. , 1998; 
Cohen & Fauci, 2001). Seidlin et al. (1993); Weiss (1996); Royce et al. ( 1997); 
Denny et al. (1998); UNAIDS (1999); Wawer et al. (1999) and Maw (2000) noted that 
several factors are creating a fertile ground for the epidemic. These factors include 
host susceptibility, host genetic factors, stage of infection, rate of partner change, the 
biological property of HIV, mass unemployment and economic insecurity, social and 
cultural norms, other sexually transmitted infections and unprotectedlunsafe sex. 
2.6.2 Blood-borne Transmission of HIV 
Generally, blood-borne transmission of HIV occurs via needle sticks, other blood-
contaminated sharp objects and via blood transfusion and organ transplantation. 
The people at risk are intravenous drug users, healthcare workers and recipients of 
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blood, blood products and organs (Cardo et al., 1997). Globally, by the end of 1996, 
blood transfusion accounted for 3-5% of all adult cases of HIV infection (Efem, 1990; 
Cardo et al., 1997; Leroy et al., 1998). Routine screening procedures have 
significantly reduced this· risk , especially in developed countries. However, there are 
reported cases of HIV having been transmitted through transplantation of blood-
containing or highly vascularised organs such as the kidney, liver, heart, pancreas, 
bone, skin and via artificial insemination (Efem, 1990; Smith & Nichols, 1991). 
Healthcare workers are continually at risk of acquiring blood-borne infections, in 
particular Hepatitis Band C viruses and HIV (Bragbjerg, 1993). 
2.7 The Biology of HIV 
There are two types of HIV which show approximately 40-60% amino acid homology 
and these two types are discussed below. 
2.7.1 Type 1 (HIV-1) 
Type-1 is found throughout the world and is responsible for the majority of cases of 
HIV infection (Fox, 1996; SAHIVCS, 2001). HIV-1 strains are further divided into 
group M (major) and group 0 (outlier) strains . Group M viruses are a prevalent group 
accounting for most HIV-1 infections worldwide. On the other hand, the smaller 
group 0 strains are rare and are quite diverse from the group M viruses (Kuritzkes, 
1999). The reason for the genetic diversity of HIV-1 is related to the inherent 
potential of the virus to mutate and in some instances is due to the recombination of 
distinct virus strains. 
The initial epidemic in South Africa was due to a clade B virus, but this has been 
overtaken by a clade C epidemic (Martin, 2000). It was confirmed that each HIV 
particle is composed of two copies of the single-stranded RNA viral genome 
packaged inside a protein core or capsid. The core (Gag) proteins include the major 
structural proteins p24 (capsid) and p17 (matrix), the internal structural protein p7 
(nucleocapsid) and the Gag-Pol precursor protein p55. The virus particle also 
contains polymerase (Pol) proteins that are essential for the early steps in the life 
cycle of the virus. This includes the reverse transcriptase p66/p51 and the 
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endonuclease/integrase p31 (Pantaleo et aI., 1998). The capsid of HIV is 
surrounded by lipid envelope derived from the infected cells, in which HIV envelope 
glycoproteins (Env) are embedded. These comprise the outer envelope glycoprotein 
gp120, the transmembra'ne glycoprotein gp41 and the precursor glycoprotein gp160 
(Vogt et al., 1997; Martin, 2000). 
2.7.2 Type 2 (HIV-2) 
Type 2 is currently and predominantly found in West Africa and countries with 
historical or commercial ties to this region (Efem, 1990, Fox 1996). HIV-type 2 was 
isolated first in 1986 from AIDS patients in West Africa where it is most prevalent and 
mainly acquired through heterosexual relationships. The incidence of HIV-2 has also 
been reported from East Africa, Europe, Asia, North America and Latin America. 
Five HIV-2 sub-types (A-E have been described (Moore et a/., 1997; Young, 1997; 
Kuritzkes, 1999; Martin, 2000). 
2.7.3 Cellular Receptors for HIV 
HIV is known to infect certain types of cells; these are cells expressing the CD4+T-
cell receptor. These cells include T-helper cells (CD4+ T-cells or T4 cells), as well as 
other white blood cells, including monocytes and macrophages. Glial cells in the 
central nervous system, chromaffin cells in the intestine and Langerhans cells in 
mucous membranes and skin that express the CD4+T-cell receptor can also be 
infected with HIV (Sagasra et al., 1992; Paxon et al., 1996). 
However, some cells, for example, neurones that do not express the CD4+T-cell 
receptor, may become infected with HIV. This raises the possibility that other cellular 
targets may exist for the human immunodeficiency virus. Research findings indicate 
that specific human cell surface proteins identified as co-receptors in addition to the 
CD4+T-cell, have been found to mediate fusion between HIV and its target cells 
(Paxon et al., 1996; Grossman & Herberman, 1997). Two of the prominent co-
receptors are: C-C chemokine receptor CCR-5, expressed by monocytes and 
lymphocy1es which mediate entry of non-syncy1ium inducing (NSI), monocy1otropic 
strains of HIV-1, and the C-X-C chemokine receptor CXCR-4 (also known as fusin)-
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expressed on T-Iymphocytes which mediates entry of syncytium-inducing (SI), T-cell 
tropic strains of HIV-1. This possibly explains the reason why monocytotropic strains 
of HIV can infect both monocytes and primary (both of which express CCR-5) but not 
T-cell lines (which lack CCR-5 and why T-cell tropic strains of HIV-1 can not infect 
monocytes (which lack CXCR-4). The CCR-5 and CXCR-4 co-receptors function as 
receptors for chemokines in the human body system. 
It has been postulated that chemokines that are produced by CD8+ cells in response 
to immune activation, such as RANTES (regulated upon activation, normally T-cell 
expressed and secreted), MIP-1 a and MIP 1 P (macrophage inflammatory proteins), 
bind to CCR-5, blocking the entry of HIV-1, thereby inhibiting in vitro infection with 
monocytotropic but not T-Iymphotropic strains of the virus (Cocchi et a/., 1995; Paxon 
et a/., 1996; Ullum et a/., 1998). 
2.8 Pathogenesis of HIV Infection 
2.8.1 Introduction: 
Most characteristically, HIV-1 infection in man results in the loss of function and 
death of CD4+T-cells with a resultant increased incidence of opportunistic infections 
and malignancies (Levy, 1993; Fox, 1996). Patients that are seropositive for HIV-1 
positive, progress through the infection at different rates and factors that affect the 
progression are clues to the pathogenesis of HIV-infection (Schechter et al., 1994; 
Dalgleish & Colizzi, 1992; Levy, 1993; Kreiss et a/., 1997). Literature tends to agree 
that genetic predisposition, reflected in different human leucocyte antigen (HLA) 
types, concurrent infections, age, dose of the inoculum, the route of exposure, the 
variant of the virus as well as other factors, plays a role in the pathogenesis of HIV-1 
and in determining how the immune system handles the infection. 
2.8.2 Processes of Pathogenesis of HIV Infection 
The sequence of events associated with the processes of pathogenesis by Fox 
(1991); Fox et al. (1992); Fox & Cottier-Fox, (1992); Fox et al. (1994); Fox, (1996) 
can be summarized as follows: 
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• HIV, covered with cell membranes, antibodies, and/or complement from 
the infected individual enters into a new host. 
• The infecting virus is immunologically recognized as an "antigen complex" 
and as such is attacked by CD4+T-cells . Contact with protruding gp120 
results in infection of the host cells. 
• The infected cell produces many more viral particles that are not coated 
with antibodies and are therefore able to freely produce infection among 
CD4+ bearing cells. 
• Infected virus-producing cells shed antigens in the form of virions and viral 
proteins. These substances are immunogenic. 
• There is lymphoid hyperplasia accompanied by B-cell expansion and 
increasing levels of humoral antibodies and plasma cells. This is followed 
by a proportionate decrease in the numbers of circulating productively 
infected cells. This reciprocal change in virus-producing cells may either 
be due to cytotoxic T-Iymphocytes, or to virus inactivation by humoral 
antibodies or both . 
• There is an accumulation of HIV as a viral-immune complex on the surface 
of the cell membranes of follicular dendritic cells. This is attached by Fc 
receptors on the cell surface. The virus reservoir is requ ired for the 
progression of HIV infection and viral concentration of 1 x1 09 particles per 
cubic centimetre may be reached in the germinal cells. 
• The infected individual assumes a steady state of infection in which the 
CD4+ T -cells become infected as they migrate through the germinal cells. 
It is said that depending on the time from infection to activation and viral 
expression , infected cells produce viral particles in the lymphoid tissue or 
at distant sites elsewhere in the body system. 
• The depletion of CD4+T-cells exceeds formation by a slight margin . This 
phase of the infection/disease can continue for many years. 
• Due to the prolonged loss of CD4+T -cells and their functional interactions, 
the integrity and function of the lymphoid tissues are broached and there is 
loss of filtration of virus/virions as well as general disorganization of the 
lymph nodes. Lymphoid tissues seem to depend on complex ecological 
interactions, modulated by cytokines and dependent on micro-
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environmental interaction. At some point in this process, the AIDS-defining 
stage is reached. 
• Immune function decreases until opportunistic AIDS-defining infections 
overwhel m the patient. 
2.8.3 Principles of HIV Pathogenesis 
Infection with HIV-1 initiates a process that leads to progressive destruction of the 
population of CD4+T -cells with roles in the generation and maintenance of host 
immune responses (Fauci, 1988; Fauci et a/., 1991; Feinberg, 1995; Koot et a/., 
1996; Haynes et aI., 1996). The target cell preference for HIV-1 infection and 
depletion is determined by the identity of the CD4+T-cell surface that is recognized by 
the HIV-1 envelope (env) glycoprotein as the virus binds to and enters host cells to 
initiate the virus replication cycle (Feinberg, 1995; Koot et ai, 1996). It has been 
found that the process of cell fusion (syncytium formation) which depicts a significant 
cytopathic consequence of HIV-1 infection of CD4+ T-cells, also depends on the 
specific interaction between CD4+T-cells and the HIV-1 env glycoprotein (Feinberg, 
1996; Bartlett, 1998). 
2.8.3.1 Decline of CD4+T-cells 
After initial infection of the human host, the pace at which immunodeficiency 
develops and the susceptibility to opportunistic infections and malignancies become 
manifest and are associated with the rate of decline in CD4+T-celllevels (Stein et a/., 
1992; Kaplan et a/., 1995; Enger et a/., 1996; USPHS/IDSA, 1996). The rate of 
CD4+T-cell decline varies considerably from person to person and is not constant 
throughout all stages of HIV-infection. Koot et a/. (1996) reported that acceleration in 
the rate of decline of CD4+T-cell numbers heralds the progression of the disease. 
According to Koot et al. (1996), the virological and immunological processes that take 
place during the point of onset of a rapid fall in CD4+T -cell count are poorly 
understood. However, they are believed to be associated with increasing rates of 
HIV-1 replication in-vivo and declining cell-mediated immune response. 
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2.8.3.2 Progression of HIV to AIDS 
In developed countries , the average time for adults to develop AIDS after initial HIV-
1 infection is about 10-12 years in the absence of antiviral therapy. However, some 
individuals (20%) manifest full-blown AIDS within five years of infection, whereas 
others «5%) have sustained long-term (>10 years) asymptomatic HIV-1 infection 
without significant decline in CD4+T-cell counts. As Haynes et al. (1996) observed, 
about 2% of HIV-1 infected persons seem to be able to contain viral replication to 
extremely low levels and maintain stable CD4+T-cell counts within the normal range 
for lengthy periods (12-15 years). Also, within this group, very rare individuals are 
infected with HIV-1 variants harbouring genetic defects. Most instances of slowly 
progressive or apparently non-progressive HIV infection are believed to result from 
more effective host antiviral immune responses. These individuals tend to have 
active reactive cytotoxic T-cell responses against HIV-1 infected cells (Haase, 1999). 
2.8.3.3 Inheritance of Specific Gene 
Inheritance of a specific gene other than the HLA gene has also been implicated in 
the rate of progression of HIV-1 disease. Researchers are uncertain as to whether 
the CD4+T -cells from different individuals vary in their susceptibility to the cytopathic 
effect of HIV-1 infection. However, few people who are not infected with HIV-1 
despite multiple exposures to the virus, display higher levels of J3-chemokine 
production and altered expression of the specific chemokine receptors, for instance 
CCKR-5 that serve as co-receptors for entry to HIV-1 into target cells (Paxon et aI., 
1996; Pakker, 1998). 
2.8.3.4 Age 
Stein et a/. (1992) and Darby et al. (1996) reported that the age of people living with 
HIV-1 infection could influence the rate of progression to AIDS and this suggests that 
the regenerative capacity of the host immune system (known to decline with age) 
may equally determine the integrity of the immune system (how it resists or repairs 
the damage caused by HIV-1 infection). 
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2.8.3.5 Environmental Factors 
Environmental factors , particularly the ones leading to activation of the immune 
system, may affect the rate of HIV-1 induced immunosuppression (Ho et al., 1995; 
Hu et al., 1996; Oguntibeju et al., 2002). Exposure to environmental antigens may 
activate HIV-1 replication, thereby increasing immune damage and enhancing 
progression of HIV-1 infection (Ho et al., 1995). The authors also believe that current 
HIV-1 replication in the presence of an active but incompletely effective host antiviral 
immune response may partly be responsible for secondary manifestations of the HIV-
1 disease. Similar to the above, Kuritzkes (1999) and MacDougall (1997) argued 
that viral attributes such as cytopathicity, replicability, syncytiality, cell tropism, 
virulence and viral load, apoptosis, antigenic dominance or competition, induced or 
random viral escape mutants, autoreactive cells of CDS+ or CD4+ phenotypes and 
inhibition of the production of pre-cursor cells, are sufficient to explain the 
pathogenesis of HIV. 
2.9 The Immune System 
2.9.1 Introduction 
The healthy human body continually comes into contact with micro-organisms and 
other environmental assaults capable of causing diseases. Despite these constant 
challenges, infection and diseases are usually prevented (Rice, 2000). The 
mechanism by which the body protects or defends itself from these environmental 
assaults constitutes the body's immune system (Cheesbrough, 1992; Haase, 1999). 
2.9.2 Classification of Immune System 
There are two types of immune responses: non-specific and specific. Specific 
immune responses are further divided into two types: cell-mediated and humoral 
(Turk et al., 1993; Feinberg, 1995). The immune system, although classified into 
natural immunity and acquired immunity for the purpose of clarity, are not separate 
systems working on their own. Both work together with some interaction, for example, 
macrophages present antigen to the T-Iymphocytes and in turn trigger B-Iymphocytes 
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to produce antibodies and other specific T -lymphocytes (Cheesbrough, 1992; 
Bartlett, 1998). 
2.9.2.1 Natural Immunity 
Natural immunity is provided by all the mechanisms that form an immediate non-
specific barrier to infection. They consist of mechanical barriers, chemical barriers, 
phagocytosis and antimicrobial commensal flora (Turk et al., 1993; Fox, 1996; Koot 
et al., 1996). 
2.9.2.2 Acquired Immunity 
Acquired immunity refers to all the mechanisms that are involved when the body 
actively responds to a foreign substance such as an infecting organism. This specific 
immunity has the hallmark abilities of learning, adaptability and memory. It learns to 
recognize a foreign body, adapt to response and remembers it, as it were, for a much 
more rapid response when next it encounters the same micro-organism 
(Cheesbrough, 1992; Turk et al., 1993). The first immune response may take some 
2-3 weeks and in some severe diseases death may occur within that time. The 
subsequent responses are usually rapid within that period of time. Studies have 
shown that acquired immunity is composed of two different systems, namely: 
(i) Humoral (soluble) immunity 
(ii) Cellular (cell-mediated) immunity 
Both systems rely on the body's ability to differentiate between self (part of the body) 
and non-self (foreign substances), determined by major histocompatibility and relies 
on the supply of stem cells from the bone marrow (Cheesbrough, 1992; Nowak , 
1997). 
(i) Humoral Immune Response 
The response of the humoral system to a non-self antigen is complex and requires 
co-operation between macrophages (antigen presenting cells), T-Iymphocytes 
(regulatory cells) and B-Iymphocytes (producers of antibody). B-Iymphocytes have a 
certain antibody (immunoglobin) on their surface. When a non-self antigen 
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associated with macrophages and T-Iymphocytes meets a B-Iymphocyte with the 
corresponding specific antibody, the antigen will combine with this antibody 
(Cheesbrough, 19992; McCune, 2001). A rapid cell division then takes place in 
which more identical B-Iymphocytes are formed and plasma cells are formed that 
produce and release specific antibodies into the blood stream to react with the non-
self antigen. Each plasma cell produces one type of antibody (Cheesbrough, 1992; 
Turk et a/., 1993; Weir, 1993). 
(i i) Cellular Immunity 
This is mediated by T -cells that mature, acquire functional repertoires and learn the 
concept of self in the thymus. They have antibody-like binding sites on their cell 
surface that bind specifically with non-self antigen (Cheesbrough, 1992; Turk et al., 
1993). Cellular imrnunity and T-Iymphocytes are mainly involved in reactions against 
non-self antigen on or in body cells , for instance they react with cells that contain 
micro-organisms. This is particularly important in viral infections (Weir, 1993; 
McCune, 2001). 
2.9.3 The Immune Response to HIV-1 
The major factor obstructing progress towards an effective vaccine to prevent or 
modulate HIV-1 infection is that the critical features needed for a protective immune 
response are not fully understood (Martin, 2000). Although, it has been found that 
potent neutralizing antibodies can protect against experimentally acquired HIV 
infection in animal models, they are scarcely generated in vivo in the infected person 
and neutralization resistant viral variants have been noticed to develop rapidly in 
chronic infection. It is generally believed that cellular irnmune responses, particularly 
specific cytotoxic T Iyrnphocytes (CTL), are important in the host response to HIV-1 
infection (Paxon et al., 1996), Paxon et al. (1996) observed that CTL develop very 
early in acute HIV-1 infection, coincident with a rapid fall in plasma vireamia, whereas 
in chronic infection their levels are inversely related to viral load. However, the 
powerful HIV-specific CTL response ultimately fails to control HIV replication. This 
could be due to the emergence of viral variants that escape CTL recognition or 
impairment of CTL function (Allen , 2000). 
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2.9.3.1 Progressive Destruction of the Immune System in Advanced HIV 
Infection 
In the absence of suppressive antiviral therapy, HIV infection advances and 
progressively infects more cells in the follicular dendritic cell (FDC) network, resulting 
in the destruction of lymph node architecture. This promotes the release of more 
viral particles into the circulation (SAHIVCS, 2001). The release of HIV into 
circulation causes CD4+T -cells to be infected and destroyed at a faster rate than they 
can be replaced, thereby shifting the dynamic equilibrium in favour of the virus (Wei 
ef al., 1993; Ho ef al., 1995; Chun, ef al., 1997). Recent studies have shown that an 
important cause of declining CD4+T-cell counts is the failure of the regenerative 
capacity of the immune system to produce immune cells (Ho ef al., 1995). This is a 
result of HIV infection of precursor stem cells and is also due to failure of 
"programming" of CD4+T-cells in the HIV-infected thymus gland. This culminates in 
the destruction of the immune system and consequent failure to mount immune 
responses that are adequate to prevent opportunistic infection andlor neoplasmic 
disease (Wei ef al., 1993; Ho et al., 1995; Roederer, 1995). 
2.9.4 CD4"'-cell and its Signif icance 
2.9.4.1 Introduction 
CD4+ is a molecule found primarily on the surface of helper T-Iymphocytes. The 
designation CD stands for "Cluster of Differentiation" and refers to a nomenclature 
applied by immunologists who are all involved in the business of generating 
monoclonal antibodies against surface proteins of blood cells as a means of 
identifying the surface proteins and studying them. When a "cluster" of monoclonal 
antibodies (antibodies produced in-vitro by single clones of B-Iymphocytes) is found 
to react with the same protein, it represents a group of reagents defining a specific 
marker and that marker is given a CD number (SAHIVCS, 2001). 
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2.9.4.2 Functions of CD4+T-cell 
The CD4+ molecule is also the main receptor involved in combating HIV-1 infection 
and docks with the 120 glycoprotein found on the envelope of the HIV-1 viral particle. 
The CD4+T-cell has a central and coordinating role in the immune response (Hughes 
et al., 1997). These cells, also known as T4 or helper/inducer T lymphocytes, 
recognize antigens presented by cells bearing HLA class 11 molecules such as 
monocytes and macrophages. The CD4+molecule helps to stabilize the binding of 
these T-lymphocytes to the HLA 11 molecule on the antigen-presenting cell (Wilson, 
1990). Once an antigen is recognized, CD4+T lymphocytes orchestrate the body's 
antigen-specific immune response. Specific functions of CD4+ T lymphocytes include 
the following: (1) coordinating B-lymphocyte production of antibodies to these 
antigens; (2) producing cytokines, and (3) induction of cytotoxic lymphocytes. These 
functions make CD4+ T lymphocy1es critical elements of the immune system and their 
dysfunction and destruction in HIV-1 infection seriously impairs the ability to respond 
to diverse pathogens (Bowen et al., 1995; SAHIVCS, 2001). 
2.9.4.3 Dynamic Equilibrium between CD4+T-cell Production and Clearance 
The initial process in the life cycle of HIV infection is the binding of HIV glycoprotein 
(pg120) that is present on the surface of the virus to CD4+ molecule (Dalgleish & 
Colizzi, 1992; McDougal et al., 1996; Bentwich et a/., 1999). Once the virus gains 
entry into the cell, it begins the process of viral replication following binding to CD4+T-
cell and fusion with the cell membrane. A direct cytopathic effect of HIV on CD4+T-
cells may occur via the destruction of the cell membrane that is subsequent to 
massive viral budding (Rowland-Jones et al., 1997; Denny et al., 1998), the presence 
of large amounts of non-integrated viral DNA, heterodisperse RNAs and viral core 
proteins in the cytoplasm of the infected cell that interferes with proper cell function, 
and the complexing of HIV gp120 with intracellular CD4+ molecules (Rosenberg and 
Fauci, 1990; Weiss, 1996; Hughes et al., 1997). 
The depletion of CD4+T-cells may also be due to the destruction of precursor cells 
that give rise to CD4+T-cells in vivo or cells which produce factors essential for 
CD4+T-cell grow1h (Rosenberg & Fauci, 1990). An alternative mechanism for CD4+T-
26 
© Central University of Technology, Free State
cell depletion involves the formation of short-lived multinucleated giant cells or 
syncytia between an HIV-infected CD4+T-cell and a cluster of uninfected CD4+T-
cells. It has been estimated that between 100 million and 10 billion virus particles are 
produced and cleared every 24 hours. Thus, virus production occurs not only during 
the primary and advanced stages of the disease (typically symptomatic) but also 
during the intermediate stage of the infection (the virus is not truly latent) (D'Souza & 
Haden, 1996; Wong et a/., 1997). At the intermediate stage of HIV infection, levels of 
the virus in the plasma are the result of a dynamic equilibrium between the 
production of HIV and its clearance by the immune system. In this continuous 
turnover of the virus population, about 50% of the circulating virus is suggested to be 
replaced with newly produced virions daily (Young, 1997). The extensive production 
of HIV is closely related to the destruction and replacement of CD4+T-cells. 
Scientists have estimated that the half-life of HIV-producing CD4+T-cells is about 1.2 
days and between 1-2 billion new CD4+T-cells are produced every day (Pantaleo et 
a/., 1998). There appears to be a difference between the half-lives of various 
populations of HIV-infected cells. It is said that productively infected CD4+T-cells 
constitute a short-lived population (about 1.2 days), while other HIV-infected cells, for 
instance macrophages, constitute a long-lived population with an average half-life of 
14 days (Young, 1997; Wong et a/., 1997; Pantaleo et a/., 1998). 
2.9.4.4 HIV Attacks the Immune System via the CD4+T-cell 
HIV attacks the immune system by targeting the heart of the immune system, the 
CD4+T-cells which are the conductors of the immune system. When a pathogen is 
introduced into the body as either a virus or a bacterium, it is first recognized by 
CD4+T-cells. The CD4+T-cells are responsible for coordinating each of the host 
immune defences, namely the killer cells, the antibodies and the phagocytes that will 
eliminate the pathogens (Autran & Katlama, 2000). However, if the CD4+T-cells are 
destroyed, the immune defences that remain become less functional and are unable 
to eliminate the pathogens and the latter can proliferate to cause disease (Autran & 
Katlama, 2000). In the body, HIV is replicating in its niche, which is the memory 
CD4+T-cells-the cells that are very actively mobilized against the most current 
infections. Each time a memory CD4+T/cell is infected by HIV and each time HIV is 
replicating in a memory CD4+T-cell, this cell dies and is eliminated. In the healthy 
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young adult or at the beginning of the HIV infection, these dying memory CD4+T-cells 
are replaced by a constant source or a reservoir of na'ive CD4+T-cells originating 
from the thymus, It is reported that during the course of HIV infection, about one 
billion HIV particles are produced per day, resulting in increasing numbers of infected 
CD4+T-cells, The infection spreads in the memory cells, in the na'lve CD4+T-cells 
and in the thymus; the source is therefore progressively exhausted, surpassing the 
capacity to produce new CD4+T-cells (Autran, 2000), 
Scientists have observed that progressive loss of CD4+T -cells is the cardinal 
manifestation of the effects of HIV infection, The CD4+T-cell count can therefore 
serve as a useful indicator of the severity of the infection, providing both a convenient 
measure of immunological status and giving some indication of the risk of 
opportunistic infections and neoplasia, particularly in individuals who have already 
begun to show a substantial CD4+T-cell decline, The CD4+T-cell count indeed has 
considerable importance in some systems used to stage HIV infection and by 
implication the guidance of treatment decisions, It is particularly important in 
determining whether it is appropriate to initiate prophylactic therapy for opportunistic 
infections (8agasra et ai" ~ 1992; Hughes et ai" ~ 1997), The significance of the 
destruction of CD4+T-cells in an HIV-infected person becomes evident when their 
functions are considered, 
2,9,4.5 CD4+T-cell Depletion in HIV Disease 
In many parts of the world, most of the time, infection with the HIV leads to death if 
not treated, In time, it became clear that the virus could replicate within human 
CD4+T-cells in vitro, that the viral envelope protein could bind to CD4+T-cell and 
circulating CD4+T-cells decreased in number as the disease progressed (Martin, 
2000), It was also apparent that CD4+T-cells were crucial in coordinating cellular and 
humoral immune responses against exogenous antigens, As a result of these 
observations, it was not difficult to imagine that HIV-associated immunodeficiency 
was due to virally mediated destruction of CD4+T-cells (McCune, 2001), 
(i) Evidence for CD4+ T-cell Depletion 
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There is a growing realization that the T -lymphocyte compartment is comprised of 
multiple subpopulations and that there are inadequate means by which to monitor the 
relative growth, death and movement of these sub populations in an individual patient 
over time. The definitio'n of CD4+T-cell loss in HIV disease thus remains unclear 
(McCune, 2001). Most researchers agree that HIV infection results in the 
progressive loss of CD4+T-cells from circulation as well as the depletion of CD4+T-
cells from total body stores (Haase, 1999; Wong et a/., 1997; Martin, 2000). 
Quantitative estimates, using a variety of assumptions, indicate that the normal 
young «30 year old) adult harbours about 2 x 1011 mature CD4+T-cells (Haase, 
1999). In the HIV-infected patient, this total number is halved by the time the 
peripheral blood CD4+T-cell count falls to 200 cells/ml. As the HIV infection 
progresses to a more advanced stage, destruction of parenchymal lymphoid spaces 
is so extensive that enumeration of the total body CD4+T -cell count has not been 
attempted. With further disease progression, there is also a decrease in the 
proportion of resting na'lve (CD45RA+CD62L+) T-cells and an increase in the 
proportion of activated memory/effector (CD45RO+) T cells; concomitantly, the T-cell 
receptor (TCR) repertoire is both perturbed and restricted. Among those cells that 
persist, many may be dysfunctional. 
In summary, HIV induces both quantitative and qualitative defects in the CD4+T-cell 
compartment and the circulating CD4+T-cell count continues to be one of the best 
surrogate markers by which to gauge prognosis in late infection and to trigger 
treatment interventions (Haase, 1999; McCune, 2001). 
(ii) Possible Causes of CD4+ T-cell Depletion 
Several mechanisms have been proposed to explain HIV-mediated depletion of 
CD4+T-cells. All are based on experimental observations (Martin, 2000; McCune, 
2001). The total body CD4+T-cells may be depleted in absolute number because 
they are destroyed or because their production is impaired. In addition, the fraction 
of circulating cells may decrease if viral infection results in their redistribution out of 
the intravascular space and into the confines of lymphoid organs (McCune, 2001; 
SAHIVCS, 2001). 
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The balance of destruction and production is one important factor that can be 
explained by multiple mechanisms. It is possible, for example, that CD4+T-cell 
depletion is related directly to the virally mediated destruction of infected cells. On 
the other hand, physiological responses to HIV infection might initiate events that 
result in the destruction of un infected cells. In either case, loss of mature cells 
should be compensated for by increased production of new cells and mature CD4+T-
cell depletion should occur only if cells lost in the periphery cannot be replaced . The 
devastating feature of HIV infection is that the virus can have direct and indirect 
pathogenic effects on both mature CD4+T-cells and on the progenitor cells from 
which they arise (McCune, 2001). 
(a) Accelerated Destruction of Mature CD4+T-cells 
Early experiments done with laboratory-adapted HIV isolates in tissue culture 
revealed a cytopathic virus with exquisite tropism for CD4+T-cells. The provision of 
potent (protease inhibitor-containing) antiretroviral medications to patients with 
advanced HIV disease caused the viral load to drop and the CD4+T-cell count to rise. 
By making reasonable and largely accepted assumptions about T-cell distribution 
and by assuming that antiretroviral therapy does not alter the production rate of T-
cells, the statement was interpreted to mean that, before therapy, continuous rounds 
of infection sustained the viral load and that as many as 2 x 109 infected CD4+T -cells 
were destroyed per day. By extension, HIV disease is a high state, accelerated 
destruction of mature CD4+T-cells and leads to eventual exhaustion of the immune 
system (Ho et al., 1995; Wei et aI., 1993). In HIV-infected human subjects, 
quantitative image analysis revealed decreased numbers of CD4+T-cells and 
increased levels of cellular proliferation and apoptosis in lymphoid tissue (Ho et al. , 
1995; McCune, 2001). 
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(b) Chronic Activation and CD4+T-cell Death 
It is agreed that CD4+T-cell death may occur in un infected cells as a by-product of 
HIV infection of other cells. According to Grossman & Herberman (1997), HIV 
disease is typified by a state of chronic activation driven in part by the antigenic 
stimulus of HIV and in part by an antigen-independent mechanism. For instance, 
cytokines are released by apoptotic cells and activated T -cells. Multiple bursts of 
activated cells spread throughout the body and would be characterized by apoptotic 
cell-mediated activation of resting lymphocytes, cytokine-driven expansion of 
responding cells and contraction of the responding population by activation-induced 
cell death . It is believed that if apoptotic cells are infected by or otherwise carry HIV, 
antigen-specific cell activation could support virus dissemination to responding 
CD4+T-cells, irrespective of their TCR specificity (Pope, 1994). 
Reciprocally, the virus may be spread upon activation of non-productively infected 
CD4+ memory T-cells in the context of immune responses to HIV or other antigens. 
During the asymptomatic phase of infection, when the fraction of infected cells is 
much lower than the fraction of activated cells , these bursts would predictably 
continue in a local , recurrent and asynchronous fashion, and CD4+T-cell depletion 
might be driven by several mechanisms (Bentwich et al., 1999). It has been 
suggested that the relentless activation of na"ive cells into the activated/memory pool 
may not be fully compensated for by replenishment of new na"ive cells from the 
thymus or by the generation of viable memory cells (Hazenberg et al., 2000). 
Altematively, chronic stimulation of resting T -cells might have a negative effect on the 
homeostatic regeneration of these cells. The relevance of this process to CD4+T-cell 
depletion is underscored by the observation that disease progression is associated 
with immune activation and vice versa (Wilson, 1990; Bentwich et al., 1999). 
(c) Impaired Production of New CD4+T-cells 
This mechanism focuses on mature CD4+T -cells, but these cells are often derived 
from early progenitors that may also express CD4+T-cells . Such progenitors, 
including multi-lineage and lineage-restricted haematopoietic progenitor cells are 
uniquely endowed with the capacity to persist with long half-lives and to generate 
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large numbers of differentiated progeny rapidly upon stimulation. If these cells are 
destroyed or rendered non-functional, mature progeny could not be made (McCune, 
2001). Evidence for suppression of multi-lineage and lineage-specific 
haematopoiesis has been available since the beginning of the AIDS epidemic 
(Pakker, 1998). 
Laboratory findings showed that when late-stage patients initially presented with 
opportunistic infections, they were not just Iymphopenic, but anaemic, neutropenic 
and thrombocytopenic as well. These findings led to multiple diagnostic bone-
marrow biopsies, the results of which were frequently abnormal. Microscopic 
examination revealed hypercellularity or hypocellularity, plasmacytosis, myeloid or 
erythroid dysplasia and a variety of other pathological changes (McCune & 
Kaneshima, 1995). Phenotypic and functional analysis of bone-marrow progenitor 
cells showed a decrease in the number of lineage-restricted colony-forming units and 
in some, but not all instances, infection and/or apoptotic death of CD4+T -cell 
progenitors. Although the mechanisms associated with such cytopenias remain 
unclear, they are often reversed upon the provision of effective antiretroviral therapy 
(Fleury, 1998). 
The thymus, housing many CD4+T-cells in varying stages of maturation, is another 
critical target organ for HIV infection. Examination of paediatric and adult specimens 
has revealed thymocyte depletion, loss of corticomedullarY demarcation and 
development of thymic medullary B-cell follicles. These changes are associated with 
immunohistochemical visualization of structural proteins within thymocytes and are 
evidence of viral replication . Although it has proven difficult to study the thymus in 
HIV-infected humans, the frequency of circulating CD4+ and CD8+ na'ive T-cells have 
been found to decrease as disease progresses (Roederer, 1995). In addition, cells 
bearing TCR excision circles also decrease in frequency with age and as a function 
of HIV disease progression (Zhang, 1998). In return, signs of thymopoiesis return 
after treatment of some individuals with effective antiretroviral therapy particularly if 
they are younger and have evidence of plenty thymocytes by computed tomography 
(Zhang, 1998). It has also been noticed that peripheral lymphoid organs undergo 
marked alterations after HIV infection. These changes include the accumulation of 
virus on and eventual destruction of the follicular dendritic cell network, 
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decompartmentalisation and depletion of both the CD4+ and CD8+T- cell populations. 
Thus. HIV infection leads to profound disruption of the bone marrow. thymus and 
peripheral lymphoid organs and. where measurable. quantitative and qualitative 
defects in important CD4+T progenitor cells (Roederer. 1995). With these cells 
eliminated or no longer functional . the immune system cannot be sustained . 
2.9.4.5 CD4+T-cell Count and Prognosis 
The CD4+T-cell count has been shown in numerous cl inical trials and natural history 
studies to be an independent risk factor for progression to AIDS and death. 
However. it has two major limitations: it is subject to considerable variation. for 
instance. inter-assay variability. diurnal variation. changes due to inter-current illness 
and thus it reflects existing damage to the immune system (Mellors et al .. 1995). 
2.9.5 Significance of Viral Load 
Research studies have demonstrated that persons with symptomatic HIV infection or 
AIDS have significantly a higher titres of plasma HIV RNA than those with 
asymptomatic infection. It is also true from these studies that those with a high viral 
load have greater risk of disease progression than those with a lower viral load 
(Metcalf et al. , 1997). It has been estimated that individuals who have plasma HIV 
RNA levels> 100 000 copieslml within six months of sero-conversion are 10 times 
more likely to progress to AIDS within 5 years than those with plasma HIV RNA 
levels <100000 copies/ml (Saag et al .. 1996). In one study. the median survival time 
among individuals with baseline plasma HIV RNA levels >36 270 copies/ml was 5.3 
years, and that among individuals with plasma HIV RNA levels < 4 500 copies/rnl 
was >10 years (Hughes et al .. 1997). 
2.10 Nutrition and the Immune System 
2.10.1 Introduction 
It is generally accepted that 
responses (Chandra. 1997). 
nutrition is an important determinant of immune 
Results from epidemiological and clinical studies 
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suggest that nutritional deficiencies alter immuno-competence and increase the risk 
of infection. It is agreed that poor sanitation and personal hygiene, overcrowding, 
contaminated food, water and inadequate knowledge of nutrition contribute to 
susceptibility to infection. Previous research findings have confirmed that impaired 
immunity is a critical adjunct factor in malnutrition-associated infection. This concept 
does not only apply to people in developing countries but to people (all age groups) 
in all countries (Chandra, 1991; Chandra, 1996; Chandra, 1997; Bell ef al., 1997; 
Bogden ef al., 2000). 
Adherence of bacteria to epithelial cells is an essential first step before invasion and 
infection can take place. The number of bacteria adhering to respiratory epithelial 
cells has been shown to increase in malnutrition as documented by Chandra (1997). 
2.10.2 Role of Micronutrients in the Immune System 
Several trace elements and vitamins have essential roles in metabolic pathways and 
immune cell functions. The deficiencies of these micronutrients have been noted and 
are known to complicate malnutrition and other systemic diseases. Likewise, human 
malnutrition is usually a composite syndrome of multiple nutrient deficiencies 
(Bendich & Chandra, 1990; Baum & Shor-Posner, 1998; Dannhauser ef al. , 1999; 
Bogden ef al. , 2000). Five general concepts have been advanced: (1) Alterations in 
immune responses occur early in the course of reduction in micronutrient intake. (2) 
The extent of immunological impairment depends on the type of nutrient involved, its 
interactions with other essential nutrients , the severity of the deficiency, the presence 
of concomitant infection and the age of the person concerned. (3) Immunological 
abnormalities predict outcome, particularly the risk of infection and mortality. (4) For 
many micronutrients, excessive intake is associated with impaired immune 
responses. (5) Tests of immuno-competence are useful in titration of physiological 
needs and in assessment of safe lower and upper limits of micronutrient intake 
(Chandra, 1997; Dannhauser ef al., 1999). An established effect of nutrition on 
immunity has led to several practical applications and its usefulness is still relevant 
today. 
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2.10.3 Nutrition and HIV Infection 
The relationship between nutrition and HIV/AIDS is well recognized. In fact, in Africa 
AIDS was initially known as "Slim Disease" because of the classical wasting typically 
experienced by persons with the disease (Piwoz & Preble, 2000). HIV infection 
compromises the nutritional status of infected persons and in tum poor nutritional 
status can affect the progression of HIV infection (Friis & Michaelsen, 1998; 
Niyongabo et a/., 1999; Piwoz & Preble, 2000; Fawzi, 2003). 
From a clinical view, infections may affect the nutritional status of an individual 
suffering from HIV/AIDS in various ways, such as a reduction in food intake and 
nutrient absorption and by increasing the utilization and excretion of proteins and 
micronutrients (Semba & Tang, 1999). It has also been observed that HIV infection 
accelerates the release of pro-oxidants, cytokines and other reactive oxygen species, 
leading to the increased utilization of antioxidants such as vitamin E, C, beta-
carotene and micronutrients such as iron, zinc, selenium, manganese and copper 
(Friis & Michaelsen, 1998). An imbalance between these pro-oxidants and 
antioxidants causes oxidative stress which further damages the cells, proteins and 
enzymes, thus accelerating HIV replication (Schwartz, 1996). 
It has been shown that deficiencies of nutrients may affect the immune function in 
ways that may influence viral expression and replication, which further affect 
progression of HIV disease and mortality of the patient (Semba & Tang, 1999). 
Hormones such as glucagons, insulin, epinephrine and cortisol which are involved in 
the metabolism of protein, carbohydrate and fat, have been reported to be affected 
by HIV infection (Macallan, 1999). Increased levels of these hormones is believed to 
contribute to weight loss and the wasting syndrome seen in HIV/AIDS patients 
(Macallan, 1999; Piwoz & Preble, 2000). Research studies have confirmed that 
nutrient deficiencies are associated with immune dysfunction and accelerated 
progression to AIDS (Fawzi & Hunter, 1998; Macallan, 1999). Furthermore, 
deficiencies of protein and essential fatty acids interfere with immune function . 
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2.10.3.1 Diet and Nutrition in Africa: Current Status 
Certain foods are preferentially utilized in specific African countries and communities 
(Watson, 1994). The important staple foods eaten by Africans and the protein-
energy percentages of these staples are: wheat (11 %), millet (12%), rice (8%), maize 
(10%), yam (6%), plantain (4%) and cassava (3%) (Watson, 1994). The major meals 
are bulky and the amount of staple food usually consumed per average person per 
day does not provide the recommended daily allowance (RDA) of energy, protein and 
other essential nutrients (Hiel et al., 1982; Enwonwu, 1992; Moore et al., 1997 & 
1998). 
These traditional foods are often prepared and served under poor hygienic 
conditions, thus setting the stage for repeated episodes of diarrhoea, thus 
aggravating the poor nutritional status (Abrams et a/., 1993; Anyanwu & Enwonwu, 
1995). For most African countries, the first decade of the HIV/AIDS epidemic was a 
period of severe economic crisis characterized by an unsustainable foreign debt 
burden, monetary devaluation and ten-to twenty-fold rise in consumer price indices. 
Reports have linked malnutrition with HIV infection and AIDS, hence it is appropriate 
to examine malnutrition in Africa and its relationship with HIV infection and AIDS. 
2.10.4 Malnutrition 
Improving the nutrition situation in Africa has been a challenge for decades, 
complicated by a combination of individual, household, community, national and 
international factors, including, in the last two decades, the emergence of HIV 
infection and AIDS (Castetbon et al., 1997; Piwoz & Preble, 2000). It has been 
reported that disease, cultural beliefs and customs, high fertility rates, poor economic 
status and limited access to health and other social services also contribute to 
chronic, endemic malnutrition on this continent (Ndure et a/., 1999). Malnutrition is 
said to take many forms . These include protein-energy malnutrition (measured in 
terms of body size) and micronutrient malnutrition, which in its mild and moderate 
forms is not always recognized and is often referred to as "hidden hunger" (Ndure et 
al., 1999). 
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Ndure ef al. (1999) reported that deficiencies in vitamins and minerals such as 
vitamin A, B complex, iron and iodine, that are vital for the body's normal function 
and immune system, occur in populations with high infectious disease burdens. 
These deficiencies have been associated with poor quality diets characterized by 
limited consumption of animal products and seasonal or periodic food insecurity. 
Recent data suggest that little or no progress has been made in reducing the 
malnutrition in sub-Saharan Africa in the last twenty years (Watson, 1994; Niyongabo 
ef a/., 1999; Piwoz & Preble 2000. It is also indicated that, in several countries, 
malnutrition is increasing as a result of armed conflicts, deteriorating health systems, 
shrinking economies and HIV/AIDS (Murray & Lopez, 1996). 
Malnutrition among African people and especially among women of childbearing age 
is also a serious problem, with an estimated 42% of African women as a whole and 
half of the pregnant women suffering from anaemia (ACC/SCN, 2000). Between 
10% and 20% of Africans between the ages of 20 to 49 years are underweight and 
nearly 50% of the African population is at risk of developing micronutrient deficiency 
diseases (Baker ef al., 1996; Mocroft ef a/., 1999). The consequences of malnutrition 
include acquisition of some kinds of infections as well as reduced labour productivity 
(Baker ef al., 1996). 
2.10.4.1 Pathogenesis of Malnutrition in HIV/AIDS 
Food intake is inhibited indirectly in patients with malabsorption, resulting from 
different diseases or systemic infections due to the release of specific factors that 
inhibit appetite at the central nervous system level (Wheeler ef al., 1998; Kotler ef al., 
1999). These problems may be exacerbated by economic factors or other 
impediments to obtaining food (Kotler, 1992). 
(i) Localized Pathology and Nutrient Malabsorption 
Watson (1994) indicated that oesophageal ulcers of viral, mycobacterial and 
neoplastic varieties were known to affect food intake. Anorexia may be a side effect 
of various medications. It is also known that neurological disease may impair 
appetite or produce swallowing disorders. There is also evidence that unabsorbed 
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micronutrients such as vitamin A, zinc and iron in the lower bowel (ileum and colon) 
are associated with signals that decrease appetite (Hecker & Kotler, 1990). 
Repletion of body cell mass through effective treatment of disease and by proper 
nutrition is an important consideration, although repletion is difficult, if not impossible, 
in patients with untreated serious disease complications (Watson, 1994). 
(ii) Weight loss & lean Body Mass 
The importance of this progressive condition has been reinforced by the expansion of 
the AIDS case definition to "HIV Wasting Syndrome" by the Centers for Disease 
Control and Prevention (Watson, 1994). Weight loss as well as low serum albumin 
levels are predictive of an increased risk of morbidity and mortality in hospitalized 
patients. Studies have established that the frequency of complications from 
malnutrition increases sharply when serum albumin levels fall below 30 gIl (Trujillo et 
al., 1992; Babamento et al., 1994; Macallan, 1998). 
HIV/AIDS patients typically lose 46% of their potassium by the time of death , and this 
potassium is lost over the last nine months of life. The patients also lose 34% of their 
ideal body weight during the last 4 to 5 months prior to death (Babamento et aI., 
1994). 
In a study reported by Watson (1994), lean body mass (estimated from the 
potassium pool) was greater than the loss in body weight. The amount of lean body 
mass is sufficient in itself to be the cause of death . World War 2 era starvation 
studies point out that loss of less than 40% of body weight resulted in death (Watson, 
1994). Studies of body composition in AIDS patients demonstrate that body cell 
mass depletion is out of proportion to losses of body weight or fat and findings 
indicated that nutritional support can improve the nutritional status of HIV/AIDS 
patients (Watson, 1994; Piwoz & Preble, 2000). 
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(iii) Relationship between HIV/AIDS & Malnutrition 
The epidemiology of malnutrition and of infectious diseases is intermingled 
particularly in impoverished communities in the Third World (Maletnlema, 1991; 
Scrimshaw & SanGiovanni , 1997). The relationship between HIV/AIDS and 
malnutrition presents a classical example of the well-recognized "vicious cycle" of 
immune dysfunction, infectious diseases and malnutrition. Changes in the immune 
function due to malnutrition are strikingly similar to those induced by HIV/AIDS. In 
fact, for many years, the impairment to immune function caused by malnutrition has 
been referred to as the "Nutritional Acquired Immune Deficiency Syndrome" or 
NAIDS (Savage & Burgess, 1995; Piwoz & Preble, 2000). Since normal immune 
function is dependent on good nutritional status, some researchers have come 
forward with the hypothesis that malnutrition is the predominant underlying cause for 
the full clinical expression of AIDS in HIV-seropositive persons (Maletnlema, 1991; 
Piwoz & Preble, 2000). According to these authors, inadequate nutrition may 
influence specific systems involved in the progression from asymptomatic HIV 
infection to the full-blown condition of AIDS, as well as intensify the susceptibility to 
opportunistic infections, and may also contribute to the severity of HIV-related 
disease (Kelly et al., 1999). Malnutrition has clinical and social implications and is 
thus examined below. 
(a) Clinical Implication 
Long before the AIDS epidemic emerged in Africa in the early 1980s, the synergistic 
interactions between infections, nutritional status and immune function were 
recognized . Infectious diseases, no matter how mild, influence nutritional status and 
conversely, almost any nutrient deficiency, if sufficiently severe, will impair resistance 
to infection (Scrimshaw & SanGiovanni, 1997). The physical environments contain 
infectious microbes including viruses, bacteria and fungi. These are often more 
prevalent in Africa than in industrialized countries. In healthy individuals, the immune 
system protects the body from damage by these microbes. It has been noted that 
people with HIV/AIDS, whose immune systems are compromised, have difficulty in 
resisting a variety of serious infections (Piwoz & Preble, 2000). HIV acts by 
replicating inside host cells. To eliminate the infection, the immune system must 
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recognize and destroy these infected cells. The cells that mediate immunity include 
lymphocytes. Among the lymphocytes, CD4+T-cells (also called T4 cells and T-
helper cells) are critical to the immune system functioning. HIV infection destroys 
CD4+T-cells and leads to a deterioration of the overall immune system (Chandra, 
1997, Martin 2000; Bouic et al., 2001; Fawzi, 2003). 
Infections affect nutritional status by reducing dietary intake and nutrient absorption 
and by increasing the utilization and excretion of protein and micronutrients as the 
body mounts its acute phase response to invading pathogens (Maletnlema, 1991; 
Chandra, 1997). Infections also result in the release of pro-oxidant cytokines and 
other reactive oxygen species. This leads to the increased utilization of anti-oxidant 
vitamins, for example vitamins E, C and beta-carotene as well as sequestration of 
several minerals that are used to form anti-oxidant enzymes (Friis & Michaelsen, 
1998). 
(b) Social Implication 
Malnutrition associated with HIV infection has serious and direct implications for the 
quality of life of people living with HIV and AIDS (Watson, 1994; Chandra, 1997). 
Weight loss is often the event that begins a vicious cycle of increased fatigue and 
decreased physical activity, including the inability to prepare and consume food 
(Norse, 1991; Babamento & Kotler, 1997; Fawzi & Hunter, 1998). 
Malnutrition associated with HIV/AIDS affects entire families and their dependants 
and they require continuous care during bouts of illness . In parts of Africa where 
farming is a primary occupation and nutritional requirements are usually met through 
local food production, HIV/AIDS among agricultural workers is affecting farm 
incomes, food productivity and nutritional status (Babamento & Kotler, 1997). 
2.11 Nutritional Consequences of HIV Infection in HIV/AIDS Patient 
To understand the relationship between nutrition and HIV/AIDS, one must consider 
the effect of the disease on the body size and composition (weight, lean body mass 
and body cell mass) as well as the effect on the functioning of the immune system. 
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Nutrition plays a role in each of these conditions. One must also keep in mind that 
malnutrition may be a contributor to HIV disease progression as well as a 
consequence of the disease (Baum et a/., 1995; Babamento et a/., 1994; Beck, 2000; 
Piwoz & Preble, 2000). ·In populations in which malnutrition is endemic, body size 
and composition changes associated with protein-energy malnutrition may always be 
associated with deficiencies in vitamins and minerals which are important for the 
functioning of the immune system. 
The wasting syndrome typically found in adult AIDS patients in Africa is a severe 
nutritional manifestation of the disease (Babamento et al., 1994). It has been noted 
that weight loss typically follows two patterns in people living with HIV/AIDS: slow and 
progressive weight loss from anorexia and gastrointestinal disturbances, and rapid, 
episodic weight loss from secondary infections. Observations have also shown that 
even relatively small losses in weight (5%) have been associated with decreased 
survival in individuals with AIDS (Boelaert et al., 1996; Castaldo et al. , 1996; 
Macallan, 1999). Research studies have shown that weight loss and wasting in 
HIV/AIDS patients may develop as a result of three major overlapping processes 
(Babamento et al. , 1994; Keating et al., 1995; Macallan, 1999). These major 
overlapping processes are discussed below. 
2.11.1 Reduction in Food Intake 
This may be due to painful sores in the mouth, pharynx and oesophagus. Some data 
have shown that fatigue and depression, including changes in mental state, may also 
playa significant role by affecting appetite and interest in food (Babamento et al., 
1994). Reductions in food intake are believed to be an important cause of slow and 
progressive weight loss (Abrams et al. , 1993; Macallan, 1999). 
2.11.2 Nutrient Malabsorption 
Malabsorption that accompanies frequent bouts of diarrhoea due to intestinal 
parasites and other pathogens has been reported in people with HIV/AIDS. Some 
HIV-infected individuals have demonstrated increased intestinal permeability and 
other intestinal defects in early infection (Keating et a/., 1995; Macallan, 1999). 
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Malabsorption of fats and carbohydrates has been found to be common at all stages 
of HIV infection in both adults and children (Semba & Tang, 1999). It has been 
pointed out that fat malabsorption, in turn, affects the absorption and utilization of fat-
soluble vitamins. 
2.11.3 Metabolic Alterations 
Changes in metabolism occur during HIV infection from severe reduction in food 
intake as well as from the immune system's response to the infection. When food is 
restricted, the body responds by altering insulin and glucagon production that 
regulate the flow of sugar and other nutrients in the body (Cimoch, 1997). Over time, 
the body uses up its carbohydrate stores from muscle and liver tissue and then 
begins to break down body protein to produce glucose. This process could cause 
protein loss and muscle wasting (Grimble, 1990, Babamento & Kotler, 1997; Cimoch, 
1997). 
Existing studies suggest that infections result in a loss of 0.6 g to 1.2 g of protein per 
kilogram body weight per day in adults when amino acids are mobilized from skeletal 
muscle for gluconeogenesis, synthesis of immune proteins and enzymes in response 
to the release of cytokines (Fawzi & Hunter, 1998). For these reasons, protein 
requirements are substantially higher in HIV-infected individuals than in non-HIV-
infected persons (Fawzi & Hunter, 1998; Scrimshaw & SanGiovanni, 1997). 
2.12 Relevance of Nutritional Factors to the Progression of HIV Infection 
The host's response to infection and inflammatory stimuli is mediated by cytokines 
(Haynes et al., 1996; D'Souza & Harden, 1996). Cytokines are a range of 
polypeptides that have multiple biological activities including enhancing the attraction, 
proliferation. activation and differentiation of white blood cells, as well as mediating a 
wide range of metabolic alterations (Grimble, 1990). Cytokine production and actions 
are affected by malnutrition (Grimble, 1990; Cimoch, 1997). Abnormalities in 
cytokine production characterize HIV infection. Impaired cellular anti-oxidant status 
has been identified as a consistent prominent feature of protein-energy malnutrition 
and other forms of malnutrition. This may playa key role in the rapid replication of 
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HIV in malnourished individuals (Enwonwu, 1992; Semba et a/., 1998; Piwoz & 
Preble, 2000). It has been demonstrated that in a chronically HIV-infected T 
lymphocyte cell line, non-toxic concentrations of ascorbate in the cell culture medium 
reduces the level of extra-cellular reverse transcriptase by 99% and the expression of 
p24 antigen by 90% (Harakeh et a/., 1990). 
2.12.1 The Role of Vitamins and Minerals in HIV/AIDS Patients 
Many vitamins and minerals (also referred to as micronutrients) are important to the 
HIVlnutrition relationship due to their critical roles in cellular differentiation, enzymatic 
processes, immune system reactions and other body functions (Fawzi & Hunter, 
1998). The role of micronutrients in other infectious diseases such as measles, 
diarrhoea and respiratory infections has been extensively studied and it is known that 
several vitamins and minerals are required by the immune system and major organs 
to fight infectious pathogens (Fawzi & Hunter, 1998; Semba & Tang, 1999). Persons 
with inadequate intakes, blood levels or body stores of these micronutrients have 
difficulty in resisting infection. As a result, the role of micronutrients in HIVIAIDS is of 
special importance in individuals and populations with marginal or low micronutrient 
intakes (Friis & Michaelson, 1998). This applies to most AIDS-affected Africans and, 
as already noted, micronutrient deficiency is endemic (Piwoz & Preble, 2000). 
Studies in both industrialized and developing countries have confirmed that HIV-
infected individuals have decreased absorption, excessive urinary losses and low 
blood concentrations of vitamins A, B1, B2, B6 , B12, C, E, as well as of folate, beta-
carotene, selenium, zinc and magnesium (Tang & Smit, 1998). At present, it is not 
known whether these deficiencies are independent markers of disease progression 
resulting from a compromised immune system, or whether they are causally related 
to the development or exacerbation of symptoms of HIVIAIDS. This distinction is 
important in order to determine whether nutritional therapy and management can 
retard or alter the course of the disease. 
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2.12.2 Micronutrients and HIV Disease Progression and Mortality 
Review studies published by Tang & Smit (1998), Fawzi & Hunter (1998), Baum & 
Shor-Posner (1998) and Semba & Tang (1999), have concluded that micronutrient 
deficiencies associated with HIV infection vary across populations and according to 
the disease stage are associated with an accelerated progression of HIV infection to 
AIDS and are predictive of AIDS related mortality. Micronutrient supplementation, 
unlike many other AIDS treatments, has the potential in Africa to be an affordable 
and relatively easy way to deliver a public health measure. The roles of specific 
micronutrients in HIV disease progression and mortality and findings from published 
intervention trials are summarized below. 
2.12.2.1 Vitamin A 
Of all the micronutrients, the role of vitamin A in HIV infection has received the 
greatest attention in Africa. This is because of its well-known role in affecting child 
morbidity and mortality as well as early observations that vitamin A status was 
associated with increased risks of mother-to-child-transmission (MTCT) of HIV 
(Semba et aI. , 1994); with HIV viral load in breast-milk and vaginal secretions (Nduati 
et a/., 1995; John et a/. , 1997); with progression to AIDS (Tang et a/., 1993; Tang et 
a/., 1996); with adult survival (Semba et a/., 1994, Semba, 1997), and with infant 
morbidity (Coutsoudis et a/., 1995) and mortality (Dushiminana et a/., 1992). The 
potential for vitamin A supplementation to impact positively the course of HIV/AIDS is 
worth pursuing since vitamin A is beneficial in HIV-negative populations, is 
inexpensive and is relatively easy to administer with minimal side effects, however 
megadose can be dangerous to health (Semba et a/., 1994; Nduati et a/., 1995). 
Vitamin A deficiency may be caused by insufficient dietary intake of vitamin A-rich 
food, malabsorption, impaired storage (because of liver disease), and/or increased 
utilisation or urinary loss of vitamin A during acute and chronic infection (Semba, 
1997). Vitamin A deficiency causes growth retardation and xeropthalmia, and 
increases the incidence and/or severity of many infections. While vitamin A 
deficiency is relatively rare among HIV-negative adults in industrialized countries, up 
to one-third of HIV-positive adults in industrialized countries may be vitamin A 
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deficient (Kennedy et a/., 2000). The percentage incidence of vitamin A deficiency in 
HIV-positive people in developing countries, including Africa, is reported to be higher 
(Nimmagadda et a/., 1998). Vitamin A forms a key ingredient in the liquid 
supplement under investigation in this study. 
2.12.2.2 Vitamin E 
Vitamin E is necessary for the proper functioning of the immune system and it 
increases humoral and cell-mediated immune responses, including antibody 
production, phagocytic and lymphocytic responses and resistance to viral and 
infectious diseases (Odeleye and Watson, 1991; Watson, 1994). The oxidative 
stress created by HIV and related opportunistic infections increase the utilization of 
antioxidant vitamin E, possibly leading to deficiency. Vitamin E deficiency, in turn, 
further debilitates the immune system because of its role in immune stimulation and 
functioning, leaving people with HIV/AIDS more susceptible to opportunistic 
infections (Piwoz & Preble, 2000). 
Studies in the USA found that high baseline serum vitamin E levels were associated 
with decreased HIV progression after taking into account HIV-related symptoms, 
CD4+T cell count, age and other confounding variables (Tang et a/., 1997). 
Individuals with serum vitamin E levels greater than or equal to 23.5 mmol/l took 34% 
longer time to develop AIDS compared with those with low serum vitamin E levels 
(Tang et a/., 1997). Another study in Canada found that three months of 
supplementation with vitamin E (800 IU) and vitamin C (1000 mg) significantly 
reduced oxidative stress and HIV viral load (Allard et a/., 1998). A study in Zambia 
among AIDS patients suffering from persistent diarrhea found that vitamin E 
deficiency at enrolment predicted mortality in the following month (Kelly et a/., 1999). 
Vitamin E is also included in the liquid supplement used to investigate its influence on 
the immune status of HIV-positive/AIDS patients. 
2.12.2.3 Vitamin C 
Research studies have suggested that at high doses (greater than 1000 mg), vitamin 
C has a unique pharmacological function, displaying the potential to serve as an 
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antioxidant and primary source of electrons under conditions of drug-induced 
glutathione (GSH) deficiency or severe free-radical toxicity (Cathcart, 1991 ; 
Martenson & Meister, 1991; Semba & Tang, 1999. Due to the fact that antioxidant 
depletion and a chronic s'corbutic-like state are associated with HIV/AIDS, metabolic 
functions of vitamin C essential for preventing these conditions in healthy subjects 
are potentially relevant to the control and management of such conditions in persons 
with HIV infection and AIDS (Watson, 1994). 
HIV/AIDS patients manifest striking GSH deficiencies and often exhibit symptoms of 
acute-induced scurvy characterized by life-threatening weight loss, brittle bones and 
swollen glands (Cathcart, 1991). It has been reported that GSH deficiency can result 
from changes in dietary vitamin C intake. Volunteers fed controlled diets containing 
vitamin C at levels lower than the recommended daily allowance (60 mg/dl) had 
decreased concentrations of GSH in blood plasma (Watson, 1994). Administration of 
an ascorbate repletion diet (250 mg/dl) in the same study resulted in restoration of 
the plasma GSH level (Martensson & Meister, 1991; Watson, 1994). It has been 
pointed out that at high concentrations (obtained through supplementation), vitamin C 
can act directly to scavenge free radicals as well as convert oxidized forms of non-
enzymatic scavengers (tocopherol and GSH disulphide) to their reduced states. 
Under these conditions, vitamin C functions as a direct source of high energy 
electrons, saves GSH and acts as an essential antioxidant in the presence of GSH 
deficiency (Watson, 1994; Martensson & Meister, 1991). Cycles of reactive oxygen 
intermediate production in HIV-infected persons may induce them to consume free-
radical scavengers at an increased rate, leading to the depletion of vital antioxidants 
in the body. 
(i) Vitamin C: Immune Function and Antibacterial Effects 
Vitamin C has been found to affect immune function in several ways. It can stimulate 
the production of interferons, the proteins that protect cells against viral attack. It can 
stimulate the positive chemotactic and proliferative responses of neutrophils. It has 
also been shown that vitamin C can stimulate the synthesis of the humoral thymus 
factor and antibodies of the IgG and IgM classes (Flodin, 1988). Vitamin C 
deprivation reduces overall complement activity as adequate vitamin C has been 
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found to play an important role in stimulating the C1q biosynthesis. Watson (1994) 
showed that vitamin C was effective in the inactivation of a wide range of pathogenic 
bacteria including Staphylococcus aureus, Escherichia coli and haemolytic 
Streptoccoccus species. 
(ii) Antiviral Action of Vitamin C 
A striking property of vitamin C is its ability to inactivate viruses and inhibit viral 
growth in their host cells. Vitamin C has been shown to suppress the human 
retrovirus expression in immortalized and transformed lymphocy1ic cell lines (Watson, 
1994). It has been further proved that vitamin C is capable of inhibiting HIV 
replication in both chronically and acutely infected T cell lines in the absence of 
inducing agents, indicating that the compound (vitamin C) can directly interfere with 
specific steps in retrovirus replication in differentiated lymphocy1ic cells (Watson, 
1994). 
2.12.2.4 Vitamin B12 
Vitamin 612 deficiency is relatively uncommon in healthy, non-vegetarian populations. 
However, many studies of people with HIV in the USA reported low serum B12 levels 
even among asymptomatic persons. Low serum 612 levels are associated with 
neurological abnormalities, for example, neuropathy, myelopathy; impaired cognition; 
reduced CD4+T-cell counts, increased bone marrow toxicity and increased mortality 
(Tang & Smit, 1998). A 9-year study among homosexual and bisexual men with 
HIV/AIDS in the USA found that men with low serum 6 12 at enrolment «120 pmol/l) 
had significantly shorter AIDS-free survival times than men with adequate B12 (Tang 
et al., 1997). Another study of USA men found that improvements in 6 12 levels were 
associated with increases in CD4+T cell count. No studies of vitamin 612 and 
HIV/AIDS in Africa have been identified (6aum et al., 1995). 
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2.12.2.5 Folic Acid (folate) 
Folic acid works closely with vitamin 8 12 , but its role in HIV/AIDS remains unclear. 
Folic acid is required for ' the enzymes that produce DNA for replicating and growing 
cells , including those of the gastrointestinal (GI) tract, blood and growing foetus. 
Deficiency results in impaired cell division and protein synthesis, causing 
megaloblastic anaemia. If the GI tract is damaged as is common in HIV-related 
diarrhoea, folic acid reabsorption may be impaired, setting off a cycle in which 
deficiency results in further GI tract deterioration and malabsorption of other nutrients 
(Piwoz & Preble, 2000). 
2.12.3 Nutritional Support for HIV-positive/AIDS Patients 
As already pointed out, the nutritional status of HIV-positive/AIDS patients is 
frequently compromised. There is documented evidence that malnutrition will occur 
at some point in the disease process for more than 95% of patients (Levy, 1989; 
Fawzi & Hunter 1998). About 65% will experience malabsorption; 95% will have 
significant weight loss, while about 90% will have oral or oesophageal infections. 
This may affect food intake (Levy, 1989). Molina (1989) reported a significant 
reduction in the life-span of HIV-infected patients who had a serum albumin level 
below 2.5 mg/dl, whereas a serum albumin level of greater than 3.0 mg/dl has been 
associated with prolonged life span and decreased morbidity. Although data to date, 
especially in Africa, are limited in this aspect, retrospective data support the role of 
improved nutritional status and prolonged life with reduced morbidity. 
Many HIV-infected patients have demonstrated improved quality of life (increased 
activity, increased ability to perform activities of daily living, prolonged employment) 
after adequate provision of nutritional support (Rosenburg & Fauci, 1990). The 
corner-stone of nutritional support is the nutritional status assessment. The impact of 
nutritional interventions usually depends on the underlying nutritional status of the 
individual concerned . If a nutritional supplement is given to correct a deficiency, it is 
more likely to have an impact than when it is given to persons who are nutritionally 
replete (Watson, 1994). 
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2.12.3.1 Nutritional Intervention in Early HIV Disease 
The Physicians Association for AIDS Care (1992) and Task Force on nutritional 
support in AIDS (1989),' have established guidelines for nutritional support in early 
HIV infection which focus on improving oral intake by means of nutrient-dense food 
supplements and vitamin supplementation. It is suggested that counselling on 
nutrient selection and food preparation should begin and be periodically reinforced. 
This, it is believed, will establish a strong link between nutrition and HIV infection in 
the mind of the patient and health personnel that will alert both parties to more 
aggressive nutritional intervention when needed later. An optimal strategy would 
include measurements of energy expenditure and body composition to further the 
awareness of nutritional changes (Watson, 1994). 
2.12.3.2 Nutritional Interventions in Latent HIV Disease 
During this stage of the illness, HIV is deceptively dormant in lymphoid and 
macrophage reservoirs (Pantaleo et al. , 1993). However, evidence of ongoing viral 
replication and immune dysfunction is abundant, as follicular dendritic cells trap HIV 
particles and follicular lymph hyperplasia proceeds with subsequent activation of 
germinal B-cells and elaboration of interferon alpha (Pantaleo et al., 1993). 
It is documented that CD4+ T-cell levels fall at this stage by apoptosis and more rapid 
progression may occur by syncytia formation (Pantaleo et al., 1993). At this stage 
the Nutritional Task Force on AIDS (1992) and the Physicians Association for AIDS 
Care (1989) have established that enteral feeding supplementation be initiated with 
an intact formula. Although this present study does not focus directly on enteral 
feeding, it does agree with other authors on the importance of nutrition in the 
management of HIV infection. If augmented intake cannot be achieved or if weight 
loss continues despite enteral supplementation, assessment of the mucosal 
absorptive function must be undertaken. Efforts to stimulate the appetite with 
mesgesterol acetate or other stimulating agents have led to an increase mainly of fat 
weight. Again, a multiple strategy may be needed at this stage that provides 
adequate nutrients along with pharmacological interventions aimed at modifying the 
metabolic abnormalities driven by cytokines (Vonroenn et al., 1998). 
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2.12.3.3 Nutritional Intervention in Late HIV Disease 
As viral replication continues in lymphoid and macrophage reservoirs , destruction of 
the follicular dendritic cells in the germinal center occurs, leading to lymphocyte 
depletion and massive viraemia as the antigen presentation FOC cells degenerate in 
an accelerated mode related to a lack of cytotoxic activity (Pantaleo et al., 1993). It 
is known that cytokine activity continues but is propelled by the appearance of 
opportunistic pathogens. Opportunistic or secondary infections abound and account 
for most of the digestive and nutritional malfunction (Lahdevirta et al., 1998). It is not 
until this very advanced stage that too many clinicians finally appreciate that there 
are nutritional problems with the patients. Body weight falls below its usual pre-
illness weight by 20% and lean body mass simultaneously loses proportionately by 
another 10-15% (Kotler et al., 1989). Kotler et al. (1989) have established that death 
in these patients occurs from malnutrition. Although the Kotler et al. (1989) 
observation is subjective, it does point to the fact that malnutrition plays a significant 
role in HIV disease progression and death of the patients. 
2.1 2.4 The Importance of Micronutrient Supplementation in Improving the 
Nutritional and Immunological Status of People Living w ith HIV/AIDS 
Few people, whether or not they are nutritional professionals, would dispute the fact 
that malnutrition constrains people's ability to fulfil their potential. The joint 
FAOIWHO Food Standards Programme and the Codex Alimentarius Commission 
(CAC) were established in 1962 in response to worldwide recognition of the need to 
ensure the quality and safety of the world's food supply. The effect of HIV on the 
nutrition of a person follows a number of paths. Health and nutrition depends on the 
stage and the severity of the infection (Woznicki & D'Alessandro, 1997; Oguntibeju et 
al., 2003a). It is known that good nutrition in terms of quality and safety can 
contribute to the well-being of people living with HIV/AIOS at all stages of the disease 
and may even prolong life (Watson, 1994; Piwoz & Preble, 2000). As a result of 
malabsorption, the blood micronutrient levels of people living with HIV/AIOS are often 
lower than those without the infection or syndrome. However, determining the 
micronutrient status of these subjects is difficult, since infection causes shifti ng of 
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deficiencies can be caused by malabsorption in addition to poor dietary intake or 
increased nutritional demand (Connolly ef al., 1998). 
The aims of nutritional intervention in HIV/AIOS patients are: (a) to minimize loss of 
lean body mass; (b) to prevent vitamin and mineral deficiencies; (c) to surmount 
obstacies to nutrient intake and absorption, and (d) to prevent or moderate the use of 
nutritional approaches that may not enhance the well-being of the patients (Woznicki 
& O'Alessandro, 1997). It is important for healthcare professionals caring for HIV-
infected individuals to understand the relationship between nutrition, HIV infection 
and the immune system. Many clinicians support the use of dietary supplements by 
people living with HIV/AIOS (8aum, 1992; Abrams ef al., 1993; Fawzi & Hunter, 
1998; Oguntibeju ef al., 2003b). 
It is observed that during the active phases of HIV infection, subjects lose weight and 
lean body mass rapidly. The probability of imminent death is high when their weight 
falls to 66% of the actual weight or when lean body mass falls to 54%. Although 
good nutrition cannot single-handedly stop wasting, nutritional supplementation can 
reverse immune dysfunction related to malnutrition (Wozninki & O'Alessandro, 1997). 
2.12.4.1 Importance of Supplementation in HIV/AIDS Patients 
The provision of sufficient food and nutrition to meet people's basic needs for health, 
growth and development has been a long-standing challenge for African people. 
This challenge is further exacerbated by the emergence of HIV/AIOS. Several 
vitamins and minerals are critical for fighting HIV infection because they are required 
by the immune system and major organs to attack infectious pathogens. Research 
has shown that in the early period of HIV infection, weight gain or maintenance might 
be achieved through nutrition and has helped to reduce the consequences of wasting 
in people living with HIV/AIOS (Friis & Michaelsen, 1998; van Staden ef al., 1998). 
With HIV/AIOS, being a disease of the immune system, new strategies, including 
specific dietary nutrients to improve immune functions, quality of life and prolong 
survival in infected individuals, could provide additional or alternative approaches for 
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therapeutic treatments in HIV infected individuals. This strategy could also be used 
in establishing immunity in healthy uninfected persons (Fawzi & Hunter, 1998). 
Studies have shown that even people who eat good food are likely to have vitamin 
and mineral deficiencies when infected with HIV (Cimoch, 1997). For instance, zinc, 
selenium, magnesium, carotenoids, vitamins A, E, C, B2, B6 and B12 have all been 
found to be low in HIV-infected subjects. This can happen before visible sickness 
and the development of AIDS (Woznicki & D'Alessandro, 1997). The recommended 
daily allowance of vitamins and minerals is most often not sufficient for people living 
with HIV/AIDS. Supplementation has been shown to slow disease progression 
significantly (Semba & Tang, 1999). 
In the developing world, in which the majority of the people cannot afford 
antiretroviral therapy, good nutrition, combined with minerals and vitamins form a 
good source of therapy. From the mid 1980s until 1990, multiple deficiencies of 
vitamins and minerals were documented in people living with HIV/AIDS (Macallan, 
1999). Although at this time no aggressive supplementation was recommended, a 
report by FDA, USA (1995), suggested that supplementation of vitamins and trace 
minerals once or twice the recommended daily allowance (RDA) might offset possible 
deficits and contribute to meeting increased requirements during hypermetabolic 
states. In addition, Dwyer et at (1998) reported that multivitamin supplements might 
be helpful for debilitated AIDS patients who suffer from malabsorption. Malnutrition is 
almost universal among people living with HIV/AIDS, hospitalized or not, largely 
because of AIDS-related malabsorption. Malnutrition favours opportunistic infections 
and contributes to wasting (Cimoch, 1997; Macallan, 1999), making supplementation 
an important aspect in the management of people living with HIV/AIDS. 
There have been an increasing number of reports documenting multiple micronutrient 
deficiencies in HIV-infected/AIDS persons in the absence of proper and adequate 
supplementation. There have also been increasing recommendations for 
supplementation in this group of people (Watson, 1994; Macallan, 1999). In 
pursuance of this goal, members of the Physicians Association for AIDS Care have 
repeatedly emphasized the importance of supplementation. They carried their 
concern and objectives with emphasis to the third international symposium on 
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nutrition and HIV/AIDS where they reiterated the importance of supplementation for 
people living with HIV/AIDS . Research has indicated that HIV-related dementia may 
be prevented or controlled through good nutrition. Observations from published 
research studies suggest that many of the negative effects of protein calorie 
malnutrition (PCM) may be directly or indirectly related to a deficiency of trace 
elements (Piwoz & Preble, 2000). Baum (1992) recommended supplementation with 
vitamins A, C, E, the B vitamins, and minerals such as zinc, magnesium and 
selenium. It was also at about this time that further research documenting the 
benefits of supplementation became available. 
Abrams et al. (1993) published the results from two-six year epidemiological studies, 
one of which was a study of 296 men: a prospective study of dietary intake and AIDS 
in homosexual men. The authors observed that higher intake of all eleven 
micronutrients investigated was associated with a higher CD4+T -cell count; daily use 
of multivitamin was associated with a reduced risk of AIDS and a significantly 
reduced risk of a low CD4+T-cell count. In addition, there is increasing evidence that 
micronutrient supplementation is associated with the absence of, or reduced 
deficiencies and promotes clinical stability. 
Nutritional intervention to prevent or reverse weight loss and wasting with HIV 
infection may help to preserve independence, improve quality of life and prolong 
survival. Micronutrient intervention may help to strengthen the immune system and 
reduce the severity and impact of opportunistic infections in people living with 
HIV/AIDS. Some nutritional imbalances may directly affect HIV viral replication. 
Correcting these imbalances may also help to slow HIV disease progression and 
prolong survival . 
More research is essential to determine the dosage of various micronutrients for use 
by HIV/AIDS patients. Likewise, more defined roles of nutritional supplementation in 
immune response and in the management of HIV/AIDS patients need to be 
examined. The above statements partly explain the role that the outcome of this 
study will play in terms of providing knowledge and the importance of 
supplementation in HIV/AIDS individuals, especially in the less affluent economic 
sector of the community. 
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2.13 Dietary Intake and Weight Loss Patterns in HIV Infection 
Wasting and weight loss were recognized early in the AIDS pandemic as frequent 
and severe complications' of HIV infection. Appreciation of the importance of wasting 
was demonstrated by its inclusion as an AIDS-defining diagnosis in the Center for 
Disease Control criteria for progression to AIDS (CDC, 1987). 
2.13.1 Weight Loss 
Weight loss is very common during the course of HIV infection. It is said to occur in 
up to 50% of individuals at some stage in their illness (Kotler et al., 1989). The 
impact of wasting on quality of life and self-perception is readily evident to clinicians 
working with HIV-infected individuals. More objective data can be found in studies 
which have demonstrated a strong link between loss of body cell mass and reduced 
survival time, either in terms of time of death or in terms of Kaplan-Meier analysis of 
survival (Kotler et al., 1989; Suttmann et al., 1995). 
Observation by clinical personnel at a community level revealed the impact of 
wasting, survival and morbidity in HIV-infected patients published by the Community 
Program for Clinical Research on AIDS. The organization showed that a weight loss 
trend over a 4-month observation period predicted subsequent mortality; even weight 
loss trends of only 0-3% over 4 months were predictive of increased mortality 
(Wheeler et aI, 1998). Such studies demonstrate at a community level the impact of 
wasting, reflected by loss of weight which has been demonstrated previously using 
more complex body composition indices such as body cell mass. This may be partly 
due to the occurrence of chronic gastrointestinal infections but can also be largely 
attributed to the frequency of co-infection with tuberculosis in such populations 
(Serwadda et al. , 1985; Lucas et a/., 1994; Dannhauser et a/., 1999). 
2.13.2 Patterns of Weight Change 
Research studies have shown that, early in the AIDS pandemic, weight loss tends to 
be episodic and occurs in association with opportunistic infections (Macallan et al. , 
1993). Particularly striking was the observation that, following successful treatment 
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of episodes of secondary infection, spontaneous weight recovery occurred . Such 
weight gains could be very dramatic, showing that HIV per se does not prevent an 
anabolic response given adequate food intake in an appropriate metabolic 
environment. It was also noted that some individuals' weight remained stable for 
prolonged periods despite demonstrable metabolic abnormalities (Kotler et a/., 1989). 
A comparison of weight change patterns showed that the majority of the acute weight 
loss episodes occurred in relation to opportunistic infections, particularly those that 
interfered directly with food intake. By contrast, those individuals with a chronic 
progressive pattern of weight loss often had gastrointestinal diseases (Macallan et a/ 
1993; Suttman et a/. , 1995). 
2.13.3 Weight Loss and Energy Balance: Energy Requirements 
One of the characteristics of HIV infection appears to be its major impact on 
metabolic processes. Several studies have investigated metabolic rate in HIV 
infection. The results have been variable, reflecting the clinical and metabolic 
heterogeneity of HIV infection, but consensus seems to have emerged that in 
asymptomatic HIV infection, there is an increase in resting energy expenditure (REE) 
of about 10% (Schwenk et a/. , 1996). The heterogeneity of metabolic findings in 
groups of HIV-infected individuals is particularly striking and makes generalization 
difficult (Schwenk et a/., 1996). Some individuals are considerably hypermetabolic, 
while others are frankly hypometabolic (Schwenk et a/., 1996; Wheeler et a/., 1998). 
In studies including individuals with reduced food intake, the expected compensatory 
reduction in REE has not been observed and this may represent one aspect of 
metabolic dysregulation (Schwenk et a/., 1996). The presence of secondary 
infections tends to increase REE further; increases in REE to 29% and 34% above 
control values were seen in two studies including subjects with secondary infections 
(Grunfeld et a/. , 1992). Whether such increases are reflected in total energy 
expenditure (TEE), the true determinant of energy balance remains less clear. It is 
difficult to predict the energy requirements for an individual with HIV infection. Even 
if facilities exist to measure REE, considerable uncertainty still exists. Weight trend is 
probably the best indicator of adequate energy supply over time (Grunfeld et a/., 
1992). 
55 
© Central University of Technology, Free State
2.13.4 Energy Intake and Weight Loss 
As mentioned above, weight loss frequently occurs in relation to acute opportunistic 
infections (Macallan et al., 1993). During such periods, food intake falls markedly 
(Grunfeld et al. , 1992; Ot! et al., 1993). In studies performed among HIV positive 
patients in the United Kingdom, TEE and energy intake were measured during 
periods of weight stability, gain and loss. It was observed that TEE tended to be 
lower during weight loss and higher during weight gain phases; changes in TEE 
could not therefore account for the changes in energy balance necessary to induce 
such changes in weight. It could be inferred, therefore, that changes in energy intake 
were the prime movers in determining weight loss. Direct measurement of food 
intake using a 7-day weighed food intake measurement confirmed this supposition 
(Macallan et al., 1995). Grunfeld et al. (1992) observed that energy intake was 
similar in HIV-negative controls, asymptomatic HIV-positive subjects and AIDS 
patients without secondary infection, but was reduced by 36% in AIDS patients with 
secondary infections in whom intake fell 17% below their REE. Research studies 
have shown that most HIV-positive individuals do not lose weight because their 
metabolic requirements are excessive. In fact, the contrary is true: they lose weight 
because their intake has fallen, often to exceedingly inadequate levels (Grunfeld et 
al. , 1992; Schwenk et al., 1996; Wheeler et al. , 1998). 
2.14 Body Composition Changes during HIV Infection 
2.14.1 Introduction 
The relationships among chronic disease, malnutrition and physical debilitation have 
long been recognized. Clinical and experimental studies have shown that effective 
treatment of malnutrition may have observable benefits, irrespective of the underlying 
diseases. This has led to renewed interest in applying nutritional tools in clinical 
medicine (CDC, 1987). 
Malnutrition is a common complication of HIV infection and plays a significant and 
independent role in its morbidity and mortality. Unexplained weight loss of greater 
than 10% was established as a cl inical criterion for the diagnosis of AIDS by the 
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Centers for Disease Control and Prevention (CDC, 1987). Unexplained weight loss 
was one of the most common initial AIDS-defining diagnoses to be reported to public 
health authorities (CDC, 1987). 
Research findings have noted that macronutrients reflect only one aspect of 
nutritional status (CDC, 1987; Paton et a/., 1996; Connolly, et a/., 1998). 
Micronutrient deficiency may exist without macronutrient deficiency, while 
macronutrient deficiency almost always has associated micronutrient deficiencies 
(Zangerle et a/., 1993; Thea et a/., 1995). The concept of malnutrition also has static 
and dynamic features such as chronic stable malnutrition versus progressive tissue 
depletion. It is possible for someone to be undergoing a period of weight loss, yet 
have a nutritional status within the normal range (Kotler, 1992; Paton et a/., 1996). 
2.14.2 Patterns of Malnutrition in Relation to Body Composition 
Starvation and cachexia are the two major patterns of wasting. Starvation can be 
defined as deprivation of food, either voluntarily or involuntarily, that leads to weight 
loss. The effects of starvation can be reversed by providing food (Thea et a/., 1995; 
Raghaven et a/., 1996). Cachexia is characterized by a disproportionate loss of 
protein which results from specific alterations in intermediary metabolism (Grundfeld 
& Feingold, 1992; Macallan, 1999). These metabolic alterations are an integral part 
of the body's defence, as they provide the energy and substrate needed to fuel the 
acute-phase response which includes the production of large quantities of specific 
proteins needed for the clearance of pathogens and tissue debris, and they also 
damp the oxidative reactions that result from an inflammatory response (Flores et a/., 
1989; Kelly et a/., 1999). The process is regulated by the same cytokines that 
promote immune responses. In addition, since the metabolic changes are promoted 
by specific alterations in cellular enzymes, simple feeding may not alter the process 
substantially. Thus, an important characteristic of cachexia is that depletion of lean 
tissue may not simply be reversed by feeding the patients (Kotler, 1992; Babamento 
& Kotler, 1997). 
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2.14.3 Effects of HIV Infection and AIDS on Body Composition 
The earliest studies of nutritional status in AIDS patients conducted between 1981 
and 1983 were undertaken with hospitalized patients. Weight loss to an average of 
about 80% of ideal weight was found. Evidence of protein deficiency was 
documented by showing deficiencies in serum proteins (transferrin, albumin), 
haemoglobin and by muscle wasting (mid-arm circumference) (Kotler et a/., 1984; 
Tang et a/., 1993; Stack et a/. , 1996; Mocroft et a/., 1999). Several other studies also 
documented a very high prevalence of severe weight loss in AIDS patients at the 
time of hospital admission (Serwadda et a/., 1985; Niyongabo et a/., 1999). 
2.15 Wasting Syndrome in HIV/AIDS 
2.15.1 Introduction 
The wasting syndrome is one of the most pernicious and poorly understood 
complications associated with HIV infection (Macallan, 1999). In the early days of 
the epidemic, anecdotal reports of a wasting syndrome associated with late stages of 
HIV infection began to surface. Although transient weight loss associated with 
opportunistic infections was also seen, late HIV wasting was often severe, relentless 
and difficult to treat. This wasting syndrome has become more clearly characterized 
and is recognized as one of the hallmarks of progressive, untreated acquired 
immunodeficiency syndrome (Kotler et al., 1985; 1989; Suttmann et al., 1995; 
Enggelson et a/., 1997; Macallan, 1998 & 1999). 
In Africa, 60% of AIDS patients presented with wasting (Serwadda et a/., 1985; Piwoz 
& Preble, 2000). In 1987, the Centers for Disease Control (CDC) added wasting 
syndrome to the list of AIDS-defining illnesses (CDC, 1987). The CDC defined the 
HIV wasting syndrome as prolonged involuntary weight loss greater than 10% of 
baseline body weight. The definition also includes conditions such as chronic 
diarrhoea (at least two loose stools per day for 2!30 days) or chronic weakness and 
documented fever (2!30 days, intermittent or constant) in the absence of a concurrent 
illness or condition other than HIV infection that could explain the findings (for 
example cancer, tuberculosis, cryptosporidiosis or other specific enteritis). 
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2.15.2 Clinical Studies of HIV-related Wasting 
The earliest studies of HIV-associated wasting were clinic-based and focused on 
AIDS patients presenting with unexplained severe weight loss. Accompanying 
symptoms affecting the patients' condition and quality of life included fatigue, 
weakness, anorexia and diarrhoea. An early clue to the importance of opportunistic 
infections was noted by Kotler et at. (1989) who observed that AIDS patients treated 
for disseminated cytomegalovirus infections with antiviral therapy gained weight, 
replenished body cell mass and body fat. This shows that wasting at least, when the 
underlying cause was a treatable infection, was a potentially reversible process. 
Severe and progressive decrease in lean body mass has been found to account for 
the bulk of weight loss in AIDS patients (Kotler et a/., 1984; 1989; Zangerlie et a/., 
1993; Suttmann et a/., 1995). It is observed that wasting occurred in the presence 
and in the absence of diarrhea and the timing of death seemed to correlate with the 
extent of body-cell-mass depletion rather than the process underlying the loss (Kotler 
et a/., 1985; 1989; 1999). Kotler et at. (1989) concluded that death from wasting 
occurred when body cell mass reached 54% of normal body cell mass and body 
weight 66% of ideal weight. 
Clinical studies have suggested that several mechanisms may be associated with the 
aetiology of HIV wasting, including enteric pathogens, small intestinal injury and 
inflammatory changes in the gastrointestinal system. Nutrient malabsorption was 
documented early on in HIV-infected individuals and, interestingly enough, it was 
identified in AIDS patients both with and without diarrhoea (Dworkin et a/., 1985 and 
1990; Smith et a/., 1988; Connolly et a/., 1998). 
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CHAPTER 3 
3 METHODOLOGY 
3.1 Introduction 
In chapter 3, methods such as a socio-demographic questionnaire, a food frequency 
questionnaire, an anthropometric information sheet and a medical examination information 
sheet, employed in the collation of relevant information from patients, are described. The 
chapter also includes various procedures and tests that were applied in the determination 
of specific immunological and haematological variables. Operational definitions are 
provided for the purpose of clarity. 
3.2 Operational Definitions 
For the purpose of clarity, certain operational terms used (or what they constitute) in this 
study are explained below: 
3.2.1 Socio-demographic Status (Appendix A) 
For this study, socio-demographic status constitutes the following factors: 
• Age (in years), gender and number of years resident in Bloemfontein 
• Marital status and number of children (alive or dead) 
• Smoking habits 
• Level of education 
• Employment status 
• Financial status and number of people contributing to income per month 
• Type of house and available cooking utensils 
• Number of people living in the house and amount spent on food monthly/weekly 
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3.2.2 Anthropometry 
Anthropometry involves obtaining physical measurements of an individual, and relating 
these measurements to standards that also reflect his/her health and nutritional status, 
such as malnutrition (Lee & Nieman, 1996; Gibson, 1998). The most commonly used 
anthropometric measurements include body weight, height, hip circumference, waist 
circumference, skinfold thickness and other girth measurements. 
• A waist-to-hip circumference ratio of <0.95 and 2: 0.95, indicative of male fat 
distribution (Hammond, 2004) and a waist-to-hip circumference ratio of < 0.8 
(female), indicative of a gynoid fat distribution. 
• Waist circumference was categorised as follows: < 0.88: Normal waist 
circumference; 2:0.88: High waist circumference (female) (Smolin & Grosvenor, 
2000). 
• Weight (W) and Height (H) measurements were obtained to determine the body 
mass index (BMI) as W/H2 , with weight measured in kilograms and height 
measured in square metres (Laquatra, 2004). 
BMI: <18.5 (underweight) 
BMI: 18.5-24.9 (average weight) 
BMI: 2:25 (overweight) (Jackson & Pollock, 1985) 
• Fat percentage was categorised as follows (Laquatra, 2004) 
Low: <20 
Normal : 20:525 
High >25 
• Skinfold (SKF) Thickness 
The skinfold thickness refers to the thickness of a double fold of skin and compressed 
subcutaneous adipose tissue (Gibson, 1998). This measurement relies on total body fat 
estimates on the assumption that 50% of body fat is subcutaneous (Hammond, 2004). 
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3.2.3 Dietary Intake 
For dietary intake, reference is made to the habitual types, quantities and frequency of 
food and drink consumed on a daily, weekly or monthly basis over a period of six months 
prior to the study. A validated food frequency questionnaire (adapted from the Transition 
and Health During Urbanisation of South Africans (THUSA) study (Potchefstroom 
University), was used (Appendix C) to determine the habitual intake of the energy, macro-
and micronutrients mentioned below: 
• Energy and macronutrients (carbohydrates, fats and proteins) 
• Vitamins (vitamins A, C, E, 0, K, 86 , 8 12 , folic acid , niacin, thiamine and riboflavin) 
• Minerals and trace elements (magnesium, chromium, phosphorus, iodine, iron, 
selenium, zinc) 
The intake of each nutrient is considered to be either less than 67% or greater than 67% of 
the recommended allowance (RDA) or adequate intake (AI) 
3.2.4 Immunological and Haematological Parameters 
• Total T-cell count (940-2380 cells/mm3) 
• CD4+T-cell count (510-1310 cells/mm3) 
• CD8+T-cell count (510-1310 cells/mm3) 
• CD4/CD8 ratio (0.72-3.14) 
• Viral load (>10 OOO/ml) 
• Red cell count (3.7-5.3 x109/1 for female and 5.5-9x109/1 for male) 
• Haemoglobin (12-16 g/dl for female and 13-18 g/dl for male) 
• Haematocrit (0.35-0.451/1 for female and 0.40-0.501/1 for male) 
• Mean cell haemoglobin concentration (MCHC) (32-37 g/dl for female and 32-36 d/dl 
for male) 
• Mean cell concentration (MCH) (29.5-32 pg) 
• Mean cell volume (MCV) 86-90 fl) 
• Red distribution width (ROW) (10-15) 
• White cell count (WCC) (7.5-11 x109/1 ) 
• Neutrophil (2-75 x1 09/1) 
• Lymphocyte (1-4 x109/1) 
• Monocyte (0-0.95 x1 09/1) 
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• Eosinophil (0-0.4 x1 09/1) 
• Basophil (0.-0.1 x109/1) 
• Platelets (150-400 x1 09/1) 
3.3 Type of Study 
This was an open-labelled, clinical trial study that involved HIV-positive/AIDS individuals 
(volunteers). A total of 50 HIV-positive/AIDS patients were recruited for the study after 
signing the consent form. 
3.4 Study Population 
The target subjects for this study were volunteers living with HIV/AIDS. In the study 
population, females and males were included within the age group of 18 to 65 years. 
None of the subjects were on anti-retroviral therapy or any treatment for chronic diseases. 
No control group was used for this study due to the following reason: The CD4+T/CD8+T-
cell counts of the inclusion criteria of the patients were very low and an untreated control 
group would have too much drop-out owing to death and terminal illness. 
The data of each patient's CD4+T/CD8+T-cell counts and viral load count determined 
during the screening visit were treated as an internal control. In different studies on the 
nutritional status and dietary intake of HIV-positive/AIDS patients, Coodley et al. (1993) , 
Castetbon et al. (1997), and Van Staden et al. (1998), did not include control groups. 
3.4.1 Sample Size 
Fifty patients selected after the screening visit, who met the inclusion criteria, who did not 
meet any of the exclusion criteria, and who gave written informed consent, were recruited 
into the study. 
3.4.2 Justification for In and Exclusion Criteria 
The criteria were set to ensure a homogenous subject population for this study. 
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3.4.3 Inclusion and Exclusion Criteria 
Patients had to: 
3.4.3.1 Inclusion Criteria 
• Be male and female subjects from 18 to 65 years of age and HIV/AIDS 
positive. 
• Have CD4+T-cell counts of 100 - 350 cells/mm3 
• Display symptoms within the range of clinical acceptability in medical history 
and physical examination, and laboratory results acknowledged by the 
clinical investigator. 
• Be willing to undergo a pre-study physical examination and pre- and post 
study laboratory investigations. 
• Be able to comprehend and be willing to sign the statement of informed 
consent. 
3.4.3.2 Exclusion Criteria 
Patients were excluded on grounds of: 
• Evidence of psychiatric disorder, antagonistic personality, poor motivation to 
participate in this study or limited ability to comply with protocol 
requirements. 
• A history of, or current compulsive alcohol abuse (>10 drinks weekly), or 
regular exposure to other substances of abuse. 
• Participation in another study with an experimental supplement within eight 
weeks before the first administration of the study medication . 
• A history of hypersensitivity to the study supplement or any related drugs. 
• 
• 
Loss of blood equal to or exceeding 500 ml during the 8 weeks before the 
administration of the study medication. 
Heavy smoking (i.e. more than 20 Cigarettes per day). 
• Being pregnant. 
• Being diabetic HIV-positive individuals. 
• Being on antiretroviral therapy or any treatment for chronic diseases 
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3.4.4 Withdrawal Criteria 
Subjects were informed of their right to withdraw from the study at any time, irrespective of 
the reason. The following incidents may lead to withdrawal: 
• An adverse event as a result of taking the study supplement. 
• Protocol violation by the patients; at the discretion of the clinical investigator. 
3.4.5 Subject Identification 
• Each enrolled subject received a number (01-50) and retained this number throughout 
the study. 
• Each enrolled subject retained his initials obtained from a copy of his identification 
book. 
• Each enrolled subject was identified by date of birth. 
3.4.6 Ethical Approval 
Written approval for the final version of the protocol was obtained from the Ethics 
Committee (Ethics number ETOVS 32/03) of the Faculty of Health Sciences, University of 
the Free State, Bloemfontein, South Africa before the first administration of the study 
supplement. 
Before commencement of the screening procedures, the subjects were informed verbally 
and in writing by the clinical investigator about the nature and purpose of, and possible 
risks involved in, the screening procedures as well as the, procedures, restrictions, 
obligations, remuneration, insurance coverage and possible adverse supplement reaction 
relevant to the study. Both the informed consent discussion and the written patients' 
information were included to provide adequate information for the subjects and the 
subjects in turn voluntarily accepted the terms of the study, and agreed to co-operate in its 
conduct by signing the informed consent form (Appendix E). 
The statement of informed consent was personally signed and dated by the subject and by 
the clinical investigator who conducted the informed consent discussion, after sufficient 
time for deliberation had been provided. The subject information sheets and informed 
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consent forms were available in English, Afrikaans and Sotho. Each volunteer was 
provided with the subject information sheet and informed consent form in the language of 
his/her choice and retained copies of the subject information sheet and signed statement 
of informed consent. The subjects were also to be informed timeously should new 
information become available that might influence their willingness to continue participating 
in the study. 
3.4 Study Design 
3.5.1 The Screening visit 
The study consisted of a screening visit and monthly visits from April to September 2003. 
The monthly visit started 7 days after the screening visit. The duration of this study was 
considered suitable and was similar to the duration reported by Allard et al. (1998) in a 
previous work. Validated questionnaires (food frequency questionnaire, socio-
demographic questionnaire) were used in obtaining information from the patients. The full 
blood count (Dacie & Lewis, 1985), CD4+T-cell count, CD8+T-cell count (Romeu et aI., 
1992; Mulder et aI., 1996), anthropometric measurements (Lee & Nieman, 1996) and viral 
loads (Twigg et al., 1999) were determined using standard procedures. The methods 
applied in the determination of the above-mentioned laboratory parameters are described 
under laboratory investigations. The framework of the study is presented in figure 3.1. 
3.5.2 Follow-up Visits (Monthly visits) 
The patients were seen at the Medi Inn clinic on a monthly basis. During each visit, 
physical and medical examinations were carried out on the patients by the clinical 
investigator. Blood samples were drawn from the patients and full blood count, CD4+T-cell 
counts, CD8+T-cell counts were performed. The viral load and anthropometric 
measurements were repeated at the end of the study using standard procedures. 
Compliance with the regime was ensured by counting the supplement units on a daily 
basis and by constantly reminding the patients of the need to follow the protocol. 
All data from the screening, clinical evaluation and the post study physical examination 
and laboratory investigations were documented. Each subject was carefully monitored for 
adverse events, including abnormal laboratory investigations. In addition, information on 
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possible adverse events following supplementation was obtained from the subjects by 
regular questioning of each subject by the clinical staff, although no leading questions 
were asked. There was no complaint of adverse events having occurred during the 
period of this study. The framework of the study is presented in figure 3.1. 
! Nutritional and immune Status of HIV -positive/AIDS patients 
.. .. 
. Screening I I • Monthly visit I I • Final visit I vi it 
· 
Socia demographic 
· 
Haematologicat 
· 
Anthropometry 
profile parameters 
· 
Medical examination 
· 
Dietary Intake 
· 
Medical 
· 
Haematological 
· 
Anthropometry examination parameters 
· 
Medical 
· 
Immune parameters 
· 
Immune factors 
examination 
• · 
Viral toad 
· 
Haematological Anthropo parameters metry 
· 
Immune factors 
· 
Viral load 
Figure 3.1: Framework of the study design to determine the nutritional and immune 
status of HIV-positive/AIDS patients. 
3.6 Measuring Techniques and Procedures 
All the apparatus, techniques and procedures applied in this study were standardised. 
Methods were also standardised to ensure validity and reliability of results. 
3.6.1 Socio-demographic Status 
3.6.1.1 Socio-demographic Measurement 
Socio-demographic details such as age, gender and residential areas were obtained from 
each patient by means of a questionnaire. Information concerning financial and 
employment status, level of education, marital status, monthly income, type of house, 
amount spent weekly or monthly on food, available cooking facilities, smoking habit, 
number of children (alive or dead), and number of persons living in the house was also 
obtained and recorded (Appendix A). Due to small sample size, the statistical power of 
this data is not sufficient and will not be discussed further in this study. 
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3.6.2 Anthropometry 
In this study the restricted profile was adopted (Schmidt & Carter, 1990). Sites measured 
for the restricted profile are skinfolds and include triceps, subscapular, biceps, iliac crest, 
abdomen, front thigh, medial calf, med-axilla, gluteal (hips) and waist. Anthropometric 
indices were determined by measurement. 
3.6.2.1 Anthropometry Apparatus 
The following anthropometric equipments was used in the anthropometric measurement: 
anthropometric tape: a flexible steel tape calibrated in centimetres with millimetre 
gradations; a scale, and skinfold callipers. 
(i) Metal Tape 
This was fitted to the wall and the height of each patient was taken (without shoes) to the 
nearest 0.1 cm. 
(ii) Scale 
The 770 Seca digital electronic scale (Bizerba 75860) was used in determining the body 
mass of the respondent to the nearest 0.1 kg. 
(iii) Skinfold Callipers 
Slim guide callipers were used as recommended (Schmidt & Carter, 1990). 
3.6.2.2 Anthropometric Measurements and Data Collection 
Subjects were informed as to what measurements were to be taken and were asked to 
complete a consent form as part of the preliminaries of the test protocol. Throughout the 
marking and measurement session, each subject stood relaxed, with arms comfortably by 
the side and feet held together. However, some measurements required the subjects to 
place their feet apart. The subjects presented themselves in minimal clothing to allow for 
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measurements to be done quickly and efficiently. Previous study has shown that skin-fold 
thickness is reliable (Paton ef a/., 1996). All anthropometric measurements were done 
according to standard procedures (Lee & Nieman, 1996). 
Two persons were involved with the measurement: the measurer and the recorder. This 
was done to ensure accuracy of site location, correct sequence of measurement sites and 
accurate reading. The recorder repeated the value as it was being recorded in order to 
enable the measurer to do an immediate check. The measurement was done twice at 
each site on each subject and the average value taken. The various measurements that 
were taken and the procedures involved are described below. 
(i) Height, Weight & Body Mass Index 
Height and weight can be measured using different approaches and are useful in 
determining nutritional status in adults (Pressman & Adams, 1990; Gibson, 1998). 
Stature or standing height can be measured in various ways (Lee & Nieman, 1996). The 
simplest method that can be applied, is to fasten a measuring stick or non-stretchable tape 
measure to a flat, vertical surface, for instance, a wall without a skirting, with the subject 
not standing on a carpet (Lee & Nieman, 1996). Body weight, which provides a crude 
evaluation of overall fat and muscle stores forms one of the most important measurements 
in nutritional assessment. 
It is indicated in literature that usual body weight compares the present weight of the 
individual to the usual body weight, thus allowing changes in body weight to be assessed 
(Hammond, 2004). Actual body weight refers to weight measurement obtained at the time 
of examination. 
(a) Procedure 
Body weight in this study was measured by means of an electronic load cell scale to the 
nearest 0.1 kg with patients dressed in light clothing, and height (without shoes) to the 
nearest 0.1 cm, using a metal tape fitted to the wall. The values of the body weight and 
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height in metres were applied to calculate the BMI as BMI =W/H2 (Pressman & Adams, 
1990; Laquatra, 2000). 
(i i) Body Composition 
The interest in body composition has mounted over the past few years because of its 
relevance to health and diseases (Lee & Nieman, 1996). Body composition is defined as 
the ratio of fat to fat-free mass (Lee & Nieman, 1996; Gibson, 1998). The fat-free mass 
refers to tissue devoid of all extractable fat and is often expressed as a percentage of body 
fat. These two components can be indirectly assessed by anthropometric techniques, and 
the variations in their amount and proportion can be used as indices of nutritional status 
(Gibson, 1998). 
Body composition can be determined using skinfold thickness, bioelectric impedance and 
other available methods. For the present study, skinfold thickness was used to determine 
the body composition of patients. 
(iii) Skinfold (SKF) Thickness to determine Body Fat Percentage 
Skinfold thickness is a widely used indirect method of assessing the amount of body fat. 
Although more accurate methods for assessing percentage body fat are available, skinfold 
measurement is easy and quickly obtained. It provides estimates of body composition that 
correlate well with those derived from hydrostatic weighing (Lee & Nieman, 1996). 
The thickness of subcutaneous adipose tissue varies widely among different skinfold sites 
within individuals, and for the same skinfold site between individuals, overall subcutaneous 
adipose tissue is best assessed by taking measurements at different sites. A minimum of 
three different sites is recommended (Lee & Nieman, 1996). Skinfold sites identified as 
most reflective of body fatness are over the triceps and the biceps, below the scapula, 
above the iliac crest and on the upper thigh (Hammond, 2004). 
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(a) Procedure 
The body fat percentage was determined from the 7 skinfolds: chest + abdomen + thigh + 
triceps + subscapular + iliac crest + mid axillary, according to the method of Jackson & 
Pollock (1985), by using the following formula: 
Male (18-61 years): BO (body density) = 1.112 - 0.00043499 (HSKF) + 0.00000055 
(HSKF)2 - 0.00028826 (age). Fat percentage = [(4.85/BO) - 4.39] x 100. 
Female (18-55 years): BO (body density) = 1.0970 - 0.00046971 (HSKF) + 0.00000056 
(HSKF)2 - 0.00012828 (age). Fat percentage= [(4.37/BO) - 3.93] x 100. 
(iv) Waist-to-Hip Circumference 
The waist-to-hip ratio (WHR) is an easy method of assessing body fat distribution. It 
provides an index of regional body fat distribution and forms an important guide in 
assessing health risk (Lee & Nieman, 1996). The waist-to-hip ratio differentiates between 
android and gynoid obesity, and is the most frequently used method to measure adiposity. 
According to Hammond (2004), a WHR ~ 1.0 in men or ~ 0.8 in women is indicative of 
android obesity and seen as increasing the risk for obesity-related diseases. Plastic or 
steel measuring tapes may be used to determine the measurements. The waist 
circumference is measured at the most narrow area below the rib cage and above the 
umbilicus as viewed from the front. The subject to be measured is dressed in light 
clothing, stands erect, with abdominal muscles relaxed, arms by the side and feet 
together. The measurer then places the tape in a horizontal plane and measures the area 
of least circumference. The measurement is taken at the end of a normal expiration. 
The hip circumference is the point of greatest circumference around the hips at the point of 
greatest circumference, and the measurement was taken with the tape in close contact 
with the skin, but without indenting the soft tissues. The measurement was recorded to 
the nearest 0.1 cm. The WHR was calculated by dividing the waist circumference by the 
hip circumference (Lee & Nieman, 1996). 
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(a) Procedure 
A metal tape was used to determine the circumference of the hip and the waist at the level 
of the umbilicus. The mean of the measurements was recorded for each parameter and 
the results for waist and hip circumference were used to calculate the waist-to-hip ratio 
(WHR) as WHR =Waist girth/gluteal (hip) girth (Hammond, 2004). 
(v) Lean Body Mass 
(a) Procedure 
Lean body mass (fat free mass) (FFM) was determined using the method as described by 
Niyongabo et al (1997) using the formula: LBM= Body weight-percentage body fat. The 
various measurements that were taken are described below. 
3.6.2.3 Anatomical Landmarks 
The landmarks are identifiable skeletal pOints that generally lie close to the body's surface 
and are the markers which identify the exact location of the measurement site or from 
which a soft tissue is located. 
The landmark was identified with the thumb or index finger. The site was released to 
remove any distortion of the skin, then relocated and marked directly over the landmark. 
The mark was then checked to ensure that there had been no displacement of skin relative 
to the underlying bone. All landmarks were identified and marked before measurements 
were made (Schmidt & Carter, 1990). 
(i) Acromiale 
The acromiale is the point at the superior and lateral border of the acromion process, 
midway between the anterior and posterior borders of the deltoid muscle when viewed 
from the side of the patient. 
With the measurer standing behind and on the right hand side of the subject, the subject 
was palpated along the spine of the scapula to the corner of the acromion. The straight 
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over the triceps muscle when viewed from the side. For measurement, the arm was 
relaxed with the shoulder joint slightly externally rotated and elbow extended from the side 
of the body. 
(vi) Subscapular 
The subject was standing erect with arms by the side. The thumb was applied in palpating 
the inferior angle of the scapula to determine the undermost tip, and the marking made. 
The skinfold was raised with the left thumb and index finger at the marked site 2 cm along 
a line running laterally and obliquely downwards from the subscapulare landmark at an 
angle of 45° as determined by the natural fold lines of the skin. 
(vii) Biceps 
This skinfold was raised with the left thumb and index finger on the marked mid-acromiale-
radiale line so that the fold runs vertically, that is parallel to the axis of the upper arm. The 
measurement was made with the subject standing with the arm relaxed, the shoulder joint 
slightly externally rotated and elbow extended (Schmidt & Carter, 1990). 
(viii) Iliac Crest 
This skinfold is raised immediately superior to the iliocristale on the ilio-axilla line. The 
subject was told to place the left arm across the chest to the right hand on the iliocristale 
landmark and exert pressure inwards so that the fingers roll over the iliac crest. The left 
thumb was substituted for these fingers and the index finger was relocated a sufficient 
distance superior to the thumb so that this grasp became the skinfold to be measured. 
(ix) Supraspinale 
This skinfold was originally named suprailiac by Heath & Carter (1967). but it is now known 
as the supraspinale (Carter & Heath, 1990). This fold is raised at the point where the line 
from the iliospinale mark to the anterior axillary border intersects with the horizontal line of 
the superior border of the ilium at the level of the iliocristale and this is about 5 cm above 
the iliospinale, depending on the size of the adult subject. 
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(x) Abdomen 
This is a vertical fold raised 5 cm from the right hand side of the omphalion (midpoint of the 
navel). For maximal measurement of this site, it was ensured that the initial grasp was 
firm. 
(x i) Front Thigh 
The measurer stood facing the right side of the subject on the lateral side of the thigh. The 
subject while seated , was asked to bend his/her knee at right angles by placing the right 
foot. The site was marked parallel to the long axis of the femur at the mid-point of the 
distance between the inguinal fold and the superior border of the patella. The skinfold 
measurement was taken while the knee is bent 
(xii) Medial Calf 
With the subject in a seated position and the calf relaxed, the vertical fold was raised on 
the medial aspect of the calf at a level where it has maximal circumference and the point 
marked; the measurement was taken from the most medial point. 
(xiii) Chest 
This girth was taken at the level of the mesosternale. The measurer stood to the right of 
the subject who slightly abducts the arms allowing the tape to be passed around the chest 
in a near horizontal plane. The subject was told to breathe normally and the measurement 
was taken at the end of a normal expiration (end tidal) with the arms relaxed at the sides. 
(xiv) Waist 
For this measurement, the measurer stood in front of the subject to correctly locate the 
narrowing of the waist, and the measurement was taken at the level of the narrowest point 
between the lower costal (rib) border and the iliac crest. 
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(xv) Gluteal (Hip) 
This was taken at the level of the greatest posterior protuberance of the buttocks which 
usually corresponds anteriorly to about the level of the symphysis pubis. The measurer 
stood at the side of the subject to ensure the tape is held in a horizontal plane when 
measuring this site. The subject stood with the feet together with gluteal muscle relaxed. 
(xvi) Forearm 
The measurement was taken at the maximum girth of the forearm with the subject holding 
the palm up while relaxing the muscles of the arm (distal to the elbow) (Schmidt & Carter, 
1990). 
(xvii ) Thigh 
The girth of the thigh was taken 1 cm below the level of the gluteal fold, perpendicular to 
the axis of the thigh. The subject stood erect with feet slightly apart and mass equally 
distributed on both feet. 
(xviii) Calf 
This is the maximum girth of the calf. The subject stood facing away from the measurer in 
an elevated position as this position allows the measurer to align the eyes with the tape. 
The measurement was taken from the lateral aspect of the leg by placing the tape around 
the calf in the prescribed manner. The maximal girth was found by using the middle 
fingers to manipulate the position of the tape in a series of up or down measurements. 
The level was marked on the medial aspect of the calf (Schmidt & Carter, 1990). 
3.6.2.4 Precautions 
The following steps were taken to reduce errors and obtain accuracy in anthropometric 
measurement: 
• It was ensured that the calipers were accurately measuring the distance between 
the centre of their contact faces by using the short blades of the caliper. It was also 
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ensured that the tension of the jaws of the calipers remained constant throughout 
the range of measurement. 
• The skinfold sites were carefully located using the correct anatomical landmarks 
and each measurement was repeated twice and the average taken. 
• The skinfold was raised at the marked line and grasped in a such way that a double 
fold of skin plus the underlying subcutaneous adipose tissue was held between the 
thumb and index finger. 
• The nearest edge of the contact faces of the calipers was applied 1 cm lateral to the 
thumb and finger because if the calipers are placed too deeply or too shallow 
incorrect values would be recorded. The calipers were held 900 to the surface of 
the skinfold site during the entire period of the study and the measurement recorded 
two seconds after the full pressure of the calipers . 
• Skinfold thickness was measured in succession to avoid experimental bias 
(Schmidt & Carter, 1990). 
3.6.3 Dietary Intake 
At baseline, a validated food frequency questionnaire (adapted from the Transition and 
Health During Urbanisation of South Africans [THUSA] study [Potchefstroom University] 
was used (Appendix C) to determine the habitual types and quantities of food and drink 
consumed by respondents over the six months prior to data collection, and to determine 
the habitual intakes of total energy, macronutrients and micronutrients. The food 
frequency questionnaire (FFQ) was administered by the researcher and four other team 
members, after attending a training session delivered by an invited dietician. Both 
traditional and western foods were included in the food frequency questionnaire. A food 
frequency questionnaire was chosen to determine the dietary intake because it is believed 
to be a suitable method to use for describing the intake of groups rather than for 
individuals (Dwyer, 1998), and is commonly used in epidemiological studies on the relation 
between diet and disease (Willett, 1990; Paton et al., 1996). It also provides an overall 
picture of food intake (Dwyer, 1998; Hammond, 2000), which may be more representative 
of the usual food intake than a few days of diet records, and it is relatively inexpensive. 
The reproducibility of the FFQ was not measured due to the fact that the instrument was 
only used to asses baseline intake of the sample population. No follow-up data was 
collected. 
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Food models were used so as to assist with the accuracy of the size of food portions 
described by the respondents. Each respondent was asked to demonstrate the quantity of 
a given food that helshe consumed on a daily, weekly or monthly basis via an interview. 
The researcher and other four members of thye research team completed the food 
frequency questionnaire. Local interpreters were used for patients who could not speak 
English. 
The portion sizes were estimated using hold measures and converted to grams using the 
conversion figures in the NRINO Food Quantities Manual (Langen hoven et al. , 1998). The 
quantities of food consumed on a daily basis were entered accordingly. The quantities of 
foodstuffs not selected by the respondents per day, were calculated as food in grams 
consumed per week divided by 7 days, or food in grams consumed per month divided by 
30 days. The recorded food items were coded by means of food composition tables of the 
Medical Research Council of South Africa (Langenhoven et al., 1998). 
Complex dishes not appearing in the food composition tables were broken down into 
individual ingredients and weights and coded as such. The dietary data were analysed by 
means of a computer software programme applying the MRC food composition tables. 
The energy intake was compared to the estimated energy requirement. Macro-and 
micronutrient intakes were compared with the recommended daily allowances (ROA) or 
Adequate (AI) (USA Food and Nutrition, 1989 and 2001). A value of <67% of the ROAIAI 
was considered to be inadequate (Sappey et al., 1994). 
3.6.4 Study Supplement 
3.6.4.1 Supplement Ingredients 
Extract of Hypoxis 
Grape Fruit Seed Extract 
Sitosterol & Sitosterolin 
Beta Carotene 
Vitamin E 
Vitamin B6 
Vitamin B1 
Vitamin B2 
99 
500 mg 
4 mg 
28 mg 
1 mg 
12.5 mg 
7.5 mg 
3.75 mg 
10 mg 
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Vitamin B12 
Nicotinamide 
Vitamin C 
Olive Green Leaf Extract 
Folic Acid 
Natural Anti-Oxidant (Biocydin) 
3 iJg 
5mg 
50 mg 
35 mg 
325 iJg 
52 mg 
3.6.4.1.1 Motivation for Inclusion of each Ingredient in the Supplement 
According to Professor HC Barnard (Bermins Manual, 2004), the following motivations are 
provided for inclusion of each ingredient in the supplement: 
(i) Extract of Hypoxis: The anti-HIV and anti-inflammatory properties of rooperol 
in the extract of the African potato in Africa's Solution is of great benefit. It 
brings about a feeling of well-being and slows down the progression of the 
disease in the HIV-positive person. 
(ii) Grapefruit Seed extract (GSE): It has been proven that grapefruit seed extract 
kills over 800 assorted bacteria and virus strains. When compared to 30 
effective antibiotics and 18 proven fungicides, GSE has proven to perform as 
well as any and all agents tested, without exhibiting the harmful side effects 
usually associated with antibiotic use. It is a powerful but gentle, effective, non-
toxic agent of broad-spectrum application. 
(iii) Plant sterols (Sitosterol and Sitosterolin): Reports from scientific papers 
indicate that plant sterols have a beneficial effect on the immune system (they 
enhance the production of lymphocytes (T-cells), interleukin II and interferon n-
alpha. This immune system modulating effects of the plant sterols, mainly beta-
sitosterol and beta-sitosterolin is seen by some scientists as an important 
function of yet another essential micro-nutrients which fits the definition of a 
vitamin. 
(iv) Beta-carotene: Is a known lipid soluble anti-oxidant. It can be concluded that 
beta-carotene together with vitamin E protect the tissues of the body including 
the white blood cells against free radical damage during the oxygen burst of the 
inflammation process after an infection. 
(v) Vitamin E: Is the most important biological anti-oxidant. It prevents lipid 
peroxidation, free radical scavenger and regulation of metalloenzymes such as 
super-oxide dismutase, catalase, glutathione peroxidase. 
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(vi) Vitamin B6: Is a co-enzyme of aminotransferases, deaminases and 
decarbohydrates involved in all amino-acid reactions, biosynthesis of neuro 
transmitters. 
(vii) Vitamin B1 : Is a coenzyme for alpha-keto acid decarboxylases and 
transketolases in involved in energy production, anti-oxidant generation and 
nucleic acids synthesis. 
(viii) Vitamin B2: Is a coenzyme of L-amino acid oxidase, D-amino acid oxidase, 
dehydrogenase, vitamin K and cytochrome oxidase. It is involved in energy 
prod uction. 
(ix) Vitamin B12 : Many studies of people with HIV in the USA and Africa reported 
low serum B12 levels even among asymptomatic persons. Low serum B12 
levels are associated with neurological abnormalities, for example neuropathy, 
impaired cognition and reduced CD4+T -cells, hence its inclusion in the 
supplement. 
(x) Nicotinamide: Is a coenzyme involved in glucose-6-Phosphate dehydrogenase, 
glutamate hydrogenase and Krebs cycle. As electron transport carrier. 
(xi) Vitamin C: Vitamin C has been found to stimulate the production of interferons, 
the proteins that protect cells against viral attacks. It can also stimulate the 
positive chemotactic and proliferative responses 0 neutrophils. It has been 
shown that vitamin C can stimulate the synthesis of the humoral thymus factor 
and antibodies of the IgG and IgM classes. A striking property of vitamin C is its 
ability to inactivate viruses and inhibit viral growth in their host cells. 
(xii) Olive Green Leaf Extract: The active substance in Olive Green Leaf Extract is 
oleuropein. It is believed to be an excellent fat-soluble anti-oxidant. Research 
articles indicate oleuropein protect LDL from oxidation. In vitro studies have 
shown that oleuropein offer good membrane protection properties as an anti-
oxidant. Oleuropein like grapefruit seed extract is a natural wide spectrum anti-
bacterial, anti-viral and anti-fungal agent. It is the only known lipid anti-oxidant 
which influences the activity of membrane-bound enzymes which function in the 
cytoplasm of the cell. 
(xiii) Folic Acid: Is required for the enzymes that produce DNA for replicating and 
growing cells, including those of the gastrOintestinal (GI) tract, blood and 
growing foetus . Deficiency results in impaired cell division and protein synthesis, 
causing megaloblastic anaemia. If the GI tract is damaged as is common in 
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HIV-related diarrhea, folic acid reabsorption may be impaired, setting off a cycle 
in which deficiency results in further GI tract deterioration and malabsorption of 
other nutrients . 
(xiv) Biocydin: Proanthocyanidins, previously call condensed tannins are chemically 
very similar. They only differ in molecular size (ranging from individual units to 
complex molecules of many link units), shape and attachments of the 
polyphenol rings. These plant flavonoids are found in many woody plants. The 
best study and well known oligomeric proanthocyanidins are those extracted 
from the white pine of southern Europe (Pinus maritime, P. pinaster) and grape 
seeds . Grape seeds extracts have 7 to 15 percent more proanthocyanidins and 
has been reported to be more potent and therefore, more economical. It is clear 
that the proanthocyanidin content and anti-oxidant activity differ greatly frorn 
extracts of the same plant in different parts of the world in some cases. The 
proanthocyanidin content and anti-oxidant activity from the South African pine 
bark extract is very low. The highest anti-oxidant potency is found from pine 
bark extracts from southern Europe and Canada. In the past 10 years, the 
proanthocyanidin content and anti-oxidant activity was under investigation and a 
high proanthocyanidin and anti-oxidant activity was found in an extract from the 
bark of an indigenous South African free growing in the semi desert region of the 
country. This extract is commercialised and called biocydin . It is reported that 
the anti-oxidant activity is up to three tirnes higher than those of the pine bark 
extract. 
3.6.4.2 Supplementat ion 
Following the determination of baseline parameters at the screening visit, the patients 
were given 7.5 rnl of study supplement between 07:00 and 09:00 and 7.5 ml of study 
supplement between 16:00 and 19:00 per day. Staff members of the South African Red 
Cross Community Home Based Care Program, in the community, handled the dosing and 
monitoring of the supplement intake and compliance on daily basis for three months. 
It was ensured that records of the receipt and administration of the study supplement were 
kept and that the supplement was not used for purposes other than as directed by the 
protocol. On the cornpletion of the study, the rernainder of the study supplement (with the 
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exception of the retention sample) was returned to the sponsor, together with a letter of 
acknowledgement of receipt. This document was signed by the sponsor and thus formed 
part of the supplement file documentation and it was archived as such. The retention 
sample, supplied by the sponsor was stored for a period of time in accordance with the 
sponsor's requirements. Patients carried on with their normal diet. 
3.6.5 
3.6.5.1 
Laboratory Investigations 
Blood Sampling 
Baseline immunological and haematological parameters were performed on the blood 
samples that were collected from the patients by registered medical personnel before 
supplementation. Full blood count, CD4+T-cell count, CD8+T-cell count were determined 
at screening and monthly visits, while the viral load was done at the screening and at the 
end of study. 
3.6.5.2 Haematological Parameters 
A Beckman Coulter machine was used to determine the haematological parameters. The 
haematological parameters determined in this study include red cell count, haemoglobin, 
white cell count, differential count, haematocrit (Hct), mean cell volume (MCV), mean cell 
haemoglobin (MCH), mean cell haemoglobin concentration (MCHC), red cell distribution 
width (RDW), and platelet count. 
(i) Principle of Operation of the Beckman Coulter Machine 
The Coulter method counts and sizes cells by detecting and measuring changes in 
electrical resistance when a particle in a conductive liquid passes through a small 
aperture. As each cell goes through the aperture, it impedes the current and causes a 
measurable pulse. The number of pulses signals the number of particles. The height of 
each pulse is proportional to the volume of that particle. 
While the number of pulses indicates particle count, the amplitude of the electrical pulse 
produced depends on the cell's volume. Theoretical analysis of the behaviour of particles 
within an aperture shows that the height of the electrical pulse produced by the cell is the 
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characteristic that most nearly exhibits proportionality to the cell volume (Dacie & Lewis, 
1985). 
(ii) Procedure 
(a) White blood cell, Red blood cell and Platelet count 
The procedure for determining the haematological parameters was done according to the 
manufacturer's instruction (Beckman, USA). 
(b) Measurement of Haemoglobin 
The system used the lysed WBC dilution to measure haemoglobin. The absorbance of 
light from a Light Emitting Diode (LED) is measured at 525 nm through the optical 
pathlength of the bath. A beam of light from an LED passes through the sample, through a 
525 nm filter and is measured by a photodiode. The signal is amplified and the voltage is 
measured and compared to the blank reference reading. 
(iii) Derivation of Parameters 
(a) White blood cell (WBC) counts 
This is the number of leucocytes measured directly, multiplied by a calibration constant 
and expressed in thousands of leucocytes per microlitre of whole blood. 
WBC = n x 103/~1 
(b) Red blood cell (RBe) counts 
This is the number of erythrocytes measured directly, multiplied by a calibration constant 
and expressed in millions of erythrocytes per microlitre of whole blood 
RBC = n x 106/~1 
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(c) Platelet count 
This is the number of thrombocytes derived from the platelet fitted curve, multiplied by a 
calibration constant and expressed in thousands of thrombocytes per microlitre of whole 
blood. 
Platelet = n x 103 celis/iJl. 
(d) Mean cell volume (MCV) 
This is the average volume of individual erythrocytes derived from the RBC histogram. 
The system multiplies the number of RBC in each channel by the size of the RBC in that 
channel. The products of all channels between 36 fl and 360 fl are added. The analyser 
then multiplies the count by a calibration constant and expresses MCV in femtolitres (fl). 
(e) Haematocrit (Hct) 
This is the computed relative volume of erythrocytes and is expressed as a percentage. 
Haematocrit (%) = RBC x MCV/10 
(f) Mean cell haemoglobin (MCH) 
This is the computed weight of haemoglobin in the average erythrocyte, expressed in 
picograms (pg) 
MCH (pg/celi) = Haemoglobin x10/RBC. 
(g) Mean cell haemoglobin concentration (MCHC) 
This is the computed average weight of haemoglobin in a measured dilution, expressed in 
grams of haemoglobin oer decilitre (dl) of erythrocytes. 
MCHC (g/dl) = Haemoglobin x 100/Haematocrit. 
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(h) Red cell distribution width (ROW) 
This is the size distribution spread of the erythrocyte population derived from the RBC 
histogram. It is the coefficient of variation (CV) expressed as a percentage of the RBC 
size distribution. 
Platelet = n x 1 03 cells/~I. 
3.6.5.3 Method for Determining C04+T-cell Count 
The CD4+/CD8+T-cell counts are measured using a principal method called flow cytometry 
in which blood cells are passed through a specially designed flow chamber and the 
physical characteristics of the cells (size and granularity) are measured with laser 
technology. This process also leads to the detection of any surface markers, such as 
CD4, which have been stained with fluorescent monoclonal antibodies. The four-colour 
direct immunofluorescence technique with a suitably equipped flow cytometer for CD3+, 
CD4+ and CD8+T-cell counts supplied by Becton Dickinson (BD Ltd , South Africa was 
used for this study. 
(a) Principle 
When whole blood is added to the reagent, the fluorochrome-labelled antibodies in the 
reagent bind specifically to the leucocyte surface antigens. During acquisition, the cells 
travel past the laser beam and scatter the laser light. The stained cells fluoresce. These 
scatter and fluorescence signals, detected by the instrument, provide information about the 
cell 's size, internal complexity and relative fluorescence intensity. Multi TEST reagents 
employ fluorescence triggering, allowing direct fluorescence gating of the lymphocyte 
population to reduce contamination of unlysed or nucleated red blood cells in the gate. 
The Multi TEST program on the FACSCCalibur flow cytometer automatically gates the 
lymphocyte population from a CD45 against side scatter display (Jackson, 1990). 
Human lymphocytes can be divided into three major populations based on their biological 
function and cell-surface antigen expression: T -lymphocytes, B-Iymphocytes and natural 
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killer (NK) lymphocytes. SD Multi TEST CD3 FIT/CD8 PE/CD45 PerCP/CD4 APC is used 
to identify and determine the percentages and absolute counts of mature human T-
lymphocytes (CD3+), suppressor/cytotoxic T-Iymphocyte subsets (CD3+/CD8+) and 
helper/inducer T -lymphocyte subsets (CD3+/CD4+) in an erythrocyte-lysed blood sample 
(Jackson, 1990; Romeu et aI., 1992; Martin, 2000). 
(b) Procedure for Measuring CD4+/CDS+T cell Count 
The EDTA tube containing a patient's blood sample was vortexed for a few seconds to 
allow for proper mixing of the sample. Each sample was checked for clots with an 
applicator stick and the applicator stick was subsequently disposed of. Ten (10) 4.1 (1 : 1 
diluted) of CD3/CD4/CD45 monoclonal antibody was placed into each tube. Fifty (50) 4.1 of 
the patient's whole blood was added to the tube containing the antiserum. The same was 
done with the Immuno-Trol control. The tube was vortexed and incubated in the dark at 
room temperature for 15 minutes. Five hundred (500) 4.1 of lysing solution was added to 
the mixture of antibody and blood and spun on a vortex machine. The tube was further 
incubated in the dark at room temperature for 15 minutes. The specimen mixture was 
then analysed on the FACS Calibur MUL TISET programme 
3.6.5.4 Determination of Viral Load (HIV-RNA) 
The Amplicor HIV-1 Monitor Test, version 1.5 (v 1.5) was used for the quantitation of HIV-
RNA in this study (Roche Diagnostic Systems, Inc., USA). It is an in vitro nucleic acid 
amplification test for the quantitation of HIV-1 in human plasma. 
(i) Sample Collection 
The Amplicor HIV-1 Monitor Test, v1.5, is used with plasma specimens only. Five ml of 
blood was collected from each patient into sterile EDTA sample tube. 
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(ii) Separation of Blood Sample 
The plasma was separated from the whole blood by centrifugation at 800 revolutions per 
minute for 20 minutes at room temperature. The separation occurred within 6 hours of 
collection. Plasma specimens were stored frozen at -80°C and analysed in due course. 
(iii) Specimen Preparation 
The AMPLICOR HIV-1 MONITOR Test, v 1.5, can be used with either of two specimen 
preparation procedures, viz the Standard procedure or the Ultra Sensitive procedure. For 
this study, the standard procedure was used. In the Standard specimen preparation 
procedure, HIV-1 RNA was isolated directly from plasma by lysis of virus particles with a 
chaotropic agent followed by precipitation of the RNA with alcohol. A known number of 
quantitation standard RNA molecules were introduced into each specimen with the lysis 
reagent. The HIV-1 Ouantitation Standard was carried through the specimen preparation, 
reverse transcription, amplification and detection steps and used for the quantitation of 
HIV-1 RNA in the test specimen. 
(iv) Principle of the Test 
The Amplicor HIV-1 Monitor Test, v 1.5, is based on five major processes: specimen 
preparation; reverse transcription of target RNA to generate complementary DNA (cDNA); 
PCR amplification of target cDNA using HIV-1 specific complementary primers; 
hybridization of amplified DNA to oligonucleic probes specific to the targets, and detection 
of the probes bound amplified DNA by colorimetric determination. In the Amplicor HIV-1 
Monitor Test, v1.5, the reverse transcription and amplification of HIV-1 and quantitation 
standard (OS) RNA occur simultaneously. The Master mix reagent contains a biotinylated 
primer pair specific for HIV-1 and OS target nucleic acid. 
The quantitation of HIV-1 viral RNA is performed using the HIV-1 Ouantitation Standard 
(OS) (Tris HCL buffer: <0.001 %, non-infectious in vitro transcribed RNA (microbial 
containing HIV-1 primer binding sequences) and a unique probe binding region «0.005% 
Poly rA (synthetic), EDTA, Amaranth dye, 0.05% Sodium azide). The HIV-1 Quantitation 
Standard is a non-infectious RNA transcript that contains identical primer binding sites to 
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the HIV RNA target and a unique probe binding region that allows quantitation standard 
amplicon to be distinquished from HIV-1 amplicon. The Quantitation Standard is 
incorporated into each individual specimen at a known copy number and is carried through 
the specimen preparation,reverse transcription, PCR amplification, hybridization and 
detection steps along with the HIV-1 target, and is amplified together with the HIV-1 target. 
HIV-1 RNA levels in the test specimens are determined by comparing the HIV-1 signal to 
the quantitation standard signal for each specimen. The quantitation standard 
compensates for effects of inhibition and controls the amplification process to allow the 
accurate quantitation of HIV-1 RNA in each specimen (Myers & Gelfand, 1991; Wilson, 
1990; Kwok & Sninsky, 1993; Saag et al., 1996). 
3.6.6 Physical Examination 
A general physical examination was performed during the screening and monthly visit by a 
medical practitioner (Appendix 0). All concomitant medications given to patients during 
the course of study were documented in the clinical reference form (CRF). 
3.7 Statistical Analysis 
The results obtained from this study were analysed by an independent Biostatistician at 
the University of the Free State, South Africa. For all the patients as well as for genders 
separately, the following statistical analysis was done for the monthly, screening and final 
visits. 
Continuous variables were described by using mean, standard deviation and median or 
percentiles where applicable. Categorical variables were described by frequencies and 
percentages. Some variables were classified into categories (normal values, less than 
normal or greater than normal values) and were described by frequencies and 
percentages, together with other categorical variables. 
The difference between screening visit and final visit (screening-final) was calculated for 
continuous variables and described by medians and percentiles and the results were 
compared using the Willcoxon Igned Rank test as well as non-parametric confidence 
intervals for the median paired difference. 
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The change in categories of the variables, classified according to normal ranges from 
screening visit to final visit, was described by contingency tables. 
The difference between the genders during each of the screening and final visits was 
calculated and the genders were compared using the Chi-Square test for categorical 
variables. Continuous variables were compared using the Mann-Whitney test and 95% 
non-parametric confidence intervals. 
Spearman rank order correlations were calculated between some of the variables. The 
analysis of variables was done using SAS (1990). 
3.8 Good Clinical Practice (GCP)/Quality Assurance 
The study was conducted in compliance with the protocol and the following 
recon:mendations and guidelines: 
• Department of Health, South Africa (Clinical Trials Guidelines, 2000) 
• The declaration of Helsinki (Scotland Revision, 2002) 
• ICH Guideline for Good Clinical Practice (1997) 
Internal checking was carried out at all stages of the study. 
3.9 Summary 
This was a clinical trial to determine the influence of a nutritional supplement on the 
immune, haematological parameters, anthropometric profile and clinical conditions of HIV-
positive/AIDS patients. 
The socio-demographic composition of the patients was determined using a questionnaire. 
A validated food frequency questionnaire was used to assess the baseline macronutrient 
and micronutrient intakes of the patients. Weight, height, circumference (waist and hip) 
and skinfold measurements were obtained and employed to calculate the body mass 
index, fat distribution and percentage fat of patients respectively. Assessrnent of the 
physical and medical conditions of the patients was done by a medical practioner and the 
information entered into a clinical reference form (CRF). 
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At baseline, the socio-demographic and food frequency questionnaires were completed . 
The anthropometric measurements were performed at baseline as well as at the end of 
nutrient supplementation. Blood samples were collected by health personnel for 
haematological parameters, "immune factors and viral load and determined by standard 
methods and procedures. The haematological parameters, immune factors were 
repeatedly monthly while the viral load was repeated at the end of the study. 
The statistical analyses (mean, median, percentiles, differences and correlations) of the 
variables was done by an independent Biostatistician at the Faculty of Health sciences, 
University of the Free State. 
3.10 Limitations of the study 
Certain factors limited the outcome of the results of this study and stated below: 
In general, the cross-sectional nature of the study, the small number of patients studied, 
the absence of a control group and the lack of references adapted for HIV-positive/AIDS 
patients, make it difficult to extrapolate the results of this study. 
Furthermore, in the present study, there is a lack of information on some important 
predictors of patients' nutritional status, for instance, blood levels of the corresponding 
nutrients analysed using food frequency questionnaire in the study were not determined 
and therefore prevent one from making casual references or definite conclusions 
Although necessary precautions were taken in collating dietary data from patients (a food 
frequency questionnaire was used to determine the habitual types, quantities and 
frequency of food and drink consumption by recording consumption on a daily, weekly and 
monthly basis over a period of six months prior to the study), it is possible that difficulties 
regarding recalling food intake correctly and over reporting were experienced and possibly 
contributed to the dietary intake recorded . Also, whether the increase in energy intake is 
sustained every day or is only representative of their intake during best days or days 
during during recording of food intake, cannot be confirmed by the food frequency 
questionnaire at baseline. 
It is possible that certain factors such as malabsorption, and drug-nutrient interaction (for 
example, TB treatment) could have limited the potential positive effect of the supplement 
on the parameters measured. 
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Time of collection and analysis of blood samples was a factor that limited the outcome of 
the study. 
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Chapter 4 
An Analysis of the Baseline Dietary Intake of HIV-
positive/AIDS Patients Residing in a Low Socio-
economic Community in Bloemfontein 
4.1 Abstract 
This study analysed the baseline dietary intake of people living with HIV/AIOS in the 
African community of Bloemfontein. A validated food frequency questionnaire was used to 
assess the dietary intake of both macronutrients and micronutrients in 35 HIV-
positive/AIDS patients. The patients demonstrated energy and dietary intake of major 
macronutrients higher than the EEl and ROA respectively and this tended to be higher 
(P<0.05) in males than in females. The result also showed that the mineral and trace 
element dietary intake exceeded the RONAl , except for iodine and selenium. The majority 
of the patients reported adequate intake of most vitamins; however a relatively high 
percentage of the patients indicated an inadequate intake for folate and vitamin O. It is 
envisaged that the high dietary intake of major macronutrients and micronutrients will help 
in maintaining the nutritional status and in reducing wasting in the patients. However, the 
relatively high percentage of the patients with an inadequate intake of iodine, selenium, 
folate and vitamin 0 is of great concern and calls for urgent attention. 
4.2 Introduction 
Good nutrition is the cornerstone for maintaining an optimum immune response (Woods et 
a/., 2002). Normal antibody production, phagocytic cell and T-Iymphocyte functions 
depend on the adequate intake of energy, protein, fat, minerals and vitamins (Semba, 
1994; Scrimshaw & SanGiovanni, 1997). It is a fact that malnutrition alters the immune 
function with a subsequent increase in susceptibility to infections (Semba & Tang, 1999), 
faster disease progression (Scrimshaw & SanGiovanni, 1997; Baum & Shor-Posner, 1998; 
Macallan, 1999), reduced functional status, quality of life, and increased morbidity and 
mortality (Scrimshaw & SanGiovanni, 1997; Kotler, 1997). 
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Nutritional deficiencies are well-documented complications of HIV infection (McCorkindale 
et al. , 1990; Cuff, 1990; Macallan, 1999). HIV-positive/AIDS patients develop severe 
protein and energy malnutrition. Several vitamins and minerals have been found to be 
deficient as well. The pathogenesis of nutritional impairment in HIV-positive patients is 
multifaceted and includes decreased food intake, decreased nutrient absorption and 
decreased efficiency of utilisation, in addition to increased nutritional demand (Abrams et 
al. , 1993; Baum et al., 1995; Castetbon et al., 1997; Piwoz & Preble, 2000). Literature 
reports (Fawzi & Hunter, 1998; Kupka & Fawzi, 2002) clearly indicate that HIV infection 
contributes to malnutrition for physiological reasons related to HIV infection itself and 
because most people living with HIV/AIDS, particularly in developing countries, often have 
diets that are deficient in energy, proteins, vitamins and other nutrients. Friis and 
Michaelsen (1998) reported that macro-and micronutrient deficiencies could impair host 
immune functions and affect viral replication and pathogenicity, thus potentially affecting 
the clinical course of HIV infection. Therefore, nutrition may playa role in the progression 
of HIV infection to AIDS, as well as mortality from AIDS . Other studies indicate that in the 
early period of H IV infection, weight gain or maintenance might be achieved through 
adequate diet and that this has helped to reduce the consequences of wasting in people 
living with HIV/AIDS (Semba & Tang, 1999; Piwoz & Preble, 2000). 
Chlebowski et al. (1989) reported reduced dietary intake in AIDS patients compared with 
asymptomatic HIV-positive subjects. McCorkindale et al. (1990) demonstrated decreased 
food intake even in asymptomatic HIV-infected subjects and early AIDS Related Complex 
(ARC) subjects during a 16-month period, and this was associated with significant weight 
loss. On the other hand, Dworkin et al. (1989) and Kotler et al. (1990) found no 
differences in dietary intake among patients with AIDS or AIDS-Related Complex (ARC) 
and asymptomatic HIV-positive controls or uninfected controls. Hellerstein et al. (1990) 
found that dietary intake was adequate in most HIV-positive/AIDS persons. 
Research findings by Tindall & Cooper (1991) and Allard et al. (1998) showed that up to 
50-90% of individuals infected with HIV develop symptomatic primary HIV infection, within 
couple of weeks of being infected with the HIV. In addition to the metabolic effects of the 
febrile illness associated with HIV infection, some specific signs and symptoms of primary 
HIV infection may contribute to the impairment of nutritional status. It is reported that with 
the progression of HIV infection to an advanced stage and in addition to fever, 
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opportunistic infections or malignancies promote reduced food intake due to reduced 
appetite or taste disturbances, such as painful mucosa and lesion of the mouth, pharynx or 
oesophagus (Tindall & Cooper, 1991). Likewise, 30-50% of patients in developed 
countries and about 90% . in developing countries developed diarrhoea and hence 
malabsorption. These factors contribute to impaired nutritional status in HIV-positive/AIDS 
patients (Smith et al., 1992; Macallan, 1999), further affecting the nutritional status of 
people living with the infection/disease. Besides this, economic factors, in particular 
poverty (Babamento & Kotler, 1997) and limited food preparation facilities may limit the 
HIV-positive patients' ability to prepare and have access to foods (Cimoch, 1997), thus 
influencing food and nutrient intake haphazardly. It has also been shown that emotional 
instabilities such as depression, isolation (as a result of social discrimination), 
inaccessibility to and unavailability of food, and difficulties patients have in caring for 
themselves in the late stage of the disease can further affect and reduce food intake 
(Grunfeld & Feingold, 1992; USAID, 2001; Department of Health, South Africa, 2002). 
The effects of HIV infection on the nutritional status are likely to be more pronounced 
among under-privileged populations with a low dietary intake. However, only few data 
have been reported in developing countries (Semba et al. , 1994; Phuapradit et al., 1996; 
Castetbon et al., Dannhauser et al., 1999). Baum et al. (1995) concluded that although 
the metabolic response to HIV infection may contribute to low nutritional status in HIV-
infected individuals, there is no doubt that the intake of nutrients at levels recommended 
for the general population does not appear to be adequate for HIV-1 infected persons. 
Thus, the importance of any possible effects of nutritional deficiency on H IV progression is 
evident. 
Malnutrition associated with HIV infection has serious and direct implications on the quality 
of life of people living with HIV and AIDS (Piwoz & Preble, 2000). Weight loss is often the 
early symptom, followed by a vicious cycle of increased fatigue and decreased physical 
activity, including the inability to prepare and consume food (Semba & Tang, 1999). 
Malnutrition associated with HIV/AIDS affects entire families when infected adults become 
too debilitated to work steadily, unable to provide for themselves and their dependants and 
require continual care during bouts of illness (Piwoz & Preble, 2000). 
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An association between physiological nutritional deficiencies and disease progression has 
been demonstrated in developed countries (Baum et aI., 1995), while a possible 
relationship between dietary intake and disease progression has also been established 
(Dworkin et a/., 1990). However, there are limited data in reference to dietary intakes and 
disease progression in HIV-infected persons from African countries and further studies in 
African countries have been advocated (Castebon et a/., 1997; Dannhauser et a/., 1999). 
The aim of this study was to assess the nutritional status by analysing the dietary intake 
and its association with the stage of HIV infection among HIV-positive/AIDS patients living 
in a low socio-economic community in Bloemfontein, South Africa. 
4.3 Subjects and Methods 
A cross-sectional descriptive study was carried out at Medi Inn Clinic, Bloemfontein and it 
formed part of a clinical trial that involved a target group (HIV-positive/AIDS patients). Fifty 
HIV-1 sero-positive/AIDS patients were recruited from Tsepo home-based care and from 
low socio-economic community in Bloemfontein with the assistance of the Red Cross 
home-based care. An approval from the Ethics Committee of the Faculty of Health 
Sciences, University of the Free State was obtained and all patients gave informed 
consent for inclusion in the study. See chapter 3 for details (see 3.4). 
4.3.1 Sample collection 
This is described in chapter 3 under methodology (see 3.5.5.1) 
4.3.2 Dietary intake 
The detailed information is available in chapter 3 under methodology (see 3.5.3) 
4.3.3 Statistical analysis 
The statistical analyses of results was done by an independent Biostatistician at the 
Faculty of Health Sciences, University of the Free State, South Africa. The details are 
described in chapter 3 (see 3.5.7). 
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4.4 Results 
A total of 50 HIV-positive/AIDS volunteers were enrolled in this study after screening. 
Three patients dropped out, 10 died and 2 relocated to other towns during the period of the 
trial. Eight (8) of the 35 patients who completed the food frequency questionnaire were 
male (22.9%) while 27 (77 .1%) were female. 
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Table 4.1: Baseline energy, major macro nutrients and cholesterol intake of HIV-
positive/AIDS patients. 
Nutrients Mean SO Median ROAIAI % of patients <67% 
of ROAIAI 
Energy (KJ)/day 
Male n=8 20217.4 6992.8 19316.7 12180 0 
Female n=27 18402.8 9102.2 17266.5 9240 11.1 
Whole Group n=35 18817.6 8603.5 17889.6 10710 8.6 
Plant protein (g)/day 
Male 64.8 29.0 56.8 0 
Female 64.0 35.7 62.1 0 
Whole Group 62.3 33.9 62.1 0 
Animal protein (g)/day 
Male 86.2 24.7 92.9 0 
Female 91 .5 79.9 75.3 0 
Whole Group 90.3 70.8 84.6 0 
Total protein (g)/day 
Male 155.9 48.0 131.3 63 0 
Female 159.8 98.6 131.3 50 3.7 
Whole Group 158.9 89.0 131.7 56.5 2.9 
Total CHO (g)/day 
Male 605.8 208.5 554.4 358·430 0 
Female 573.8 315.6 548.2 272·324 3.7 
Whole Group 581.2 292.1 548.2 298·346 2.9 
Total dietary f ibre (g)/day 
Male 40.5 14.1 37.2 38' 12.5 
Female 43.8 26.4 43.6 25' 14.8 
Whole Group 43.1 24.0 46.6 31.5' 14.3 
Total fat (g)/day 
Male 175.3 75.7 149.4 <96 0 
Female 140.0 65.8 132.9 <73 0 
Whole Group 148.1 68.7 144.7 <84.5 0 
Cholesterol (mg)/day. 
Male 595.2 222.0 592.0 <300 0 
Female 536.5 522.4 382.1 <300 0 
Whole Group 549.9 468.5 437.5 <300 0 
*A) (Adequate intake) 
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The nutrient intakes with their mean, standard deviation, median, ROAI AI and the 
percentage of patients with a dietary intake of less than 67% of the ROAlAI, are presented 
in table 4.1. The male (n=8) and female (n=27) HIV-positive/AIOS patients examined in 
this study demonstrated energy and dietary intakes of major macronutrients higher than 
the EER and ROA values respectively. Observation of the results showed that the dietary 
intake tends to be higher in males (P<O.05) than in females except for animal and plant 
protein which were higher in females. As whole group, the majority of the patients 
reported an adequate dietary intake. 
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Table 4.2: Baseline mineral and trace element intake of HIV-positive/AIDS patients. 
Nutrients Mean SO Median ROAIAI % of patients 
<67% of ROAIAI 
Calcium (mg)/day 
Male n=8 1637.0 816.7 1381.1 1200' 0 
Female "=27 1257.1 618.8 1281.9 1000' 18.5 
Whole Group "=35 1343.9 675.5 1295.7 1100' 14.3 
Copper (mg)/day 
Male 3.1 1.8 2.2 0.9 0 
Female 3.4 3.9 2.5 0.9 7.4 
Whole Group 3.4 3.5 2.5 0.9 5.7 
Total iron (mg)/day 
Male 25.0 13.8 19.0 8 0 
Female 25.6 19.3 22.2 18 25.9 
Whole Group 25.4 18.0 21.4 13 20 
Chromium (mg)/day 
Male 70.9 30.3 57.9 25' 0 
Female 61.0 58.0 42.8 25' 11.1 
Whole Group 63.2 52 .7 52.7 25' 8.6 
Zinc (mg)/day 
Male 20.4 7.3 20.3 11 0 
Female 18.1 10.4 16.3 8 7.4 
Whole Group 18.6 9.7 18.0 9.5 5.7 
Magnesium (mg)/day 
Male 706.4 268.7 646.6 420 0 
Female 696.8 353.7 674.4 320 7.4 
Whole Group 699.0 332.4 674.4 370 5.7 
Selenium (mg)/day 
Male 77.0 37.0 71 .5 55 12.5 
Female 71.1 78.8 38.6 55 48.2 
Whole Group 72.4 71.0 45.4 55 40 
Iodine (mg)/day 
Male 74.0 27.8 78.3 150 75.0 
Female 52.9 41.4 38.8 150 82.9 
Whole Group 57.7 39.4 46.7 150 82.9 
• Adequate Intake 
123 
© Central University of Technology, Free State
An examination of the mineral and trace element intakes as shown in table 4.2, revealed 
that the median intake exceeded the RONAl, except for iodine. In the male patients (n=8), 
12.5% took in less than 67% of the RDA for selenium while 75% of the male patients took 
in less than 67% for iodine. · On the other hand, 48.2% of the female patients (n=27) had 
an inadequate intake of selenium and 82.9% of the female patients (n=27) had an 
inadequate intake of iodine. The micronutrient intakes were also higher in the male 
patients than in the female patients with the exception of copper and total iron. This 
inadequate intake of selenium and iodine is also reflected in the whole group of patients 
studied. The difference in the number of male and female patients was taken into 
consideration in the statistical analysis of the data. 
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Table 4.3: Baseline vitamin intake of HIV-positive/AIDS patients. 
Vitamins Mean SO Median ROA/AI % of patients < 
67% ROA/AI 
Niacin (mg NE)/day 
Male n=8 38.5 20.6 29.3 19 0 
Female n=27 36.1 25.8 29.9 14 7.4 
Whole Group n=35 36.7 24.4 29.9 11.5 5.7 
Riboflavin (mg)/day 
Male 3.7 1.9 3.1 1.3 0 
Female 3.1 3.3 2.5 1.1 7.4 
Whole group 3.2 3.0 2.7 1.2 5.7 
Thiamine (mg)/day 
Male 3.3 1.9 2.6 1.2 0 
Female 3.4 2.3 2.7 1.1 7.4 
Whole Group 3.3 2.2 2.7 1.2 5.7 
Vitamin A (~g RE)/day 
Male 1485.9 1010.7 1171.6 900 12.5 
Female 2179.3 2879.7 1221 .9 700 14.B 
Whole Group 2020.8 2576.6 1221 .9 BOO 14.3 
Vitamin E (mg a TE)/day 
Male 24.03 9.92 21.3 15 0 
Female 23.85 15.89 17.0 15 14.8 
Whole group 23.B9 14.61 20.4 15 11 .4 
Vitamin C (mg)/day 
Male 199.0 213.2 137.6 90 12.5 
Female 223.7 225.6 139.4 75 1B.5 
Whole group 218.1 220.0 139.4 82.5 17.1 
Vitamin 0 (~g)/day 
Male 10.3 6.00 9.4 15- 12.5 
Female 6.2 4.5 5.0 5- 29.6 
Whole Group 7.2 5.1 5.B 10- 25.7 
Vitamin K mg/day 
Male 199.5 161.2 141.B 120- 25.0 
Female 287.0 405.1 134.9 90- 11.1 
Whole Group 267.0 363.7 134.9 105- 14.3 
'Adequate Intake 
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Table 4.3 (continued): Baseline vitamin intake of HIV-positive/AIDS Patients. 
Vitamins Mean SO Median ROAIAI % of 
patients 
<67% RDA 
Vitamin B, (mg)/day 
Male 3.4 1.5 3 .0 2.4 0 
Female 3.0 1.7 2.6 1.3 7.4 
Whole group 3.1 1.6 2.6 1.4 5.7 
Vitamin B" (~g)/day 
Male 16.8 15.2 10.2 1.7 0 
Female 23.6 47.8 10.7 2.4 0 
Whole group 22.1 42.4 10.4 2.5 0 
Folate (~g)/day 
Male 406.7 280.8 287.4 400 37.5 
Female 399.4 300.3 332.7 400 33.3 
Whole group 401 .1 291.9 332.1 400 34.3 
* Adequate Intake 
Table 4.3 shows that the majority of the male and female patients and the whole group 
demonstrated median dietary intake higher than the RDAIAI. In addition, table 4.3 
indicates the percentage of patients who took in less than 67% of the RDAIAI for these 
groups of patients. The median dietary intake of vitamins A, C, K, folate and B1 2 was 
higher in the female patients than in the male patients. The male group reported a higher 
intake of other vitamins except riboflavin and thiamine. A relatively high percentage of the 
study population reported an inadequate intake of folate and vitamin 0 
4.5 Discussion 
Adequate nutrition, which is best achieved through consumption of a balanced healthy diet 
is vital for the health and survival of all HIV-infected persons. Energy requirements are 
likely to increase by 10% to maintain body weight and physical activity in asymptomatic 
HIV-infected adults . During symptomatic HIV infection, and subsequently during AIDS , 
energy requirements increased by approximately 20% to 30% to maintain adult body 
weight (WHO, 2003). 
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As observed in this study, the median energy intake is higher than the EER for both male 
and female patients (table 4.1). This agrees with previous findings as reported by Hogg et 
al. (1995) that HIV-infected patients had a higher energy intake than their HIV-negative 
counterparts. The present results also confirm the World Health Organization (WHO, 
2003) report that energy requirements increase significantly during the symptomatic stage 
of HIV-infection. It is important to note that energy intake is related to the stage of the 
infection, rapid weight loss, anorexia, opportunistic infections, malabsorption and altered 
metabolism (Kotler et al. , 1990). In another study performed by Kim et al. (2001), it was 
suggested that energy and dietary intake is a complex socio-behavioural phenomenon that 
reflects the confluence of attitudinal, economic and lifestyle factors. In the population 
studied, these factors may have contributed in one way or the other to the higher energy 
intake. Although necessary precautions were taken in collating dietary data from patients 
(a food frequency questionnaire was used to determine the habitual types, quantities and 
frequency of food and drink consumption by recording consumption on a daily, weekly and 
monthly basis over a period of six months prior to the study), it is possible however that 
difficulties regarding recalling food intake correctly and over reporting were experienced 
and possibly contributed to the dietary intake recorded. 
It is also possible that the higher energy intake may be directly or indirectly related to the 
staple food consumed by the population. Whether this increase in energy intake is 
sustained every day or is only representative of their intake during "best" days or days 
during recording of food intake, cannot be confirmed by the food frequency questionnaire 
at baseline. If it is agreed with the WHO (2003) that energy requirements increase 
significantly as the HIV disease progresses, then it might be viewed as a good trend for 
patients with a high energy intake as reported in this study. The higher energy intake 
could assist to a certain degree in reducing wasting and improve the well-being of the 
patients. According to Macallan (1999), reduced energy intake promotes wasting. 
Both male and female patients reported a median total protein intake of 131.3 g higher 
than the RDA of 63 9 and 50 g respectively, while 3.7% of the female patients took in less 
than 67% of the RDA (table 4.1). Walsh et al. (2003, unpublished work) also reported a 
median total protein intake in HIV-positive patients that was higher than the RDA. 
According to Dannhauser et al. (1999), and Kim et al. (2001) studies carried out on HIV-
infected patients in the Free State province of South Africa and in Boston (USA) 
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respectively, reported that majority of the patients had a total protein intake that met at 
least 67% of the RDA. The high intake of total protein as observed in this study is 
suggested to be associated with urbanisation. It is believed that, in some cases, 
urbanisation is accompanied by an increased intake of animal protein depending on the 
economic status of the individual. It has been observed that diets become diverse with 
urbanisation and that more people add meat, fish, diary products. eggs and cheese to their 
meals (Drewnowski & Popkin, 1997). The availability of cheaper cuts of red meat, offal, 
sausage, chicken and chicken offal could have contributed to the high intake of total 
protein in the studied population. The median plant protein intake (62.1 g) in the female 
subjects was higher than that of their male counterparts [56.8 g] (table 4.1). The median 
plant protein intake reported for male and female subjects was lower than the animal 
protein intake for both sexes (being 92.9 g in male and 75.3 g in the female subjects, table 
4.1). This is in line with the work of Macintyre (1998) who found that the ratio of plant to 
animal protein intake has changed significantly in the diets of urbanised Africans, with rural 
Africans consuming more plant proteins than their urban counterparts. The high total 
protein intake may compensate for the increased urinary nitrogen loss, increased protein 
utility, decreased skeletal protein synthesis and increased skeletal muscle breakdown that 
is reported in HIV-infected individuals. The differences in plant and animal protein intake 
between male and female subjects, as seen in this study, is not clear, but may partly be 
related to economic and social factors. 
The median total carbohydrate intake of both male and female subjects exceeded the RDA 
and may have contributed significantly to the energy intake, required to meet the metabolic 
needs of HIV-positive/AIDS patients. The median intake of dietary fibre in the male 
patients was slightly lower than the AI intake, but was not significantly lower than the AI 
while the median dietary fibre intake of female subjects exceeded the AI (table 4.1). The 
dietary fibre is known to reduce colonic cancer and the consumption of minimally 
processed foods such as whole-wheat bread and whole-wheat rice should be encouraged 
in respect of HIV-positive/AIDS patients. On the whole, the total carbohydrate intake may 
compensate for increased peripheral glucose utilization and increased gluconeogenesis 
common in advanced HIV disease (Piwoz & Preble, 2000). 
The total fat intake of 149.4 g/day for male patients and 132.9 g/day for female patients 
(table 4.1) exceeded the RDA of <96 g and <73 g per day for male and female subjects 
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respectively . In both male and female patients the dietary intakes were significantly higher 
than the RDA, with the male patients showing a higher intake. The high intake of fat may 
be ascribed to preference for cheaper fatty red meat, eggs, brick margarine, meat 
drippings and potato crisps. There is no evidence that total fat needs are increased 
beyond normal requirements as a consequence of HIV infection. To ensure macronutrient 
intakes at RDA, HIV-positive/AIDS patients are encouraged to consume healthy diets, 
nevertheless the dietary intake of macronutrients at RDA may not be sufficient to correct 
nutritional deficiencies in HIV-infected populations. Because weight and lean body mass 
changes are major indicators of the health status of people living with H IV/AIDS, an 
optimal intake of kilojoules and protein is vital and, according to Woznicki & D'Alessandro 
(1997), the intake of calorie-yielding nutrients (carbohydrates, protein and fat) at levels that 
exceed the RDA is advisable. 
The role of micronutrients in immune and infectious disease is well established (WHO, 
2003). Observational studies have shown that low blood levels and decreased dietary 
intakes of some micronutrients are associated with faster HIV disease progression, altered 
immune function and mortality. However, these studies' methodological limitations 
preclude definitive conclusions about the relationship between micronutrient dietary 
intakes and HIV infection. In this study, the majority of patients demonstrated an adequate 
or high intake of micronutrients that was 67% or higher than the RDA. The study also 
revealed the percentage of some micronutrients with an intake of less than 67% of the 
RDA, such as selenium and iodine (table 4.2) and vitamins, such as A, E, D and folate 
(table 4.3) in the male patients. The female patients showed a wider range of inadequate 
intake «67% of the RDA) of calcium, copper, total iron, chromium, zinc, magnesium, 
selenium and iodine (table 4.2) and of vitamins (A, E, C, D, folate, niacin, riboflavin, 
thiamine and 86 , table 4.3). 
Evidence from cross-sectional epidemiological studies have shown that some 
minerals/trace elements may be key factors in maintaining health despite human 
immunodeficiency virus infection and in reducing mortality. For instance, selenium 
appears important in reducing the virulence of HIV and slowing the disease progression, 
while a positive association has been noted between the dietary intake of zinc and the 
CD4+T-cell count of HIV-infected persons (Jariwalla, 1995; Abrams et aI., 1993). Values 
higher than the RDA were identified for calcium, copper, iron, chromium, zinc and 
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magnesium, but not iodine, in male and female patients in this study population. In male 
patients 75% had inadequate intake of iodine. The reason for the high percentage of 
inadequate intake of selenium and iodine, as seen in the population is not quite 
understood since table salt in South Africa is iodated. Each of the mineral/trace elements 
examined in this study may contribute to the general well-being of HIV-infected persons. 
Calcium has been shown to reduce diarrhoea in HIV-positive/AIDS patients (Harriman, 
1989). About 50% of HIV-positive/AIDS patients using protease inhibitors have been 
found to significantly lose calcium from their bones (Nolan ef al. , 2000). In the present 
study, the median calcium intake was higher than the RDA. Therefore, the results 
obtained from this study tend to suggest that patients with a high dietary intake (>RDA), 
might be able to replace lost calcium, especially those who may be fortunate to undergo 
antiretroviral therapy and perhaps reduce the burden of diarrhoea. There is a plan by the 
South African government to start providing antiretroviral drugs for HIV-infected persons. 
If this materialises, it is likely that an adequate dietary intake of calcium could play a 
compensatory role in correcting drug-induced calcium lost from the body. 
Copper is a mineral essential in small amount for proper health and required for red and 
white blood cell maturation, iron transport, cholesterol metabolism, glucose metabolism, 
immune function and protection against oxidative stress (Bowers, 2002). A recent study 
showed that a diet deficient in copper affects the immune system (Bowers, 2002) while 
adequate dietary intake was associated with a significant decrease in the risks of AIDS 
(Bogden ef al., 1990; Tang ef aI., 1993). In the current study, majority of the patients 
showed adequate intake of copper with only 5.7% of intake less than 67% of RDA. It is 
believed that adequate copper intake would enhance immune function and improves the 
nutritional status of the patients living with HIV/AIDS. It is therefore suggested that HIV-
positive/AIDS patients should include legumes, liver, kidney and cow's milk as they are 
rich source of copper. 
Iron is essential for the formation and functioning of red blood cells , and vitamin C is 
known to promote the absorption of iron. In both male and female patients the median 
total iron intake was higher than the RDA, nonetheless 25.9% of the female (table 4.2) 
population took in less than 67% of the RDA. Iron has been observed as a micronutrient 
that is commonly deficient in HIV infection however, an oversupply of iron is also regarded 
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as harmful in HIV infection. When oversupplied, iron can stimulate free radical production 
and further damage the immune system (Cairns, 2001). In one study, iron levels were 
higher in people with HIV infection (Cairns, 2001). Iron blood level was not determined in 
this study so as to verify its correlation with dietary intake. Considering the danger of an 
oversupply of iron, it would be appropriate to measure and monitor blood levels of iron so 
as to be able to regulate its intake in HIV-positive/AIDS patients. As mentioned earlier, 
25.9% of the female population had an inadequate intake of iron as opposed to none in the 
males. The reason for this discrepancy is not clear, but it may be related to the fact that 
iron is lacking in women's food due to a lack of knowledge, or because of extra demands 
during the menstrual cycle (women need extra iron until they pass the menopause stage). 
Anaemia has been associated with increased rates of mortality in American (Sullivan et a/., 
1998), European (Mocroft et aI., 1999) and Malawian (Semba et a/., 2001) studies of HIV-
infected persons. This may have serious implications for patients in this study with an 
inadequate intake of iron. 
Chromium is mainly involved in the metabolism of glucose but recent research in animal 
models showed that chromium can enhance the ability of the white blood cells to respond 
to infection (Hoffman, 1998). Results of the present study indicated a high intake in both 
males and females except for 11.11 % of the female (table 4.2) population with an 
inadequate intake. Information on the role of chromium in HIV information is virtually 
unavailable but it is assumed that in its normal biological function, it would help in proper 
carbohydrate metabolism in HIV-infected persons, as a carbohydrate abnormal 
metabolism has been reported in HIV-infected persons (Piwoz & Preble, 2000). As 
observed in this study, the median intake for chromium was higher than the RDA. it is 
believed that the patients examined in this study will benefit from such high intake. 
Another important element that was considered in the analysis is zinc. Zinc is a mineral 
that is necessary for protein and energy metabolism, as well as in DNA and RNA 
synthesis. It also appears to be essential for T-cell differentiation and maturation as well 
as lymphocyte activation (Chan & Collins, 1997; Kupka & Fawzi, 2002). Dietary intakes of 
zinc in both male and female patients were higher than the RDA. An intake of less than 
67% of the RDA was recorded in 7.4% of the females (table 4.2). There is some evidence 
to an indicate that inadequate dietary intake may contribute to the prevalence of altered 
nutritional status in HIV-infected individuals, underscoring the importance of maintaining 
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adequate nutritional support for HIV-positive/AIDS patients. Kupka & Fawzi, (2002) found 
a positive association between dietary intake of zinc and immune status. By deduction, an 
adequate dietary intake of zinc (other micronutrients inclusive), as seen in the study 
population , could contribute to maintaining the nutritional and immune status of HIV-
positive/AIDS patients. If this applies to other anti-oxidants such as selenium, vitamin A, C 
and E, this could help in maintaining the oxidative status and in tum in reducing the 
oxidative stress which is common in HIV-positive/AIDS patients. Oxidative stress in HIV 
disease may be related to a failure in such anti-oxidant defence mechanisms, as well as to 
the chronic and progressive inflammatory reaction associated with the development of HIV 
infection (Malvy et a/., 1994). It is possible that such a failure in antioxidant defence 
mechanisms is partly the result of an inadequate intake of these antioxidants (zinc 
inclusive) in the diets of HIV-positive/AIDS patients either because of the unavailability of 
the fruitslsources containing the antioxidant or because of economic or social factors . 
Magnesium, one of the minerals examined in the present study is needed for energy 
production and protein synthesis and is found in whole grains, legumes, leafy green 
vegetables and nuts. An adequate intake can assist in preventing muscle spasms and 
tremor and it seems likely that an adequate or high intake in HIV-positive/AIDS would 
therefore be useful to these patients . It is known from literature that nutrient requirements 
for HIV-positive/AIDS patients are higher than those of HIV-negative individuals due to the 
catabolic activity of HIV infectionldisease, and in most cases scientists have suggested 
dietary intakes higher than the RDA for HIV-positive/AIDS persons (Sappey et a/. , 1994; 
Fawzi et a/., 1998; Piwoz & Preble, 2000). The median magnesium intake reported for this 
study population is significantly higher than the RDA. This adequate intake can therefore 
help in preventing complications associated with inadequacy in HIV-positive/AIDS patients. 
Selenium, although needed in trace amounts, is important in respective H IV infection 
because of its role in the metabolism of the essential anti-oxidant glutathione. Selenium 
also function synergistically with vitamin E in blocking the rate of lipid peroxidation (Cairns, 
2001). In this study, selenium intakes of male patients were higher than the RDA, 
although 12.5% who had an intake of less than 67% of the RDA. In the fernale patients, 
selenium dietary intakes were less than the RDA while 48.2% had intakes of less than 
67% of the RDA. Selenium deficient HIV-infected persons have been found to be nearly 
twenty times more likely to die from HIV-related causes than those with an adequate 
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intake (Chan & Collins, 1997). The mean selenium intake of women in a study in 
Bloemfontein was reported to be slightly lower than the RDA and about half of the total 
population took in less than 67% of the RDA (Hattingh, 2001, unpublished result). 
An inadequate selenium intake may be a general problem in the African community, 
probably resulting from an inadequate intake/deficient in their diets, thus further 
investigation into the reason or reasons for this inadequate intake of selenium among this 
community is necessary. 
The median intake of the water-soluble vitamins (niacin, riboflavin, B6, B12, C and folate) 
was higher than the RDA required for both male and female patients. Other studies have 
documented an adequate or higher intake of these vitamins (Walsh, 2003, unpublished 
work; Vorster et al., 1997). Higher intakes of micronutrients such as riboflavin, thiamine 
and niacin have been associated with higher CD4+T-cell counts at baseline (Abrams et al., 
1993). The current study did not show any correlation between dietary intake for 
riboflavin, thiamine, niacine and CD4+T-cell count. Tang et al. (1993; 1996) observed a 
slower progression of disease and reduced risk of mortality with an increased intake of 
riboflavin, thiamine and vitamin C. 
Vitamin C has been found to affect immune function in several ways (Watson, 1994). It 
can stimulate the production of interferons; the proteins that protect cells against viral 
attack. It has also been shown that vitamin C can stimulate the synthesis of humoral 
thymus factor and antibodies IgG and IgM classes (Watson, 1994; Flodin, 1988). It has 
been shown showed that vitamin C was effective in the inactivation of a wide range of 
pathogenic bacteria including Staphylococcus aureus, and Escherichia coli (Watson, 1994; 
Chan & Col/ins, 1997). The dietary intake of vitamin C was adequate in the patients 
examined in the current study. There is accumulating epidemiological evidence that 
increased intakes of vitamin C may help to reduce the risk of diseases associated with 
increased oxidative stress (Watson, 1994; Oguntibeju et al., 2003). It is therefore 
envisaged that the adequate vitamin C intake reported among the patients in this study is 
beneficial to the patients. 
Vitamin B6 and B12 indicate no deficiency in the male patients in this study. The inclusion 
of animal sources in the diet probably eliminates the possibility of B6 and B12 deficiency. 
The adequate intakes of vitamin B6 and B12 reported in the studied group may contribute to 
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slower progression of HIV infection and reduced mortality. B6 is particularly important for 
immune function and deficiency can lead to decreased white blood cell response and 
shrinkage of the critical immune system organ, the thymus (Hoffman, 1998; Bowers, 
2002). B12 is also central" to immune processes because it governs cell division and 
growth. Deficiency of B12 negatively affects red cell maturation (Hoffman, 1998). 
Folate (folic acid) is known to play an important role in the prevention of megaloblastic 
anaemia. The relatively high percentage of folate (37.5% and 33.3% in male and female 
(table 4.3) patients respectively) having a dietary intake of less than 67% of the RDA is 
therefore a matter of concern in this group of patients. Although, the greater percentage of 
patients examined in this study had a dietary intake of the water-soluble vitamins higher 
than the RDA, it should be noted that even a mild state of deficiency of these vitamins 
could result in an altered immune function, especially in patients who are not on 
antiretroviral drugs. As HIV infection progresses, coupled with opportunistic infections and 
metabolic demand, HIV-infected individuals may be unable to meet their required 
nutritional needs due to decreased oral intake, decreased nutrient absorption, increased 
nutrient requirements and changes in metabolism and nutrient transport, which could 
steadily result in greater inadequacies of these vitamins (Dannhauser ef a/., 1999). The 
percentage of nutrients with an intake of less than 67% of the RDA reported in some of the 
patients for the above-mentioned vitamins, may be related to their high intake of maize, a 
poor source of these nutrients, in addition to other biological factors. Dannhauser ef a/., 
(1999) alluded to the fact that regular consumption of maize-meal could be the cause of an 
inadequate intake of these vitamins. 
In this study, a significantly higher percentage of the patients had a dietary intake of higher 
than the RDA for B6, B12 and folate. Although the risk of progression of HIV infection to 
AIDS was not tested in the current, nonetheless, by inference, the higher intake reported in 
the patients for this study could be considered beneficial to the patients in terms of the risk 
of HIV progression to AIDS. 
Researchers have provided both animal and human evidence that an adequate vitamins A 
and E intake and their corresponding blood levels are important for modulating normal 
immune function (Ross, 1996). The dietary intake of other fat-soluble vitamins is reported 
and discussed in this study. The dietary intake of vitamin A in this study was higher than 
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the RDA for a greater percentage of the patients, with only 12.5% of male and 14.81 % of 
female having an intake of less than 67% of RDA (table 4.3). Karter et al. (1995) reported 
that 12%-19% of HIV-positive patients at various stages of HIV infection showed vitamin A 
deficiency/inadequacy and that this inadequacy may be more prevalent in women than in 
men. The reported 12.5% (male) and 14.81% (female) of vitamin A intake of less than 
67% of the RDA in this study is similar to the trend reported by Karter et al. (1995). On the 
other hand, Walsh et al. (2003, unpublished result) reported a high intake of vitamin A 
(higher than the RDA) in HIV-positive patients that is similar to the results of this study. 
Previous study has shown that there is a relationship between the dietary intake of vitamin 
A, its blood levels and immune function (Van Staden et al., 1998). The high dietary intake 
of vitamin A observed in the patients may be related to metabolic demand during the acute 
phase of HIV infection, or an increased dietary intake, while the low intake could probably 
be associated with a more rapid progression to AIDS (Rich et al., 2000); the presence of 
local pathological conditions such oral thrush, and a reduced dietary intake, among other 
factors (Dworkin et al., 1985; Cuff, 1990; Macallan, 1999). 
An inadequate vitamin E intake (table 4.3), found in this study population, occurred in 
females (14.81 %), in males (12.5%) and in the whole group of patients (14.3%). 
Meanwhile the majority of the patients documented an intake of vitamin E that was higher 
than the RDA. In this population, the same factors tend to influence a high or low dietary 
intake for most of the vitamins, vitamin E inclusive. In a study (Hogg et al., 1995) of 100 
asymptomatic HIV-sero-positive persons, 26% had an intake of vitamin E that was less 
than the RDA and 27% had an overt or marginally deficient intake. In another study 
(Cairns, 2001), 50% of 18 AIDS patients, 58% of 12 ARC patients and 38% of 13 HIV-
positive persons had an intake of vitamin E less than the RDA. The 14.8% reported in the 
present study is lower than that reported by Cairns (2001). Factors such as increased 
dietary intake, differences in methodologies and design, stages of HIV infection and study 
population could possibly explain the difference in the percentages ( high or low) of vitamin 
E. 
There is limited and conflicting evidence on the influence of vitamin D on immunity and 
HIV infection. Some research suggests that high intake/levels of vitamin D may have a 
suppressive effect and that it may stimulate HIV replication (Cairns, 2001 ). This evidence 
is based on test tube studies (Cairns, 2001). On the other hand, the active form of vitamin 
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D has been shown to stimulate macrophages and white blood cells . A study (Haug, 1998) 
compared 54 HIV-infected people with non-HIV-infected controls . Fifty-four percent of the 
HIV-positive group were deficient in vitamin D in contrast to the control group, who were 
not vitamin D deficient. Inadequate intake in this study was reported for vitamin D (table 
4.3) in 12.5% of male patients and 29.63% of female patients (intake less than 67% of AI). 
This value was significantly lower in this study than that of Haug (1998), however, the 
29.63% inadequate vitamin D intake found in the female group is similar to that reported 
by Hattingh, 2001 , (unpublished results). Significantly, a higher percentage of the patients 
had a vitamin D intake higher than the required AI. 
The median intakes of vitamin K were high, with both male and female patients exceeding 
the AI. Inadequate intake was found in 25% of male and 11.11 % of female patients (table 
4.3). Scientific reports on the intake of vitamin K in HIV-positive/AIDS is very limited. An 
adequate intake of vitamin K may be vital for HIV-positive patients with bleeding disorder. 
Previous studies carried out on HIV-positive/AIDS patients in the Free State province of 
South Africa did not analyse the vitamin K intake. However, it was shown to be adequate 
or higher than the AI in the HIV-negative population in the Free State province (Van 
Staden et a/., 1998; Dannhauser et al., 1999; Hattingh, 2001 , unpublished results). 
4.6 Conclusion 
The results of this study provide comprehensive information (survey data) on the 
dietary/nutritional intakes of HIV-positive/AIDS patients, particularly those living in 
Bloemfontein, and perhaps reflect the dietary intakes of HIV-positive/AIDS patients in the 
African community. Generally, the dietary intakes were higher than the ROAIAI. The 
study therefore establishes that the EER (estimated energy requirements), macronutrient 
and micronutrient intakes of most clinically stable AIDS and HIV-sero-positive patients 
meet the RDA standards. This high intake may be related to employment status, the 
provision of food security from families, friends and monthly allowances from the 
government. The high intake could help in correcting nutritional impairment and retard 
wasting to a certain extent and , in turn, in maintaining the nutritional level of the nutrients 
in the blood . On the other hand, the high percentage of patients with an inadequate intake 
of iodine and selenium is of great concern and calls for further investigation. 
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The cross-sectional nature of the study, the small number of patients studied, the absence 
of a control group and the lack of references adapted for HIV-positive/AIDS patients, make 
it difficult to extrapolate the results. Furthermore, in the present study, there is a lack of 
information on some important predictors of patients' nutritional status, for instance, blood 
levels of the corresponding nutrients analysed in the study were not determined and 
therefore prevent one from making casual references or definite conclusions. However, it 
is suggested that many serum micronulrients are affected by infection and inflammation 
(hence their blood levels may not reflect a true picture of the nutritional status of HIV-
infected/AIDS patients), therefore, the determination of dietary intake thus plays an 
important role in the assessment of nutritional status of HIV-positive/AIDS patients. Both 
macronutrients and micronutrients play an important role in maintaining nutritional status, 
and probably delay disease progression. Irrespective of the availability of anti-retroviral 
therapy, an adequate, well balanced diet, providing required foods and consequently 
adequate nutrients to meet the increased requirements of HIV infection/AIDS, is an 
important measure in maintaining nutritional health in people living with HIV/AIDS. 
4.7 Application 
Assessment of HIV-positive/AIDS patients is important at all stages of the disease in order 
to identify those with inadequate dietary intake who will require counselling. The 
inferences drawn from this study will in no small measure assist the government and 
health professionals in designing nutritional support for HIV-infected persons. Results 
from the study may also provide useful information for health professionals who are 
involved in studies on the nutritional implications of antiretroviral drugs which the 
government intend to provide in a couple of months from now. 
4.8 Recommendations 
To avoid malnutrition in people with HIV/AIDS, nutritional counselling is imperative and is 
therefore suggested in order to assist people with HIV/AIDS to maintain their body weight 
and quality of life. The nutritional counselling should : 
• Provide information on adequate and well balanced diets, including recipes for 
preparing meals 
• Stress the importance of optimising and maintaining nutritional status 
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• Stress early treatment of opportunistic infections as infections increase the need 
for nutrients, impair nutrient absorption and reduced dietary intake 
• Discuss alternative therapies 
• Provide guidelines for home-based assessment of body weight. 
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Chapter 5 
Anthropometric Profiles of HIV-positive/AIDS patients at 
baseline and end of Nutrient Supplementation 
5.1 Abstract 
This is the first study in the Free State Province of South Africa to have examined the 
potential influence of a nutrient supplement on the anthropometric profiles of HIV-
positive/AIDS patients and the correlation between anthropometric profile, CD4+T-cell 
count and viral load. Anthropometric profiles were determined according to standard 
procedures in 35 HIV-positive/AIDS patients at baseline and in 28 patients at final visit. At 
baseline, of the 35 patients recruited into the study, 32 (94.1 %) showed a fat percentage 
below normal range. Twenty-four of the patients (68.6%) had body mass index (BMI) 
within normal range, while a greater percentage of the patients had a normal waist-to-hip 
ratio (WHR). Twenty-eight patients completed the study. Of these, 26 (96.3%) reported a 
fat percentage of below 18.5%. There was no significant difference (P>O.05) between the 
fat percentage at baseline and end of the experiment in the whole group, however, this 
differed significantly (P<O.05) according to gender, being lower in the male group than in 
the female group. The results showed that 19 (67.9%) had a BMI within the normal range 
after nutrient intervention. The body weight did not decline significantly (P>O.05). In 
general, the BMI and lean body mass (LBM) produced a trend towards an improvement. 
At baseline visit, the viral load showed a significant correlation with the BMI, and the 
CD4+T-cell count significantly correlated with fat percentage. As expected, there was a 
significant positive correlation between the BMI and fat percentage. At the final visit, the 
CD4+T-cell count showed no correlation with any of the anthropometric indices while the 
viral load showed a significant negative correlation with the LBM and BMI. The short 
duration of the study probably limited the positive trend of the supplement. 
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5.2 Introduction 
Infection with the human immunodeficiency virus (HIV) has a devastating effect on the 
nutritional status of infected persons. Weight loss, often profound in magnitude depending 
on the stage of the infection and associated infections, are outstanding features of HIV 
infection. HIV-positive/AIDS patients may lose 30-50% of their body mass before 
progressing to AIDS (Gorbach & Knox, 1992). According to different researchers, weight 
loss can be caused by five mechanisms, namely, inadequate food intake, reduced 
intestinal absorption, abnormal utilization, increased excretion of nutrients and increased 
host requirements (Herbert, 1973; Kotler et al., 1989; Grunfeld & Feingold, 1992; 
Macallan, 1999). It is also agreed that weight loss contributes to the progression of HIV 
infection to AIDS (Chlebowski, 1985; Dannhauser et al., 1999). 
Malnutrition has been an endemic problem in Africa for decades and it is complicated by a 
combination of factors and more recently by the impact of HIV/AIDS (Piwoz & Preble, 
2000). HIV/AIDS and malnutrition are interrelated. Research suggests that malnutrition 
increases the progression of HIV infection and in turn HIV infection exacerbates 
malnutrition through its attack on the immune system and body composition (Fawzi & 
Hunter, 1998; Friis & Michaelsen, 1998; Oguntibeju et al., 2003a). The relationship 
between malnutrition and HIV/AIDS is well recognised. In fact, in Africa, AIDS was initially 
known as the "Slim Disease" because of the classical wasting condition experienced by 
persons with HIV disease (Piwoz & Preble, 2000). 
To understand the relationship between HIV infection and nutritional status, one must 
consider the effect of the infection/disease on the body size and composition (weight, lean 
body mass and body cell mass). In populations in which malnutrition is endemic (as it is in 
Africa), body size and composition changes are associated with protein-energy 
malnutrition (Babamento & Kotler, 1997). Weight loss and body composition changes are 
said typically to follow two patterns in people living with HIV/AIDS. This includes slow and 
progressive weight loss resulting from anorexia and gastrointestinal disturbances, and 
rapid, episodic weight loss following secondary infections. It has been observed that even 
relatively small losses in weight (5%) have been associated with decreased survival in 
individuals with AIDS (Macallan, 1999). 
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The earliest studies of nutritional status in AIDS patients conducted between 1981 and 
1983 were undertaken with hospitalized patients. Weight loss to an average of about 80% 
of ideal weight was found. Evidence of protein deficiency was documented by showing 
deficiencies in serum proteins and muscle wasting (Kotler et a/., 1989 & 1996). Other 
studies also documented a very high prevalence of severe weight loss in AIDS patients at 
the time of admission (Serwadda et a/., 1985; O'Sullivan et a/., 1985; Niyongabo et a/., 
1999). 
Studies by Kotler et a/. (1985), mostly with symptomatic HIV-positive patients with 
advanced disease, found that total body potassium, an index of body cell mass, was 
reduced in patients who were compared to controls. Body fat was also depleted , but to a 
lesser extent than body potassium, indicating a greater depletion of lean body mass in the 
immuno-deficient patients. In more stable ambulatory patients with AIDS, however, the 
researchers found that weight loss was not associated with reductions in lean body mass, 
body fat or total water. The researchers noted that the cause of weight loss in these 
patients was unclear. On the other hand, in a small group of HIV-infected women, loss of 
body fat was greater than loss of lean body mass (Macallan, 1999). 
The aims of nutritional support or supplementation are to provide adequate levels of all 
nutrients; to preserve lean body mass and functional status; to improve quality of life, and 
to maximise response to medical therapy (Woznicki & D'Alessandro, 1997; Oguntibeju et 
a/. , 2003b). According to Oliver and Hyder (1992), it should be a general practice to 
supplement all HIV-positive persons at all clinical stages, especially those with a low socio-
economic status. Appropriate and timely nutritional intervention may reverse the weight 
loss caused by problems with food ingestion and may consequently result in an increase in 
weight and body cell mass (Kolter et a/., 1990; 1991; Summerbell, 1994). Available 
studies suggest that nutritional supplementation is effective in restoring the lean body 
mass of HIV-infected persons especially in the absence of any chronic infection (Calderon 
et a/., 1990; Gorbach & Knox, 1992). 
Research has shown that in the early period of HIV infection, weight gain or maintenance 
might be achieved through nutrition intervention, and this has helped to reduce the 
consequences of wasting in people living with HIV/AIDS (Friis & Michaelsen, 1998; Dwyer, 
1998). In the developing world , where the majority of people living with HIV cannot afford 
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antiretroviral therapy, good nutrition combined with mineral and vitamin supplementation 
could be a good source of therapy. Malnutrition is known to favour opportunistic infections 
and contributes to wasting (Cimoch, 1997; Niyongabo et al., 1997), making 
supplementation an important aspect in the management of people living with HIV/AIDS. 
Nutritional intervention may help to strengthen the immune system and reduce the severity 
and impact of opportunistic infections in people living with HIV/AIDS (Raiten, 1990; 
Woznicki & D'Alessandro, 1997; Dwyer, 1998). 
Some studies (Dannhauser et al. , 1999; Niyoganbo et al., 1999) have examined the 
relationship between HIV infection and adult anthropometry in South Africa and elsewhere 
in Africa. However, none has examined the association between HIV infection, 
anthropometry and nutrient supplementation in adult male and female populations. This 
paper examined the influence of nutrient supplementation on the anthropometric profile of 
HIV-positive/AIDS patients in Bloemfontein, South Africa, so as to establish whether 
nutrient supplementation has any influence on the anthropometric indices of HIV-
positive/AIDS patients. 
5.3 Methodology 
The study consisted of a baseline visit and a monthly visit that lasted from April to 
September 2003. The duration of this study is similar to that of Allard et al. (1998). An 
approval from the Ethics Committee of the Faculty of Health Sciences, University of the 
Free State was obtained (ETOVS 32/03). The patients signed the consent form at their 
first visit after they had been told the purpose and protocol of the study. The inclusion 
criteria included male and female patients between 18 and 65 years of age that were HIV 
positive; willing to undergo a pre-study physical examination; were not on antiretroviral 
therapy; had been found to be within the range of clinical acceptability in medical history 
and physical examination; had a CD4+T-cell count of 100-350 cells/mm3 , and were able to 
comprehend; and willing to sign, the statement of informed consent. 
5.3.1 Sample Collection 
This is described in chapter 3 under methodology (see 3.5.5.1) 
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5.3.2 Anthropometric measurements 
At baseline and by the end of the study, the following anthropometric indices were 
determined and included body mass index (8MI) calculated from body weight and height in 
metres squared; waist-hip-ratio (WHR) calculated from waist circumference, and hip 
circumference and skin-fold thickness (to estimate percentage of body fat). For the 
anthropometric measurements, the subjects presented themselves in minimal clothing to 
allow measurements to be done quickly, accurately and efficiently. Two persons were 
involved with the measurement: the measurer and the recorder. This was done to ensure 
accuracy of site location, correct sequence of measurement sites and accurate reading. 
The recorder repeats the value as it is being recorded in order to enable the measurer to 
do an immediate check. The measurement was done twice at each site on each subject 
and the average value was taken. Throughout the marking and measurement session, 
each subject stood relaxed, with arms comfortably by the side and with feet together. 
However, a few measurements required the subjects to place their feet apart. During the 
measuring period, the measurer was able to move around the subject easily and also to 
manipulate the equipment. All anthropometric measurements were done according to 
standard procedures (Lee & Nieman, 1993; 1996; Laquatra, 2000). 
5.3.3 Supplementation 
This is described in chapter 3 under methodology (see 3.4.2). 
5.3.4 Follow-up Visits 
This is described in chapter 3 under methodology (see 3.5.4.2) 
5.4 Results 
The results of the baseline visit of 35 patients are indicated in Table 5.1. Thirty-two of the 
respondents (94.1 %) had a fat percentage below 20% while 2 (5.9%) had fat percentage 
above 25%. One patient (female) was excluded from fat percentage due to cut-off range 
for age. 
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Of these 35 patients, 8 (22.9%) had a BMI of less than 18.5 kg/m 2 , 24 (68.6%) had a BMI 
range of 18.5-24.9, while 3 (8.6%) of the respondents had a BMI greater than 25. Seven 
(87.5%) of the respondents reported a WHR of less than 0.95 and 1 (12 .5%) of the 
respondents reported a WHR of greater than or equal to 0.95 for males. In the female 
group, 13 (48.1%) of the respondents reported a WHR of less than 0.8 while 14 (51.9%) 
reported a WHR of greater than or equal to 0.8 (table 5.1). 
The results of the final visit of 28 patients are indicated in Table 5.1. The result showed 
that 26 (96.3%) of the patients reported fat percentage of below 20 while one had fat 
percentage of above 25%. One patient was excluded from fat percentage due to cut-off 
range for age. 
Of the 28, 7 (25%) had a BMI of less than 18.5 kg/m2, 19 (67.9%) had a BMI within the 
range of 18.5 kg/m 2-24.9 kg/m 2 , and 2 (7.1 %) had a BMI greater than or equal to 25 kg/m 2 . 
Seven (87.5%) of the patients had a WHR of less than 0.95 and 1 (12.5%) had a WHR of 
greater than or equal to 0.95. Ten (50%) had a WHR of less than 0.8 and 10 (50%) had a 
WHR greater than or equal to 0.8 for female patients (table 5.1). 
Table 5.1: The frequency and percentage of body fat, BMI and WHR of HIV-positive 
patients at baseline (n=35) and at final visit (n=28). 
Anthropometric profile Baseline visit n=35 Final visit n=28 
Freq & percentage Freq & percentage 
Fat %* 
<20 32 (94.1%)* 26 (96.3%)* 
20S25 0(0%) 0(0%) 
>25 2 (5.9%) 1 (3.7%) 
BMI (kg/m ) 
<18.5 8 (22.9%) 7 (25%) 
18.5-24.9 24 (68.6%) 19 (67.9%) 
~25 3 (8.6%) 2(7.1%) 
WHR 
<0.95 (male) 7 (87.5%) 7 (87.5%) 
~0.95 (male) 1 (12.5%) 1 (12.5%) 
<0.8 (female) 13 (48.1%) 10 (50%) 
~0 .8 (female) 14 (51.9%) 10 (50%) 
·One patient (female) was excluded from fat percentage due to cut-off range for age. 
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Table 5.2: Anthropometric profiles of HIV-positive/AiDS patients at baseline visit and final visit. 
Anthropometric Before nutrient supplementation (n=35) After nutrient supplementation (n-28) 
indices Mean SD Median 25 75 Mean SD Median 25 75 
percentile percentile percentile percentile 
Weight (kg) 55.2 8.2 57.0 49.0 60.0 55.7 7.4 56.0 50 60.0 
Height (m) 1.6 0.1 1.6 1.55 1.7 1.6 0.1 1.6 1.6 1.7 
Forearm (cm) 22.2 2.3 22.0 21.0 24.0 22.7 2.0 22.0 21.5 1.7 
Calf (cm) 31.6 4.1 31.5 28.5 35.0 31.4 3.7 32.0 28.0 34.8 
Thigh (cm) 39.9 7.2 40.0 35.0 46.0 40.9 7.1 40.5 35.8 45.0 
Waist (cm) 73.9 5.7 73.0 70.0 76.0 73.9 5.9 74.0 70.0 76.0 
Hip (cm) 91.9 8.4 91.0 85.0 99.0 91.0 7.9 91.3 86.0 96.5 
Triceps (em) 11.5 3.5 11.0 9.5 13.5 11.3 3.4 11.0 9.5 12.0 
Subscapular (cm) 10.7 2.8 10.5 9.0 12.5 10.2 2.8 10.0 8.3 11.3 
Iliac crest (cm) 10.9 4.2 10.5 8.0 13.0 10.7 3.9 10.0 9.0 12.3 
Abdominal (cm) 11.9 3.5 11.0 10.0 14.5 11.8 3.6 10.8 10.0 13.8 
Chest (cm) 6.3 1.9 6.0 5.6 7.0 6.4 2.1 6.0 5.3 7.0 
Front thigh (cm) 14.6 4.2 14.0 11.5 16.5 14.8 4.6 13.5 11.5 17.0 
Medial calf (cm) 11.2 4.1 11.5 7.0 14.0 10.9 4.2 10.0 7.5 14.3 
Mid-axilla (cm) 9.9 3.7 9.5 7.0 12.0 9.9 3.4 10.0 7.5 11.3 
% fat 17.8 4.7 19.2 13.6 20.3 17.2 4.9 17.9 12.6 20.7 
BMI (kg/M') 21.2 3.3 20.4 18.7 23.2 21.2 3.4 20.7 18.8 23.2 
WHR 0.8 0.1 0.8 0.8 0.8 0.8 0.1 0.81 0.8 0.9 
LBM (kg) 45.2 6.2 45.5 40.4 49.3 45.7 5.4 46.1 41.3 49.6 
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The mean, median, standard deviation, 25 percentile and 75 percentile of the 
anthropometric indices are presented in Table 5.2. The median fat percentage of 19.2% at 
baseline was not significantly lower than the normal range (20';;25%). The fat percentage 
had not decreased significantly (P>0.05) by the end of nutrient supplementation (table 
5.2). The median BMI of the population (inclusive of male and female adults) fell within the 
accepted/normal range of 20 kg/m2 and less than 25 kg/m2 (Laquatra, 2004). At baseline, 
the median BMI was 20.4 kg/m2 (within a normal range). It showed a slight trend towards 
an insignificant increase to 20.7 kg/m2 (P>0.05) following supplementation. The median 
WHR of 0.81 showed normal waist circumference of the study population without gender 
differentiation. The median WHR was maintained up to the end of nutrient 
supplementation (table 5.2). The median LBM increased insignificantly (P>0.05) from 45.5 
kg at baseline to 46.1 kg by the end of nutrient supplementation (table 5.2). 
Table 5.3A : Anthropometric variables between gender at baseline vis it. 
Indices Mean SO Median 25 percentile 
Male n=8 
% fat 11 .0 1.6 11.0 10.0 
WHR 0.8 0.1 0.8 0.8 
Female n=27 
% fat 19.9 2.9 20.1 17.9 
WHR 0.8 0.1 0.8 0.8 
Table 5.38: Anthropometric variables between gender after nutrient 
supplementation (final visit). 
Ind ices Mean SO Median 25 percent ile 
Male n=8 
% fat 10.9 1.7 10.9 9.7 
WHR 0.8 0.1 0.8 0.8 
Female n=27 
% fat 19.9 2.8 19.7 17.6 
WHR 0.8 0.1 0.8 0.8 
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Table 5.3A displays anthropometric variables between genders at baseline. A median fat 
percentage of 11 .0% was reported for male patients. This value is significantly (P<0.05) 
less than 20% and significantly (P<0.05) lower than the value reported for the female 
patients. On the other hand, the fat percentage of 20.1 % for the female patients falls 
within the normal range of 20 less than or equal to 25 (Laquatra, 2004). This value 
probably reflects a wasting process (sub-clinical in the female) but shows a slight declining 
trend in the male patients. For the male and female patients, there was no significant 
difference (P>0.05) in the median WHR. Values less than 0.88 indicated normal female 
waist circumference. Therefore, it could be said that the female patients reported normal 
waist circumference indicating peripheral fat distribution. The median WHR of 0.8 (table 
5.3A) as reported in male patients is lower than normal range of <0.95. 
The median fat percentages of the patients were relatively maintained at the end of 
nutrient supplementation (Table 5.38). The WHR showed no significant difference 
(P>0.05) between gender at both baseline and end of study. The nutrient supplementation 
may have possibly reduced further wasting in these patients. 
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The correlation between anthropometric indices, CD4+T-cell count and the viral load at 
baseline and by the end of nutrient supplementation were determined and are presented 
below (table S.4) 
Table 5.4: Correlation between different anthropometric profiles, CD4+T-cell count 
and viral load at baseline and final visit 
Correlation Between 
Variable 1 Variable 2 
LBM % fat 
BMI 
WHR 
CD4 T-cel l count 
Viral load 
% 1at BMI 
WHR 
CD4 T-cell count 
Viral load 
BMI WHR 
C04 T-cell count 
Viral load 
WHR CD4 T-cell count 
Viral load 
CD4 T -cell count Viral load 
Viral load CD4 T-cell count 
NS (not significant): P>O.05 
*: P<O.OS 
**: P<O.01 
***: P<O.001. 
Baseline visit 
Baseline visit n 35 
r 
0.036 
0.39 
-0.13 
0.25 
-0.37 
0.74 
-0.38 
0.06 
-0.39 
-0.45 
0.2 
-0.61 
-0.07 
0.4 
-0.3 
-0.3 
Final visit n-28 
p-value r p-value 
0.84 -0.08 0.7 
0.02- 0.14 0.5 
0.45 -0.07 0.7 
0.2 0.08 0.6 
0 .04- -0.45 0.02-
<0.0001-- 0.81 <0 .0001*** 
0.02- -0.4 0 .05' 
0.74 0.006 0.97 
0.03' -0.25 0.2 
0.006- -0.31 0 .1 
0.32 0.02 0.9 
0.0002' -0.5 0 .008' 
0 .7 0.05 0.7 
0.01 ** 0.3 0 .2 
0.2 -0.21 0.3 
0.21 -0.21 0.3 
This study did not indicate a significant correlation between the LBM and percentage of 
body fat (P>O.OS), the WHR (P>O.OS) and the CD4+T-cell count (P>O.OS) (table S.4). 
However, the results showed a positive significant correlation between the LBM and the 
BMI (P<O.OS) and the viral load (P<O.OS). The fat percentage showed a positive and a 
significant correlation with the BMI (P<O.0001) but a negative significant correlation with 
the WHR (P<O.OS) and viral load (P<O.OS). There was no significant correlation between 
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the fat percentage and the CD4+T-cell count (P>0.05). The BMI indicated a negative 
correlation with the WHR (P<0.05) and viral load (P<0.0002). There was no significant 
correlation observed between the BMI and the CD4+T-cell count (P>0.05). There was a 
positive significant correlation between the WHR and the viral load (P<0.1) but not so with 
the CD4+T-cell count (P>0.05). The CD4+T-cell count did not correlate significantly with 
the viral load (P>0.05) (table 5.4). 
When the result was analysed according to gender, in the male group; the CD4+T-cell 
count significantly correlated with the fat percentage (r=O.77, P<0.05) and showed a 
positive association with the BM!. 
In the female group, a different pattern was observed . The LBM correlated positively with 
the fat percentage (r=0.57, P<0.002), and the BMI (r=0.89, P<0.0001) while the fat 
percentage showed a positive and a significant correlation with the BMI (r=0.59, P<0.001) 
The LBM (r= -0.64, P<0.001), fat percentage (r= -0.53, P<0.05) and the BMI (r= -0.69, 
P<0.0002) showed a negative correlation with the viral load while the WHR (r=0.055, 
P<0.05) showed a positive correlation with the viral load. There was no significant 
correlation between the CD4+T-cell count and the anthropometric profiles or between the 
CD4+T-cell count and the viral load. 
Final visit: 
In the final visit, there was no significant correlation between the LBM and the fat 
percentage, the BMI, the WHR, the CD4+T-cell count and the viral load (table 5.4). The fat 
percentage correlated significantly (positively) with the BMI (P<0.0001) and correlated 
negatively with the WHR (P<0.05). The BMI showed a significant negative correlation with 
the viral load (P<0.05). There was no significant correlation between the CD4+T-cell count 
and the viral load. 
In the male group, the BMI indicated a positive association with the fat percentage (r=0.64) 
(data not shown in a table). Other anthropometric indices showed no correlation. There 
was no correlation between the CD4+T-cell count, the viral load and the anthropometric 
indices. In the female group, the LBM showed a positive association with fat percentage 
(r=0.51, P<0.05), the BMI (r=0.82, <0.0001) and a significant negative correlation with the 
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viral load (r= -0.75, P<0.05) (data not shown in a table). The fat percentage correlated 
significantly (positively) with the BMI (r=0.59, P<0.05). The CD4+T-cell count showed no 
significant correlation with any of the anthropometric indices while the viral load showed a 
significant (negative) correlation with the BMI (r= -0.79, P<0.0001). 
5.5 Discussion 
Studies in developed countries have reported the impact of HIV infection on nutritional 
status at different stages of the infection (Kotler ef a/., 1989; Ott ef aI., 1993). It is reported 
that malnutrition is a general problem among HIV-infected patients, but it has become 
much less frequent among HIV-infected persons in developed countries, mainly due to the 
provision of highly active antiretroviral therapy (HAART) and nutritional interventions 
(Carbonnel ef a/., 1998). There have been increasing recommendations for 
supplementation to form part of the general nutritional interventions to correct some of the 
nutritional complications associated with HIV infection. The goals of nutritional 
assessment and intervention are aimed at improving nutritional status, prolonging survival 
and enhancing quality of life. 
In this study, anthropometric indicators of HIV-positive/AIDS patients were determined at 
baseline and the end of the nutritional supplementation so as to be able to observe the 
potential influence of the nutritional supplement on the anthropometric indicators. The 
body weight of the patients had not declined significantly by the end of nutrient 
supplementation. This finding agrees with the trend reported by Parisien ef at. (1993) for 
the body weight of HIV-positive/AIDS patients. Studies have shown that weight loss and 
decrease in body weight have been indicated as signs of a deterioration of nutritional 
status in HIV-positive/AIDS patients (Myers, 1997; Dannhauser ef aI., 1999; Macallan, 
1999). In a study, McCorkindale (1990) reported that seven patients at an advanced stage 
of HIV infection did not show a significant decline in body weight or fat percentage. His 
patients were on an antiretroviral drug (AZT) for five months. This trend of change 
underscores the different but yet unclear mechanisms involved in the wasting process in 
HIV infection. However, in his study although the patients were not on any antiretroviral 
therapy, the supplement did not demonstrate an observable effect on the body weight. 
Other factors may explain why the expected weight gain did not occur. Firstly, patients 
with HIV infection/AIDS may be hypermetabolic, therefore the anticipated weight gain is an 
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overestimation because energy needs and expected weight gain are calculated on the 
basis of normal metabolic states (Melchoir ef al., 1991). Secondly, HIV infection disrupts 
the normal lipid and protein metabolism which causes nutrients to be used inefficiently and 
wasted. For example, increased lipogenesis by the liver increases the thermogenesis of 
food (Hellerstein ef al., 1993). 
According to Wiley & Samuel (1989); Serwadda ef al. (1985) and O'Sullivan ef al. (1985), 
weight loss and/or a decrease in body weight is a prominent feature of HIV infection/AIDS. 
O'Sullivan ef al. (1985) noted that of the 50 HIV-positive/AIDS patients admitted to 
hospital, despite the fact that their pre-illness weights were higher than normal body 
weights, 59% of the patients were classified as moderately depleted and 62% had lost >10 
of their pre-illness weight. In this study, the pre-illness weights of the patients were not 
determined because patients were unable to recall their pre-illness weights. The reduction 
in weight of the patients by the end of nutrient supplementation was not significant. If 
Serwadda's ef al. (1985) report did reflect the process of nutritional depletion taking place 
in HIV-positive/AIDS patients as reflected in the reduction of weight, then we are tempted 
to believe that the supplement probably has a positive but not visible effect on the weight 
of the patients. In other words, since the patients were not on antiretroviral therapy, weight 
reduction or reduction in other anthropometric indicators should have been higher than 
observed. Likewise, nutritional deterioration of the patients should have been clearly 
demonstrated in the clinical conditions of the patients. The clinical conditions improved 
during the course of nutrient supplementation (data on clinical conditions is presented in 
chapter 6). 
The percentage of body fat determined anthropometrically at baseline had not changed 
significantly by the end of the study (table 5.1). The change in percentage of body fat was 
significant according to gender, being higher in the females than in the males, indicating 
that the male patients tended to be leaner than the female patients in this study. This 
result is similar to that reported by Dannhauser ef al. (1999). At baseline 94.1 % of the 
population reported fat percentage below the 18.5%, while 96.3% of the population (table 
5.1) reported fat percentage by the end of the study, thus the fat percentage showed no 
significant depletion. This pattern of depletion resembles a stressed or injured state rather 
than starvation or semi-starvation that is associated with nitrogen saving and increased fat 
utilization. The result showed a positive correlation between the BMI and fat percentage 
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while the latter did not show a significant correlation with the CD4+T-cell count, but a 
negative correlation with the viral load. Generally, the BMI, LBM and WHR were 
maintained over the course of the study (table 5.2). 
The fact that in this population of HIV-positive/AIDS patients, the LBM was relatively 
preserved possibly suggests that no major aggressive factor was obviously present. One 
previous study (MacClave et al., 1992) identified an aggressive factor (Tuberculosis-TB) 
that significantly contributed to the severity of malnutrition. TB was present in 6 of our 
patients (17.1%) at baseline; it reduced to 5 (16.7%) at visit one, 2 (6.9%) at visit two and 
none at visit three, but the patients with TB were treated during the course of the study. It 
is presumed that the treatment reduced the aggressive impact of TB on the lean body 
mass. The results seem to show that the wasting process was curtailed, probably to a 
certain degree in the presence of the supplement and other factors such as the TB 
treatment. It is believed that the wasting process would have been more aggressive in the 
absence of the study supplement and treatment because during active phases of infection, 
people with HIV/AIDS lose LBM rapidly (Gorbach & Knox, 1992). 
The probability of imminent death is high when the lean body mass falls to 54% of normal 
value (Kotler et al., 1996). Clinical conditions associated with wasting include 
disseminated cytomegalovirus infection, cryptosporidiosis, microsporidiosis, toxoplamosis, 
kaposis sarcoma, lymphoma and dementia. Most of these conditions were not present in 
our patients. It is therefore beneficial to study and understand the underlying 
pathophysiological mechanisms involved in the wasting process which negatively affect 
the anthropometric indicators of HIV-positive IAIDS patients. The results obtained in this 
study for the BMI and LBM are similar to those reported by Kennedy et a/. (2001) following 
nutrient supplementation. The BMI significantly correlated with the LBM. The LBM 
showed no correlation with the CD4+T-cell count. The viral load significantly correlated 
with the LBM. 
The BMI and fat percentage were lower in patients with CD4+T-cell counts <200cells mm/3 
than in those with CD4+T-cell counts >200 cells mmP. This is understood and expected in 
patients with immunodeficient diseases such as AIDS, especially when the patients are not 
on antiretroviral therapy. This finding is similar to that reported by Castetbon et al. (1997) 
and Dannhauser et a/. (1999). It has been shown that a decrease in the lean body mass is 
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related to the decrease in body cell mass (Niyongabo ef al., 1997) and that body cell mass 
depletion is out of proportion to losses of body weight for fat (Kotler, 1992; Kotler ef al., 
1996; Kotler, 1997). It has also been shown that death from wasting in AIDS is related to 
the body cell mass depletion rather than to the specific underlying cause of the wasting 
(Kotler ef al., 1989). As previously demonstrated by anthropometry, decline in weight and 
BMI have been associated with a decline in percentage of body fat. 
Although a greater percentage of patients (68.6%) had a BMI within a range of 18.5-24.9, 
22.9% of the patients had a BMI of less than 18.5 (table 5.1), therefore for those patients 
with a lower BMI, reduced body fat may have contributed. It is expected that as the HIV 
infection/disease progresses, wasting may become more pronounced, which in most 
cases is reflected in the amount of fat loss or lean body mass. In this study, instead of the 
wasting continuing significantly, as would have been indicated by a significant decline in 
the anthropometric indicators, it was relatively curtailed. It is possible that certain factors 
such as malabsorption, non-compliance, short duration, and drug-nutrient interactions 
contributed to the non-significant effect of the supplement on the anthropometric indicators 
(Pronsky ef al., 2001). 
In a population in which antiretroviral therapy is not readily available or accessible, the 
findings that nutrient supplementation more or less maintained the BMI or LBM or has the 
potential of maintaining the BMI or LBM, lends hope for a relatively inexpensive treatment 
to improve the quality of life and the general well-being of HIV-positive patients. 
5.6 Conclusion 
The body weight did not decline significantly. In general, the BMI, WHR and LBM 
produced a trend towards an improvement. The short duration of the study and small 
sample size probably limited the positive trend of the supplement. 
5.7 Limitation of the study 
It is possible that certain factors such as malabsorption, short duration and drug-nutrient 
interaction (for example, TB treatment) could have limited the potential positive effect of 
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the supplement on the anthropometric indicators . In addition, the small sample size and 
lack of a control group limited the interpretation of the results of this study. 
5.B Application 
Nutritional abnormalities are frequent and a characteristic feature of infection with the 
human immunodeficiency virus (HIV), and they represent a major determinant of survival. 
Nutritional status may have an impact at all stages of HIV infection: from the initial 
acquisition of infection, clinical manifestations, progression of the disease and palliation of 
advanced disease. Nutritional care of HIV-infected patients should therefore begin at the 
time of diagnosis so as to assess baseline nutritional status and to provide dietary 
counselling/guidelines. Dietary guidelines should include the recommendation of a 
nutrient supplement containing anti-inflammatory agents and antioxidants. Close 
monitoring of nutritional status and clinical status is essential in identifying nutritional 
problems. 
5.9 Recommendations 
The following recommendations are made in the light of the results obtained from this 
study: 
o Nutritional intervention should begin early in patients with HIV infection and AIDS. 
o Nutritional supplementation should form an important aspect of the clinical 
management of HIV-positive/AIDS patients as it may help to strengthen the immune 
system, replace lost vitamins/minerals and reduce the severity of impact of 
opportunistic infections in people living with HIV/AIDS. 
o Standardised evaluation of nutritional status should be done regularly. 
o In future, supplementation-based research studies should be directed towards 
patients with HIV infection and AIDS, with secondary infections and with and 
without wasting. 
o Confirmation of the results of our study is required using the same dietary and 
patient-entry criteria, and a control group but for a longer period, for example one 
year. 
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Chapter 6 
The influence of a nutritional supplement on the 
immune status, haematological parameters and clinical 
conditions in HIV-positive/AIDS patients 
6.1 Abstract 
The influence of a nutritional supplement on the immune status, haematological 
parameters and clinical conditions of HIV-positive/AIDS patients was tested using standard 
procedures . This clinical trial comprising 35 patients consisted of a baseline visit and three 
months of supplementation from April to September 2003. The results showed that the 
viral load decreased significantly (P<0.002) with time following supplementation . The 
mean cell volume (MCV) and mean cell haemoglobin concentration (MCHC) increased 
significantly (P<0.002, P<0.0002) respectively, reflecting the positive effect of the 
supplement on a few of the haematological parameters. The supplement showed no 
effect on the CD4+T-cell counts and the CD4+T-cell count decreased significantly with HIV 
disease progression. The supplement also showed observable positive effects on a few of 
the clinical conditions. Because of certain limitations (small sample size, short duration of 
study and the final stage of HIV infection of the patients), further studies are needed to 
confirm the effect of the supplement. 
6.2 Introduction 
In recent years, the importance of nutrition in human health has received growing 
attention. Therapeutic and preventive supplementations with vitamins and minerals have 
been used successfully for a long time for various clinical conditions (Singhai & Austin, 
2002). These include vitamin A for maintenance of vision, beta-carotene in erythropoietic 
protoporphyria, vitamin C in scurvy and niacin in pellagra. In vitro and animal studies have 
shown the immuno-stimulatory and anti-cancer properties of several micronutrients, 
leading to large epidemiological trials of micronutrient supplementation (Bijlsma, 2001; 
Singhai & Austin, 2002). Correction of the nutritional imbalance in HIV infection is being 
recognized as an important part of the comprehensive care of persons infected with HIV. 
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Evidence from different studies (Coutsoudis et al., 1995 and 1997; Allard et al., 1998; 
Coutsoudis et al., 1999; Kanter et aI., 1999; Bouic et al., 2001) continues to accumulate, 
showing that carefully chosen supplementation may help in enhancing a better quality of 
life. 
Micronutrient supplementation has been advocated for HIV-infected persons, especially in 
low-income countries such as South Africa (Van Staden at al., 1998; Kennedy at al., 2000; 
Singhai & Austin 2002). Supplementation has been shown to be associated with a 
significant slowing of HIV disease progression, better preservation of CD4+T -cell counts 
and lower viral loads (Dworkin, 1994; Fawzi et aI., 2004). There is evidence that nutritional 
intervention assists in maintaining and optimising nutritional status and immune function; 
prevents the development of nutritional deficiencies, loss of weight and lean body mass; 
promotes the response to medical treatment, and increases longevity in HIV-infected 
persons (Coodley, et al., 1996; Fawzi & Hunter, 1998; Fawzi at al., 1999; 2000; Piwoz & 
Preble, 2000; Willsumsen, 2003; Oguntibeju et al., 2003; Fawzi, 2003). 
It has been further demonstrated by Bijlsma (2001) that micronutrient supplementation 
may be an important prophylactic and therapeutic measure for HIV-1 infected persons and 
is possibly one of the few potential therapies that could improve the patient's quality of life 
by maintaining strength, comfort, level of functioning and self-image. For example, daily ~­
carotene supplements of 180 mg provided for HIV-positive persons for one month resulted 
in a small but statistically significant increase in total white blood cell count and a 
percentage change in CD4+ T-cell count in one trial (Coodley et al., 1993; 1996). In 
another study, Fawzi et al. (1999) reported that supplementation with multivitamins 
resulted in a significant increase in the number of CD4+T-cell counts and CD8+T-cell 
counts. In the same study, haemoglobin levels were significantly increased. 
In a clinical trial conducted by Allard et al. (1998) in Canada, it was observed that daily 
mega doses of vitamins C and E intake provided for three months resulted in a clinically 
important reduction in viral load. In 1998, Lamprecht and his co-workers published two 
pilot studies on cats infected with FIV (feline immunodeficiency virus), the feline equivalent 
of HIV. In both studies, the cats that received a mixture of sterol and sterolins (100:1) 
maintained stable CD4+T-lymphocyte counts and suffered no death due to FIV within three 
years. These results prompted an open trial of 80 human patients with HIV over a three-
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year period with clinical monitoring every three months. The average CD4+T lymphocyte 
counts remained stable for three years with no significant declines, which is similar to the 
results obtained with the experimental cats. There was also a decrease in average viral 
load (Bouic et aI., 2001). Kanter et at. (1999), in a study in South Africa found that a daily 
vitamin B-complex and multivitamin intake delayed the onset of AIDS and death. 
However, studies on nutritional supplementation in HIV positive persons are still scarce in 
Africa and South Africa (Muslimatun et a/., 2001). 
Researchers share the view that as the virus infects and selectively attacks and depletes 
T-Iymphocytes bearing the CD4 receptor (T-helper cells) in the host, it causes a 
predisposition to opportunistic infections and malignancies (Wilson et a/., 2000; SAHIVCS, 
2001), and the CD4+T-cell count is noted to provide prognostic information, diagnose 
immunological AIDS and determine when prophylactic treatment is needed. Therefore, 
the CD4+T -cell count remains an important measure of the status of the immune system 
and it is still used to make important clinical decisions regarding prophylaxis for a number 
of opportunistic infections. For instance, a CD4+T-cell count of < 300-350 cell/mm3 may 
warrant anti-tuberculosis treatment to be considered while a CD4+T-cell count of < 200 
cells/mm3 might be an indication for prophylaxis against Pneumocystis carinii (Martin, 
2000). 
The entire natural history of HIV infection from transmission to death can most easily be 
described in terms of various disease stages, each of which relates to particular levels of 
immune system functionality (SAHIVCS, 2001). At present, HIV infection is commonly 
divided into stages, predominantly on the basis of CD4+T-cell counts and the most 
common clinical symptoms, but also on the basis of rates of viral replication. Martin (2000) 
indicated that the most striking laboratory feature of acute sero-conversion is marked 
Iymphopaenia, with depletion of CD4+T and CD8+T-lymphocytes. According to Martin 
(2000), this is often followed by a period of relative lymphocytosis (mostly CD8+T-
lymphocytes), with a high proportion of atypical lymphocytes. Close to the time of 
resolution of primary infection symptoms, the CD4+T-cell count increases, but rarely 
returns to baseline, while the normal CD4+/CD8+ ratio is reversed (Martin, 2000). 
It has been shown that early-stage disease can be defined by a CD4+T -cell count of > 500 
cellsimm 3, corresponding to the World Health Organization (WHO) clinical stages 1 and 2 
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and the only consistent physical examination finding with this stage is generalised 
lymphadenopathy (WHO, 1993; UNAIDS, 2002). There is evidence that the intermediate 
stage of HIV disease can be defined immunologically as that occurring in persons with a 
CD4+T-cell count of 200-500 cells/mm 3, or clinically by the presence of WHO stage 3 
diagnoses, while late-stage and advanced stages can be defined by CD4+T-cell counts of 
50-200 and < 50 cells/mm3 respectively (Martin, 2000), with a high risk of developing 
opportunistic infections and wasting. 
On the other hand, viral load can independently predict the rate of progression of immune 
suppression and is the most meaningful tool for determining response to anti-retroviral 
therapy (Coombs et a/., 1996; Martin, 2000). In one study, each two-fold decrease in the 
viral load level during treatment correlated with a 27% reduction in the relative hazard of 
disease progression (Coombs et a/., 1996). It has been reported that each three-fold 
decrease in the viral load level is associated with a 63% reduction in the relative hazard of 
progression (O,Brien et a/., 1996). It is believed that factors such as genetic susceptibility, 
viral load, concurrent infections, as well as the pre-existing immune status at the time of 
HIV infection, determine the duration of clinical latency to progression to AIDS (Piwoz & 
Preble, 2000; Semba & Tang, 1999; Fawzi, 2003). Most research findings support the 
view that the plasma viraemia is very high during acute sero-conversion, while circulating 
viral particles remain detectable throughout all stages of the disease, unless treatment is 
provided with highly active antiretroviral therapy (Clark & Shaw, 1993; Bouic et a/., 2001). 
From previous studies, researchers have expressed the view that further and urgent 
community-based research studies are needed on nutritional supplementation among HIV-
positive/AIDS individuals. For instance, Van Staden et at. (1998) reported deficiencies in 
several micronutrients in HIV-1 sero-positive patients in the Free State province of South 
Africa and suggested a multi-vitamin/anti-oxidant supplementation to improve the immune 
status in these patients. In the developing countries where a majority of the people cannot 
afford antiretroviral therapy, nutrition combined with supplementation could form a good 
source of therapy. Although nutritional supplementation cannot single-handedly reverse a 
severely depleted immune system, nutritional supplementation could improve the immune 
function, nutritional status and general well-being of HIV-positive/AIDS patients. 
As the HIV/AIDS pandemic enters its third decade and case numbers continue to increase, 
neither have definitive cures been found nor has an effective vaccine been developed. It 
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is therefore time to examine other approaches to reducing the HIV infection burden. 
Nutritional intervention may be one such an approach, particularly in the Free State 
Province of South Africa where the effect of nutritional supplement on the immune status 
of HIV-positive/AIDS patients has not been examined. 
It is against this background that the influence of a nutritional supplement on the immune 
status, haematological parameters and clinical conditions of HIV-positive/AIDS patients 
was examined. 
6.3 Materials and Methods 
This was an open-labelled, multiple-dose clinical trial consisting of 50 HIV-positive IAIDS 
volunteers. Of the 50 volunteers that met the inclusion criteria and were recruited into the 
study, 3 dropped out, 10 died, while 2 relocated to other towns during the three months 
period. Of the 35 patients that completed the food frequency questionnaire and had their 
anthropometric parameters measured at baseline, only 29 completed this section of the 
study (blood parameters measurement). The dietary intakes and anthropometric profile of 
the patients are reported in chapters 4 and 5 respectively . An approval from the Ethics 
Committee (ETOVS 32/03) of the Faculty of Health Sciences, University of the Free State 
was obtained and all patients signed informed consent forms for inclusion in the study. 
Inclusion criteria include: male and female patients between 18 to 65 years of age that are 
HIV-positive, not on antiretroviral therapy, are willing to undergo a pre-and post-study 
physical and medical examination, are found to be within the range of clinical acceptability 
in medical history and physical examination, have a CD4+T-cell count of 100-350 
cells/mm 3 and are able to comprehend and willing to sign the statement of informed 
consent. Only the patients that met the inclusion criteria were included in this study. 
The study was conducted in two separate clinics, namely Tsepo House (home based care) 
and Medi Inn clinic in Bloemfontein. The patients seen at Medi Inn clinic were patients 
from the South African Red Cross home-based care, Bloemfontein, and transported to the 
Medi Inn clinic on arrangement and in agreement with the Red Cross management with 
the consent of the patients. The study involved a baseline visit and 3-monthly visits to 
Medi Inn clinic and Tsepo House (home based care) from April to September 2003 (at 
these two clinics, the patients were seen, signed the consent form, were examined 
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medically, completed the food frequency questionnaire with their anthropometric values 
determined and had blood samples drawn for analysis). The duration of this study is 
similar to the one reported on by Allard et a/. (1998). 
6.3.1 Sample Collection and Processing 
Ten ml (10 ml) of blood was collected from each patient by a registered health professional 
into EDTA sampling tubes for the determination of full blood count, CD4+T-cell count and 
viral load. Blood samples were kept at room temperature and processed within 4 hours. 
Haematological parameters were performed on all patients using a Beckman cell Coulter 
(USA). 
The patients' T-cell subset numbers were determined by using a Becton Dickinson Multi 
TEST CD3 FITC/CD8 PE/CD45 Per CP/CD4 APC, four-colour direct immuno-fluorescence 
monoclonal antibodies with a suitably equipped flow cytometer (Coulter. Hialeah. FL. 
U.S.A) to identify and determine the counts of mature human T-Iymphocytes in lysed 
whole blood. 
A quantitative HIV-1 RNA polymerase chain reaction (PCR) was performed on batched 
samples using an H IV-1 monitor assay according to the manufacturer's instructions 
(AMPLICOR HIV-1 Monitor Test Roche Molecular Systems. Inc Somerville, N.J., U.S.A) 
for the detection and quantitation of the viral loads. In each case, 50iJi of each prepared 
RNA sample was used for PCR. Following amplification and detection of the PCR 
product, the starting HIV-1 RNA load in each sample was calculated in accordance with 
the internal quantitation standard (OS), with results expressed as HIV-1 RNA copies/ml 
plasma (Romeu et ai, 1992). The above-mentioned parameters were determined at 
baseline and after supplementation. The patients' HIV status were already known as 
evidenced by previous laboratory records, hence they were not determined in this study. 
6.3.2 Supplementation of patients 
Following the determination of the baseline dietary intake, anthropometry profile, 
haematological and immunological parameters and viral loads, the patients were given 7.5 
ml of the test supplement twice daily (between 07:00-09:00 and 16:00-19:00 hours). The 
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daily intake of the supplement by patients was monitored by members of the South African 
Red Cross Society, Bloemfontein and the medical staff at Tsepo House. 
6.3.3 Follow-up Visits 
The patients visited the clinic on a monthly basis. On each visit, physical and medical 
examinations were carried out on each patient by the clinical investigator in the study. 
Blood samples were taken and the full blood count and CD4+/CD8+T-cell count were 
determined at the monthly visit while the viral load was repeated at the end of the study. 
The haematological and immunological parameters were repeated at the end of the study 
to determine the possible influence of the supplement on the haematological and 
immunological status of the patients. For detailed procedure, see chapter 3 (methodology 
3.4.2). Compliance with the regime was ensured by counting the supplement units on a 
daily basis and at each visit and by constantly reminding the patients of the need to follow 
the protocol. Compliance with supplement intake by patients was monitored by assistants 
of the Red Cross home-based care, Bloemfontein . 
6.4 Statistical analysis 
The results for this study were analysed by an independent Biostatistician at the University 
of the Free State, Bloemfontein, South Africa, using SAS (1990). A detailed description is 
contained in chapter 3 (see 3.5.7) 
6.5 Results 
The results indicate that the female patients (n=27) were significantly more (P<0.05) than 
the male (n=8) patients. The results in some cases were categorised according to gender. 
Table 6. 1 shows the mean, standard deviation, median and the p-value of haematological 
parameters of the whole group of HIV-positive/AIDS patients at baseline and final visit. 
Haematological parameters with the same superscript showed statistical significance 
(P<0.05). Symbols and what they represent are indicated below each of the tables which 
follow. 
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Table 6.1 : Haematological parameters of the whole group of HIV-positive/AIDS 
patients at baseline and final visit. 
Variables Baseline visit Final vis it P·value 
N=35 N=29 
Mean SO Median Mean SO Med 
RBC: x 10'/1 4.0 0.6 4.1 4.4 1.7 4.0 NS 
Haemoglobin : gldl 12.1 1.9 12.0 11.9 1.7 11.9 NS 
Hct: III 0.37 0.1 0.36 0.38 0.1 0.36 NS 
MCHC: gldl 32.8 0.9 33 33.6 1.0 34 <0.0002" 
ESR: mm/hr 83.7 32.8 86 86.7 24.1 83 NS 
MCV: II 91.8 5 92 87.7 4.9 90 <0.002" 
MCH: pg 30.2 5 31 30.1 2.4 30 NS 
ROW 15.1 1.5 14. 15.2 2.0 14.5 NS 
WCe: x 10'/1 5.7 3.9 4.9 4.8 1.6 4.8 NS 
Neutrophil: x l O II 2.7 2.6 22 2.2 1.0 2.2 NS 
Lymphocyte: x 10'/1 2.1 0.8 1.9 1.9 0.9 1.9 NS 
Monocyte: x I 0 II 0.6 0.4 0.5 0.4 0.3 0.4 <0.001" 
Eosinophil: x I 0 II 0.3 0.4 0.2 0.3 0.3 0.2 NS 
Basophil : x l O'11 0.1 0.5 0.02 0.03 0.D2 0.02 NS 
Platelets count: x l 0/1 254.3 82.3 252 239.6 74.4 234 NS 
The P value tested the difference between the haematological parameters at baseline and 
final visit. 
*: Parameters with the same superscript showed statistical significance (P<O.05). 
NS (non significant), Med (median), SO (standard deviation). RBC (red blood cell), Hct 
(Haematocrit), MCV (mean cell volume), MCH (mean cell haemoglobin), MCHC (mean cell 
haemoglobin concentration), ROW (red cell distribution width). 
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Table 6.2 shows haematological parameters at baseline and final visits according to 
gender. 
Table 6.2: Haematological parameters of HIV-positive/AIDS patients at baseline and 
final visits according to gender. 
Variables 
RBC:xIO /I 
Male 
Female 
Haemoglobin: gldl 
Male 
Female 
Hct: III 
Male 
Female 
MCHC: gldl 
Male 
Female 
ESR: mmlhr 
Male 
Female 
MCV: fl 
Male 
Female 
MCH: pg 
Male 
Female 
RDW 
Male 
Female 
WCC: xlO'/1 
Male 
Female 
Neutrophil: xlO'/1 
Male 
Female 
Lymphocyte: xlO'/1 
Male 
Female 
Monocyte: x I 0 II 
Male 
Female 
Eosinophil: xlO I I 
Male 
Female 
Basophil: x I 0 II 
Male 
Female 
Platelets count: x l O~/ 1 
Male 
Female 
.. 
*<0.05 (slgmflcant) 
>0.05 (insignificant) 
Baseline visit 
N=35 
Mean SD 
4.4 0.8 
3.9 0.6 
13.7 2.5 
11.6 1.5 
0041 0.1 
0.36 0.04 
33.5 0.9 
32.1 0.9 
95.9 24.9 
80.1 34.4 
90.8 4.3 
89.2 3.9 
33.5 2.2 
30.0 1.9 
15.6 1.7 
16.0 2.3 
5.9 3.8 
4.8 2.7 
2.9 2.6 
2.4 1.9 
2.3 0.8 
1.8 0.7 
0.6 0.4 
0.7 0.5 
0.3 0.2 
0.4 0.3 
0.1 0.5 
0.1 0.5 
258.5 83.1 
250.1 79.7 
Final visit 
N=29 
P value M~an SD P va lue 
0>0.05 4.4 2.0 0>0.05 
4.4 2.0 
<0.03' 13.4 2.6 0.1 
11.4 3.1 
<0.02' 0.39 0.1 0>0.05 
0.38 0.1 
<0.05' 33.8 l.3 0>0.05 
33.5 0.9 
0>0.05 87.4 18.8 0>0.05 
86.4 26.2 
0>.05 92.8 4.6 <0.05' 
91.6 4.9 
<0.01' 32.5 1.8 <0.05' 
29.1 2.1 
>0.05 13.1 2.0 0>0.05 
15.7 2.1 
0>0.05 4.8 1.6 0>0.05 
4.4 l.3 
0>0.05 3.0 3.2 0>0.05 
2.3 2.6 
0>.05 2.4 0.9 0>0.05 
2.1 0.9 
0>0.05 0.5 0.1 0>0.05 
0.6 0.3 
0>0.05 OJ 0.3 0>0.05 
0.2 0.2 
0>0.05 0.02 0.01 0>0.05 
0.03 0.02 
0>0.05 241.2 76.1 0>0.05 
238 74.7 
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Table 6.4: Immunological parameters of HIV-positive/AIDS patients according to 
gender. 
Variables 
Mean 
Total T-cell count/mm-' 
Male 1617 
Female 1498 
CD4+T -cell count/mm' 
Male 204.2 
Female 202.4 
CDS+T-cell count/mm 
Male 1411 
Female 1390 
CD4/CD8 ratio 
Male 0. 16 
Female 0.18 
Viral load/ml 
Male 374308 
Female 374304 
. . 
*; P<O.05 (significant) . 
P>O.05 (insignificant) 
Baseline visit 
N=35 
SD P value 
737.1 0>0.05 
746.3 
83. 8 0>0.05 
81.2 
671.3 <0.02 -
686.5 
0.1 0>0.05 
0.1 
300301 0>0.05 
300304 
Final visit 
N=29 
Mean SD P value 
1543 697 0>0.05 
1344 701.9 
188.6 86 .2 0>0.05 
182.2 90.1 
1255 675.3 0>0.05 
1247 668.4 
0. 18 0.1 0>0.05 
0.17 0.1 
279371 244876.2 0>0.05 
279373 244878. 1 
Table 6.4 shows the immunological parameters of HIV-positive/AIDS patients according to 
gender. The CD8+T-cell count was significant (P<O.02) at baseline between male and 
female. Other parameters as shown in table 6.4 were not significant (P>O.05) between 
male and female at baseline and final visit. The supplement tends to indicate a positive 
effect on the CD8+T -cell count according to gender but was not significant. 
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In Table 6.5, ten (28.6%) of the patients had ear infection at baseline and this decreased 
to 5 (17 .2%) following treatment and supplementation. Eight (22.9%) of the patients had 
candidiasis at baseline and this decreased to 5 (17.2% with supplement administration. 
Six of the patients (17.1%) had tuberculosis (T8) at baseline. At the end of the study, 
there was no incidence of T8 reported . Three of the patients (8.6%) had diarrhoea at 
baseline visit, which decreased to 2 (6.9%) by the end of study. Liver enlargement was 
observed in 7 of the patients and it persisted through the study. Skin rashes decreased 
from 10 (28.6%) at baseline visit to 3 (10.3%) by the end of study. 
Most of the patients had low blood pressure and a greater percentage had a normal pulse 
rate. Overall, the patients showed slight improvements in clinical condition as well as 
physical appearance and quality of life. 
Table 6.5: Physical and Clinical Conditions of HIV-positive/AIDS Patients before and 
after nutrient supplementation. 
System Baseline vi sit V1 V2 V3 
n=35 n=30 n=32 n=29 
1. Eyes 
· 
Jaundice 0 0 0 0 
· 
Discharge 0 0 0 0 
· 
Infection 1 (2.9%) 1 (2.9%) 0 0 
· 
Pupil Normal 29 (82 ,9%) 29 (96.7%) 29 (90.6%) 29 (100%) 
2. Ears 
· 
Pain 6 (17.1 %) 4 (13.3%) 3 (9.4%) 2(6.9%) 
· 
Infection 10 (28.6%) 8 (26.7%) 6 (18.8%) 5 (17.2%) 
· 
Discharge 7 (20%) 6(20%) 5 (15.6%) 4 (13.8%) 
3. Nose 
· 
Pain 0 0 0 0 
· 
Ulcer 0 0 0 0 
· 
Swell ing 215.7%) 0 1 13.1 %) 1 13.4%) 
4. Mouth & Lips 
· 
Pain 1 (2 .9% 0 0 0 
· 
Ulcer 6 ( 17.1'%) 5 (16 .7%) 3 (9.4%) 1 (3.4%) 
· 
Swelling 1 (2.9%) 2 (6.7%) 2 (6.3%) 2 (6.9%) 
· 
Cracked lips 2 (5.7%) 2 (6.7%) 2(6.3%) 1 (3.4%) 
· 
Candidiasis 8 (229';,) 7 (23 3';,) 6 (18.8';,) 5 117.2%) 
5. Throat 
· 
Pain 15 (46.9%) 12 (40%) 15 (46.9%) 13 (44.8% ) 
· 
Ulcer 3 (8. 6%,) 2 (6.7% ) 2 (6 .3% ) 4 (13.8%) 
· 
Infection ~~i60r'i 20 (66.7%) 21 (65.6%) 16 (55.2%) 
· 
Candidiasis 3 6.6% 4 11 3.3%) 5 (15.6%) 5 (17.2%)' 
6. Respiratory System 
· 
Cough 13 (37. 1%) 21 (70%) 17 (53.1%) 14 (48.3% ) 
· 
Shortness of 
breath/Dyspnoea 3(8.6%) 3 (10%) 3 (9.4% ) 1 (3.4% ) 
· 
Pain 7 (20'%) 12 (40% ) 9 (28.1%) 10 (34.5% ) 
· 
Haemoptysis 0 0 0 0 
· 
TB 6 (17.1%) 5(16.7%) 2 (6.9% ) 0 
· 
Abnormal breath 
sounds 51143%) 13 (43.3%) 13 (40.6%) 11 (37.9%) 
V1 (VISit one), V2 (VISit two), V3 (VISit three). 
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Table 6.5 (continued): Physical and Clinical Conditions of HIV-positive/AIDS 
Patients before and after Nutrient Supplementation. 
7. Neck 
· 
Swelling 2 (5 .7%) 2(6.7%) 1 (3.1%) 1 (3.4%) 
· 
Glands: 
Submental 5 (14 .3%) 6 (20%) 4 (12.5%) 1 (3.4%) 
Jugular 13 (37 .1%) 20(66.7%) 18 (56.3%) 15 (51 .7%) 
Posterior 
Triangle of the Neck 5 (14.3%) 7 (23.3%) 6 (18.8%) 5 (17.2%) 
Occipital 16 (45. 7%) 1i (567'i, ) 15 (46 .9'i, ) 11 (37 .9'i, ) 
8. Cardiovascular 
· 
Swelling of 2 (5.7%) 0 4 12.5'%) 1 (3.4%) 
legs/angles 
· 
Other Edema 1 (2 .9%) 0 4 (12.5%) 1 (3.4%) 
· 
Shortness of 
brea th/Dyspnoea 4 (11 .4%) 5 (16.7%) 3 (9.4%) 3 (10.3%) 
· 
Cyanotic 0 0 1 (3 .1%) 0 
· 
Club fingers 0 0 0 0 
9. Blood forming organs 
· 
Enlargement of 
spleen 0 0 0 0 
· 
Glands in the neck 17 (48.6%) 20 (66.7%) 18 (56 .3) 16 (55 .2%) 
· 
Axilla 11 (31.4%) 17 (56 .7%) 1,~?1~~ ) 11) W9'/:( 
· 
Groins 10 (28.6%i 13 (43.3'i.i 9 28. 1% 10 34.5% 
10. Digestive 
· 
Weight 20 (57.1%) 16 (53.3%) 11 (34.4%) 10 (34.5%) 
loss/Malnutrition 
· 
Eating well 17 (48.6%) 15 (50% ) 17 (53.1%) 18 (62.1%) 
· 
Normal bowel 26 (74.3%) 26 (86.7%) 28 (87.5%) 28 (96.6%) 
movement 
· 
Diarrhoea 3(8.6%) 3 (10%) 2(6.3%) 2 (6.9%) 
· 
Constipation 1 (2 .9%) 1 (3.3%) 1 (3.1 %) 1 (3.4%) 
· 
Abnonnal pain 2 (5.7%) 0 0 0 
· 
NauseaNomiting 0 0 0 0 
· 
Liver enlargement 7 (20%) 7 (23.3%) 7 (21.9%) 7 (24 .1%) 
· 
Soleen enlarqement 0 0 0 0 
11 . Genlta-urlnary 
· 
Dysuria 6 (17.1%) 4 (13.3%) 4 (12.5%) 4 (13.8%) 
· 
Dysmenorrhoea 2(5.7%) 1 (3.3) 2 (6.3%) 1 (3.4%) 
· 
Vaginal discharge 6 (17.1) 11 (36.7%) 11 (34.5%) 10 (34.5%) 
· 
Urethral discharge 0 0 0 0 
· 
STI 2 (5.7%) 2 (6.7%) 2 (6 .3%) 2 (6.9%) 
· 
Penile discharge 0 0 0 0 
· 
SwelJina of scrotum 0 0 0 0 
12. locomotor 
· 
Pain 5 (14.3%) 5 (16.7%) 8 (25%) 3 (10.3%) 
· 
Neuropathy 1(i (28.6'i,) 12 (40'iJ 7 (21 .9%) 9 (31 %) 
13. Skin 
· 
Rashes 10 (28.6%) 9 (30%) 8 (25%) 3 (10.3%) 
· 
Ulcers 4(11.4%) 5 (16.7'%) 4 (12.5%) 4 (13.8%) 
· 
Tumours 0 0 0 0 
14. Central Nervous 
· 
Paralysis 0 0 0 0 
· 
Normal stale of 
consciousness 32 (91.4%) 30 (100%) 29 (90.6%) 25 (86.2%) 
· 
Normal sensory 
system 32 (91 .4%) 30 (100%) 30 (93.8%) 29 (100'/.1 
15. Vital Signs 
· 
T emperatureJNormal 31 (88.6%) 30 (100%) 31 (96.9%) 29 (100%) 
· 
Blood 
pressure/Normal 7 (20%) 3 (10%) 5 (15.6%) 7 (24.1%) 
· 
Pulse Rate/Normal 21 (60%) 21 (70'i,) 18 (56 .3% 17 (58.6%) 
V1 (visit one), V2 (visit two), V3 (visit three). 
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6.6 Discussion 
From available information, the current study is the first clinical trial in the Free State 
Province of South Africa and the results demonstrated that in an HIV-positive population, 
daily supplementation of sterol/sterol in mixture and antioxidants significantly decreased 
the viral load. Researchers have recommended the benefit of nutrition intervention 
programmes, including supplementation with antioxidant nutrients, as part of the 
comprehensive care for HIV-positive/AIOS people (Bogden et al., 1990; Fawzi & Hunter, 
1998; Miller & Gorbach, 1999). In this study, the blood levels of these antioxidants were 
not determined because it was not the primary focus; in addition, there were financial 
constrains. However, a previous study done in the Free State by Van Staden et al. (1998) 
reported reduced levels of these antioxidants in the blood of HIV-positive persons. It was 
therefore appropriate to test the influence of a multiple combination liquid product 
containing sterol/sterolin and antioxidants on the immune status, haematological 
parameters and clinical conditions of HIV-positive/AIOS patients. It is believed that an 
extra amount of antioxidants would help in reducing the stimulation of HIV replication and 
thus have some clinical significance (Bogden et al., 1990) 
In vitro evidence has implicated oxidative stress in the stimulation of HIV replication 
through activation of the necrosis factor in a human T-cell line (Oas et ai., 1990). Addition 
of antioxidant vitamins blocked the activation of the necrosis factor and inhibited HIV 
replication (Oas et al., 1990; Harakeh et al. , 1990; Wong et al., 1991). Similar effects may 
occur in vivo as demonstrated by the significant reduction in HIV viral load in both male 
and female patients, as observed in this study following supplementation . This finding is 
similar to that reported by Allard et al. (1998) who observed that, in a clinical trial, daily 
doses of vitamin C and E supplementation provided for patients for three months resulted 
in a clinically important reduction in the viral load. In another study, Bouic et al. (2001) 
indicated that HIV-positive subjects on a sterol/sterolin mixture experienced a decrease in 
average viral load in their plasma. The supplement in the present study contains 
sterol/sterolin mixture besides antioxidants/minerals. The question as to whether the 
significant reduction in the viral load was due to the effect of the sterol/sterolin mixture or a 
combined effect of the sterol/sterolin mixture and the other supplement components 
(antioxidants/minerals), needs to be clarified in future studies. Yet, important questions are 
whether the reduction observed regarding the viral load can be sustained for an 
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appreciable period of time and whether the result truly demonstrates clinical benefits. It is 
likely that the clinical benefits of the supplement are related to duration as well as to the 
magnitude of HIV suppression, but the precise duration of HIV suppression necessary to 
effect measurable clinical benefits needs to be clearly defined. A mere observation in the 
reduction of the HIV RNA (viral load) may be inadequate in measuring the prospect of a 
clinical benefit of a supplement. For instance, one log decrease for an individual with a 
viral load of 100, 000 copies may be more beneficial to that individual than one log 
reduction for an individual with 10, 000 RNA copies. Likewise, a one log reduction for an 
individual with 100, 000 RNA copies will lower his or her viral load to 10, 000 copies, and 
one log reduction for an individual with 10, 000 RNA copies will lower the viral load to 1000 
RNA copies. Nonetheless, the result obtained from the study is envisaged to stimulate 
further work on the potential use of this supplement in HIV therapy. 
Kanter et a/. (1999) reported delayed onset of AIDS and death following supplementation 
with multivitamins. The current study did not directly measure the rate of progression of 
HIV infection to AIDS or the survival rate; however, evidence in literature (Martin, 2000; 
Piwoz & Preble, 2000; Singhai & Austin, 2002) showed that one of the factors determining 
disease progression in HIV infection is the rate of replication of the HIV. By decreasing the 
viral load significantly as observed in this study, the supplement has indirectly shown its 
positive effect on the quality of life of people living with HIV/AIDS, which relates to 
reducing the rate of disease progression. 
It has been indicated that nutrient supplementation may be an important prophylactic and 
therapeutic means for HIV-positive people to improve their quality of life and level of 
functionality (Piwoz & Preble, 2000; Macallan, 1999; Allard et a/., 1998). Decreasing the 
viral load is a scientifically accepted means of improving the quality, strength and level of 
such functionality since this boosts the immune status. The level of functionality and 
quality of life that emerged from the influence of the supplement in this study cannot be 
categorically stated, but by inference, it can be said that the supplement improved the 
quality of life by decreasing the progression of HIV infection. 
A central feature in the pathogenesis of HIV infection is the depletion of T-Iymphocytes 
bearing the CD4+ molecule (Rowland-Jones & Pinheiro, 2001). The CD4+T-lymphocyte 
quantitation measures this depletion and provides important information about the immune 
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status of HIV-1 infected persons. In this study, the CD4+T-cell count decreased 
significantly during the course of study. This does not infer that the supplement further 
decreased the CD4+T-cell counts, but the decrease in the CD4+T count reflects the severe 
state of the immune status. It was expected that, with a decrease in viral load, the CD4+T 
count would increase. This was not so, as can be seen in the study. The quantity and 
function of CD4+T-cells is dependent on the production of new CD4+T-cells . If production 
of these cells is impaired, damaged CD4+T-cells cannot be replaced, therefore a decrease 
in viral load may not necessarily result in a corresponding increase in the CD4+T count. 
CD4+T-cell depletion in HIV-1 infection is partly the result of T-cell apoptosis (Hansjee et 
al.,2004). According to Hansjee et al. (2004), the significant relationship between residual 
T-Iymphocyte apoptosis and CD4+T-cell recovery suggests that persistent apoptosis may 
impede immune restoration. Although T -lymphocyte apoptosis was not investigated in this 
study, it is possible that it contributed partly to the non-significant effect of the supplement 
on the CD4+T -cell count. It has also been observed that suppression of plasma viraemia 
in chronic HIV infection is usually associated with loss or reduction of HIV-1 specific 
cytotoxic T-Iymphocyte responses (Altfeld & Rosenberg, 2000). Could this be a possible 
mechanism that contributed in a secondary way to the reduction of the CD4+Tcell count of 
the studied patients? Although it is not clear whether it was so, further investigation could 
throw more light on this . 
In addition, researchers shared the view that nutritional intervention, including 
supplementation, should commence in the early stage of HIV infection. Both clinical and 
laboratory data suggest that the majority of the patients recruited for this study were not in 
an early stage of HIV infection. Some findings have reported that the measure of CD4+T 
count could be misleading in predicting HIV progression compared with viral load (Mellors 
et al., 1996; Wilson et al., 2000; Rowland-Jones & Pinheiro, 2001), therefore viral load 
seems a better predictor of HIV replication and the rate of decline of the immune status in 
HIV-infected persons. The viral load tells us with remarkable precision how fast the 
immune system is being destroyed. Martin (2000) indicated that CD4+ and CDS+T-cell 
counts decrease as HIV infection progresses in the absence of highly active antiretroviral 
therapy (HAART). Martin 's finding (2000) could partly explain the reason for the decline in 
the CD4+T-cell count observed in the study. Time of collection and analysis of blood 
sample could be factors as well. It is recommended that blood samples for a CD4+T -cell 
count be collected between 09:00 and 11 :00 and analysed within four hours of blood 
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collection. In this study, this was not always done because patients could not all arrive at 
the clinic at the same time for sample collection. 
In a study carried out in South Africa by Bouic et al. (2001), the CD4+T-cell count remained 
stable for three years with no significant increase or decrease following supplementation. 
The producUsupplement used by Bouic et al. (2001) contained mainly sterol and sterolin 
(an immune modulator), but no antioxidants. The supplement examined in our study 
contains sterol and sterolin mixture but in addition, also contains antioxidants. However, it 
showed no stability or increase in the CD4+T-cell count. The reason for the difference in 
result may be related to the stage of HIV infection and duration of administration of the 
supplement. One study carried out in Canada by Allard et al. (1998), reported no 
significant difference between the baseline CD4+T-cell count and the CD4+T-cell count at 
the end of three months of supplementation. The combination of the supplement (in his 
case, it was vitamin E and C), the stage of infection, and the bioavailability of supplement 
components in the individual subjects, may explain the difference in the CD4+T -cell count 
at baseline and the CD4+T-cell count at the end of study. 
Although AIDS-defining complications are common once the CD4+T-cell count is less than 
200 cells/ml , the association between the CD4+T-cell count and the risk of death in 
persons with AIDS is not well defined. In this study, ten of the patients whose CD4+T-cell 
count fell below 200 cells/mm3 died during the course of the study. However, a few of the 
patients who had a CD4+T-cell of less than 200 cells/mm3 survived till the end of the study. 
Therefore, this current work tends to suggest that this population somehow constituted a 
select group who survived to this point with such low levels of CD4+T-cell count. 
The issue of non-compliance as regards the influence of the supplement on the CD4+T-cell 
count in this study cannot be justified. This is because it could be argued that since the 
supplement significantly reduced the viral load, the patients possibly complied with the 
supplement regime. But, at the same time, it might be said that the compliance that 
produced a significant decrease in the viral load may not necessarily produce a pOSitive 
effect on the CD4+T-cell count; a better compliance would probably be required to possibly 
produce a positive effect on the CD4+T -cell count. Other reasons for the non-positive 
effect of the supplement on the CD4+T -cell count observed in this study are suggested to 
be the bioavailability of the supplement ingredients and drug/food-nutrient interaction. 
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The CD8+ T-Iymphocytes are believed to mediate antiviral activity against HIV (Yang. 
1998). This was first reported in 1986. when investigators noted that depletion of CD8+T-
cells from peripheral blood mononuclear cells of HIV-infected persons resulted in a marked 
increase in viral replication. Replacement of the CD8+T-cells caused a dose-dependent 
suppression of viral replication (Yang. 1998). Yang (1998) also reported that an increase 
in the CD8+T-cells count correlated with a decline of viraemia of primary HIV infection and 
inversely correlated with disease progression. In this study. the CD8+T cells showed no 
correlation with decrease in viral load. probably because the CD8+T-cell count did not 
increase with supplementation. It could be opined that. if the CD8+T -cells count had 
increased significantly following supplementation. a correlation of CD8+T-cell counts with 
viral load could be possible. The mechanism as to how increased CD8+T cells decrease 
viral activity is not clear. although this mechanism was not examined in this study. 
However. it is believed that CD8+T-cells may produce factors that act by inhibiting the 
promoter. the long terminal repeat of HIV. thereby suppressing viral transcription (Yang. 
1998). 
HIV infection is known to cause inversion of the CD4+T-cell/CD8+T-cell ratio (normal range 
0.72-3.14). A CD4+/CD8+T-cell ratio of 0.15 is said to correlate with a CD4+T-cell count of 
200cells/mm3. A high baseline CD8+T-cell count and subsequent fall seems to occur due 
to HIV-mediated immune hyper-activation (Wilson et al .• 2000). The median CD4+/CD8+T-
cell count ratio of 0.2 reported in this study. is similar to the 0.15 quoted above and tends 
to correlate with the level of the CD4+T-cell count. The present study also indicated that 
the CD4+/CD8+T-cell count ratio was reversed. The reversed ratio is believed to be 
associated with the significant decline in the CD4+T -cell count. 
The haemoglobin level stayed relatively constant in the patients Anaemia here is defined 
as haemoglobin below 12.0 g/dl (table 6.1). The haemoglobin level in all the patients was 
slightly above 12.0 g/dl at baseline and this level was more or less constant throughout the 
course of the study. It is possible that haemo-concentration contributed to the 
haemoglobin level reported in this population. When the patients were examined 
according to gender. there was a slight but insignificant decrease in the haemoglobin level 
of female patients following supplementation . The mean cell haemoglobin (MCH) level 
was also sl ightly maintained. The haematocrit (Hct) showed a slight but an insignificant 
increase following supplementation (table 6.1). The mean cell volume (MCV) and the 
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mean cell haemoglobin concentration (MCHC) showed significant increase following 
supplementation (table 6.1). 
Anaemia is a common manifestation of HIV infection and occurs at all stages of HIV-
associated disease (Doukas, 1998). It remains a significant problem despite recent 
advances in antiretroviral therapy and the introduction of highly antiretroviral therapy 
(HAART) into routine clinical practice (Moore, 2000). Among HIV-infected patients, 
anaemia has been linked to decreasing levels of CD4+T-cell counts (more severe with 
CD4+T-cell count less than 200), increased plasma HIV RNA levels, and a history of 
clinical AIDS-defining conditions. Anaemia in HIV-infected persons has also been linked 
to abnormally low levels of erythropoietin, decreased erythropoietin production, increased 
erythrocyte destruction, ineffective erythrocyte production and the use of multiple 
medications (Doukas, 1998) 
Taken as a group, the patients had haemoglobin levels slightly above 12.0 g/dl (table 6.1) 
at baseline, hence the patients cannot be said to be anaemic. With the progression of HIV 
infection, the level of haemoglobin in HIV infected patients is expected to decrease in the 
absence of nutritional support. In this study, it was observed that, instead of the 
haemoglobin of the patients having decreased, the level was maintained through the 
course of the study. We tend to believe that the haemoglobin level was maintained in the 
presence of the supplement. The supplement contains important ingredients such as folic 
acid, vitamin C and vitamin B1 2 that could have possibly contributed to maintaining the 
haemoglobin level . Folic acid is essential in the formation and maturation of red blood 
cells (Itam, 2003). Vitamin C is a reducing agent and its effect is to prevent the oxidation 
of iron, thus making more iron available. The effect of vitamin B1 2 in red blood cell 
synthesis is well known . In the presence of adequate amounts of vitamin B12 (10lJg), it is 
believed that megaloblastic anaemia of vitamin B12 origin can be prevented (Chemiron 
International, 1991). Although the observation may be explained by various hypotheses 
which may require confirmation via pharmaco-kinetic studies, the fact that mean cell 
volume (MCV) and mean cell haemoglobin concentration (MCHC) significantly increased 
following supplementation, showed the positive effect of the supplement on the 
haematological parameters. 
There was no significant difference between the median white cell count and median 
differential count of the patients before and after supplementation (table 6 .1). The 
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baseline total T -lymphocyte count and the total T -lymphocyte count at the end of 
supplementation did not show significant differences (table 6.1). Lymphopaenia and 
neutropenia are common in HIV-positive/AIDS, especially in Africa (Wilson et a/., 2000). 
The present study did not observe this phenomenon. 
The individual patients studied did not show thrombocytopenia, as the platelet counts were 
within the reference range (table 6.1). A high incidence of thrombocytopenia has been 
reported in some HIV-positive patients. A prevalence of thrombocytopenia of 5-12% has 
been reported in AIDS-Related Complex (ARC) patients compared with a prevalence of 
30% in patients with AIDS (McPherdran, 1999). The mechanism of thrombocytopenia in 
HIV infection appears to be due to the presence of an autoantibody acting against a 
platelet membrane protein. This protein appears to be approximately 25 kilodaltons in size 
and is present on normal platelet. It may resemble an HIV precursor protein, but the exact 
mechanisms for platelet destruction remain unclear (McPherdran , 1999). For the patients 
in the current study, the non-detection of thrombocytopenia in the current study, even at 
baseline could be due to small sample size. Could an internal factor have been present 
that provided protection to the platelets against the destruction of platelets by the HIV? 
This demands further investigation 
Different types of infections and clinical conditions have been reported in HIV-
positive/AIDS patients (Maartens, 2001). The type and severity of the infection depend on 
the nature of the immune defect. Secondly, the degree of immune suppression is 
important as HIV infection causes a progressive immune suppression in all patients who 
are not treated with antiretroviral therapy. As immunity decreases, patients become 
susceptible to a wider spectrum of infections (Maartens, 2001). In addition, organisms that 
are prevalent in the patient's environment will be responsible for a large proportion of the 
infections. This is perhaps the reason why HIV-associated infections in sub-Saharan 
Africa differ markedly in their incidence from those in industrialised countries. These 
infections range from bacterial to fungal , parasitic and viral. The quality of life and lifespan 
of HIV-infected persons is affected by these various infections. In this study, a few 
opportunistic or HIV-related conditions/infections were identified and they are discussed 
below. 
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Few cases of HIV-related opthalmological problems have been reported in HIV-
positive/AIDS patients (Cunningham, 2001). The patients examined in the current study 
reported a very low infection rate (2.9%), with no jaundice or eye discharge (table 6.5). It 
is worth noting that even the very low eye infection rate documented did not progress as 
the study proceeded. 
In this study, 28.6% of the patient population had an ear infection (table 6.5). Observation 
revealed that, the ear infection decreased to 17.2% (table 6.5) following supplementation. 
The patients were treated on recognition of the infection , therefore it makes it difficult for 
us to say with certainty whether the supplement had a positive effect on the clinical 
conditions. Nonetheless, the supplement probably aided in the healing or recovery 
process. 
Studies (Maenza et al., 1997; Tumbarello et a/., 1996; Sangeorzan et al. , 1994) have 
demonstrated the prevalence of oral infection due to Candida species in patients with 
HIV/AIDS. Greenspan (1994) reported that oral candidiasis is one of the most common 
oral infections in HIV patients. The most frequent species producing oral infection is 
Candida a/bicans, but other species are occasionally found which infect the oral mucosa 
(Greenspan, 1994). Both oral (22 .9%) and throat (8.6%) candidiasis (table 6.5) were 
diagnosed among the studied patients. Candidiasis did not decrease during 
supplementation and treatment. The reason for this is not known, but drug resistance may 
be responsible. Fluconazole resistance in Candida albicans has been reported frequently 
in HIV/AIDS patients, especially those with CD4+T-cell counts of less than 200 cells/mm3 
(Maenza et aI., 1997). Furthermore, a recent study indicated that dysfunction of CD4+T-
cells and CDS+T-cells may be associated with inadequate defence against oral and 
oropharyngeal candidiasis in patients with HIV/AIDS (Douglas, 2003). As noted in this 
study, the CD4+T-cell count decreased significantly, indicating a dysfunction in CD4+T-
cells. This could be another reason for the non-improvement in candidiasis following 
supplementation, but then it cannot be confirmed whether this mechanism (association 
between low CD4+T-cell count and candidiasis) contributed to the clinical picture in regard 
to candidiasis. This needs further investigation. 
In sub-Saharan Africa, Mycobacterium tuberculosis (TB) is the most frequent and in many 
instances the first opportunistic infection to occur in HIV-infected patients (Lucas et a/., 
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1993; Mortens & Low-Beer, 1996). The development of TB in HIV-infected patients has a 
poor prognosis and a high mortality rate (Nunn et aI., 1992). HIV/AIDS patients also have 
a significantly higher risk of contracting TB infection owing to the underlying immune 
deficiency (Wilkinson & Moore, 1996). TB infection is a public health problem in South 
Africa, especially among the lower socio-economic group of society (Wilson et al. , 2000). 
The prevalence of TB in this study was not high, occurring in 17.1 % of the patient 
population (table 6.5). The clinical conditions improved with treatment and 
supplementation. From observation, TB does not seem to be a major infection in this 
group of patients. However, since the diagnosis of TB in these patients was based mainly 
on clinical features/symptoms rather than on radiological and microbiological methods, the 
prevalence of TB as reported here is subjective and the results need to be interpreted with 
caution. It is also worthy noting that viral load increases with TB infection, and the fact that 
the viral load in this study decreased significantly in the presence of TB infection, 
demonstrates the positive effect of the supplement and indicates the importance of 
supplementation in HIV-infected persons, especially those infected with of HIV and TB. 
Swelling or enlargement of glands, especially near the neck, was observed in HIV-
positive/AIDS patients (Maartens, 2001), but the severity and frequency of the swellings 
depended on the immune responses and the stage of HIV infection. In this study, clinical 
observation showed that the prevalence of swelling was higher around the jugular and it 
did not show improvement with supplementation (table 6.5). 
Pathological abnormalities in the central nervous system have been reported in 7-90% of 
patients dying of AIDS (Levy et al. , 1985; de la Monte et al., 1987). Cognitive dysfunction 
is said to be common as well. Immune deficiency may result in opportunistic infections of 
the central nervous system (CNS), causing specific neurological dysfunction (Navia & 
Price, 1987). The patients examined showed a normal state of consciousness (91.4%) 
and all demonstrated a normal sensory system. Ten (28.6) of the patients examined, 
(table 6.5) had neuropathy at baseline and showed no consistent sign of improvement with 
supplementation. The technique employed in the diagnosis of neurological problems was 
limited, thus certa in abnormal ities that could have been identified may have been left 
undiagnosed. 
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Malnutrition and body weight loss is commonly documented in HIV infection (Niyongabo et 
a/. , 1999; Hogan et a/., 2003). Malnutrition associated with HIV/AIDS is known to be the 
result of several processes, but the degree to which nutrition therapy can positively alter 
the course of HIV disease among HIV-positive/AIDS patients in Africa is largely unknown 
(Piwoz & Preble, 2000). Malnutrition in HIV/AIDS patients includes symptoms such as 
weight loss, loss of muscle and subcutaneous fat, vitamin and mineral deficiencies, 
reduced immune competence and increased susceptibility to infection. Conditions that 
could lead to malnutrition include lack of appetite, poor nutrient intake, limited food 
availability, chronic infection, malabsorption, metabolic disturbances, fever, nausea, 
vomiting and diarrhoea, depression and the side-effects of drugs (Sodeinde et al., 1997; 
Taniguchi et al., 1999). The medical history and medical examination of patients in the 
current study showed that 57 .1% of the patients reported weight lossl malnutrition (table 
6.5). This condition improved with supplementation, falling to 34.5% (table 6.5). It is 
opined that the supplement partly contributed to this observed improvement in 
malnutrition. Another factor that could have contributed to the improvement of malnutrition 
is the fact that patients reported good appetite. Clinically, nausea and vomiting were not 
noted. This perhaps improved the nutritional status of the patients as well. 
Gastrointestinal infections include parasitic, bacterial and viral which contribute to 
diarrhoea, especially in AIDS patients. Gastrointestinal pathogens include opportunistic 
organisms that cause severe intermittent gastrointestinal disease, and non-opportunistic 
organisms that usually cause acute treatable diarrhoeal illness (Smith et al., 1992). 
Clinical assessment of the patients in the present study indicated that diarrhoea (8.6% at 
baseline) was not a prominent illness among the patients (table 6.5). This may be related 
to the adequate care provided by the home-based care. The patients were taught about 
personal hygiene and given health education. 
Vaginal discharge resulting from either candidiasis or sexually transmitted infections was 
diagnosed in the patients during the period of study (table 6.5). Candidiasis seemed to 
predominate and the prevalence increased through out the study. This might be related to 
the chronic nature of the infection. It is important to subject such diagnosis to laboratory 
testing. This could lead to the particular causative agent being detected and isolated and 
where applicable, the antibiotic sensitivity pattern determined, and, ultimately appropriate 
treatment. Laboratory test is thus recommended in future studies. 
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Jeena (2001) reported that over 80-90% of HIV-positive/AIDS patients have skin infections 
at some point during their lifetime. Local immunity of the skin is useful in determining the 
progression of HIV infection. With recurrent infections, there is impairment of the skin's 
immune system. Primary HIV infection produces a typical infectious mononucleosis-like 
rash (Jeena, 2001). Secondary mucotaneous involvement is common with viral, bacterial, 
fungal and other miscellaneous infections (Jeena, 2001). In this study, 28.6% (table 6.5) 
of the patients had skin rash at baseline but this decreased during the course of study. 
Ulcers remained stable through the course of study. The percentage of patients with skin 
infections, as indicated here, may be related to the impairment of the immune status 
(dysfunctional immune system). 
6.7 Conclusion 
This study showed that the supplement significantly reduced the viral load, suggesting that 
there may be some clinical benefit worthy of larger clinical trials. Since combinations of 
antiretroviral therapies are generally limited to privileged persons for economic, social , 
political and sometimes religious reasons, consideration of the potential of this supplement 
remains important for developing countries, particularly those in sub-Saharan Africa where 
a majority of the populace cannot afford antiretroviral therapy. It could have an 
appreciable benefit, perhaps similar to the effect of vitamin A supplementation on 
childhood mortality in developing countries. 
Although, an ideal nutritional intervention strategy has not been devised, efforts to prevent 
nutritional complications and improve immune status and clinical conditions should include 
nutritional supplementation . This study showed that sterol/sterolin and vitamin/mineral 
supplementation of HIV-infected persons may have protective effects on the progression 
of HIV disease as indicated by the significant decrease in the viral load. The reduction in 
the viral load is very important since the median time is known to increase with a reduction 
in HIV viral load. The supplement also showed positive effects on a few of the 
haematological parameters and perhaps played a contributing role in improving some of 
the clinical conditions of the patients. 
Nutritional management is basal to the care of all patients infected with HIV. 
Supplementation, unlike many other AIDS treatments has the potential in Africa to be an 
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affordable and relatively easy-to-deliver public health measure. This study forms part of a 
comprehensive care system for the nutritional management of HIV-positive/AIDS patients. 
The supplement was well tolerated, hence no patient complained of any side-effects 
throughout the period of study. Observation showed that some of the patients improved 
physically and appeared healthier by the end of supplementation than before 
supplementation. Therefore, the benefit of the supplement may also extend to improved 
physical appearance and general well-being. 
This study therefore, suggests that supplementing for longer periods (at least six months) 
could prove the effectiveness of the supplement in the clinical and nutritional management 
of HIV-positive/AIDS patients. Many vital questions, however, remain to be answered for 
one to understand fully the mechanism of action of the supplement and how best to utilize 
this new but potent therapy. 
6.8 Limitation of the Study 
This study was limited by small sample size, short duration and lack of a control group. 
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Chapter 7 
7 General Summary 
Evidence from literature indicates that, although nutritional factors are not likely to be the 
most significant aetiological determinants in HIV infection, carefully chosen nutritional 
support or supplementation in terms of quality and safety can improve nutritional status 
and immune function. It has the potential to retard viral expression and disease 
progression, thereby improving the general well-being of people living with HIV/AIDS. 
Furthermore, nutrient supplementation in HIV-infected individuals is likely to be more 
important among under-privileged populations, but unfortunately very few studies have 
been reported in developing countries. The HIV prevalence in South Africa and the rest of 
Africa is becoming critical as the epidemic shifts towards the more socially and 
economically disadvantaged populations, with a concomitant reduction in house income 
earnings and food production . Since strong relationships exist between food 
production/availability and nutritional status and between nutritional and immune status, 
these implications adversely affect both the nutritional and immune status especially of 
people living with HIV/AIDS. Therefore, a majority of people living with HIV/AIDS may 
possibly be at risk of malnutrition and micronutrient deficiencies due to inadequate intake 
or because of an increased metabolic rate resulting from the infection. 
The aim of this study was to examine the influence of a nutritional supplement (Africa's 
Solution) on the immune status of HIV-positive/AIDS patients who are economically 
disadvantaged. The results and conclusions of this are envisaged to have a broader 
impact in the industry as well as to the patients and have academic benefits. 
The study analysed the baseline dietary intake of 35 HIV-positive/AIDS patients. A food 
frequency questionnaire was used to assess both the macronutrient and micronutrient 
intakes of the patients at baseline. It is known that nutrient the requirements for HIV-
positive/AIDS patients are higher than for individuals who are HIV negative, because of the 
catabolic activity of HIV infection. However, the exact nutritional requirements for HIV-
positive/AIDS patients are not known, hence the recommended daily allowances/adequate 
intake (RONAl) was used as a standard reference so as to allow for comparison of the 
results of the study with those of previous studies. In this study the patients demonstrated 
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energy and dietary intake of major macronutrients higher than the RDAIAI and higher 
(P<O.05) in males than in females. The results also indicated that the mineral and trace 
element intakes exceeded the RDAlAI, except for iodine and selenium. The majority of 
patients reported adequate intake of most vitamins with the exception of folate and vitamin 
D. It is envisaged that the high dietary intake of major macronutrients and micronutrients 
will help in maintaining the nutritional status and in curtailing wasting in the patients. 
The influence of the supplement on anthropometric profiles and their association with the 
CD4+T-cell count and viral load were determined. The anthropometric profiles and the 
viral load of the patients were determined at baseline (n= 35) and by the end of the study 
(n=28) while the CD4+ T-cell count was performed monthly during the period of the study 
using standard procedures. Results showed that there was no significant difference 
(P>O.05) in the fat percentage and body weight before and after nutrient supplementation; 
however, the fat percentage differed significantly (P<O.05) according to gender. In 
general, the body mass index (BMI) and the lean body mass (LBM) produced a trend 
towards an improvement. There was a positive correlation between BMI and fat 
percentage. The CD4+T-cell count showed no correlation with the anthropometric profiles, 
while the viral load showed a negative correlation with the LBM, the fat percentage, and 
the BMI, but indicated a positive correlation with the WHR. 
The influence of the supplement on the immune status, haematological parameters and 
clinical conditions of the patients were also tested. The results showed that the viral load 
decreased significantly (P<O.002) with time following supplementation. The mean cell 
volume (MCV) and the mean cell haemoglobin concentration (MCHC) increased 
significantly (P<O.002, P<O.0002) respectively, reflecting the positive effect of the 
supplement on a few of the haematological parameters. The supplement demonstrated no 
effect on the CD4+T-cell count and the CD4+T-cell count decreased significantly (P<O.05) 
with HIV disease progression. The non-positive effect of the supplement on the CD4+T-
cell count may be related to the already low CD4+T-cell counts before supplementation 
(lower than 200 cells/mm3 in majority of the patients), short duration, inter-assay variation, 
changes due to inter-current illness, impaired production, redistribution within the 
intravascular spaces, drug-nutrient and food-nutrient interactions. The supplement 
showed unconfirmed but observable positive effects on the general well-being (clinical 
conditions) of the patients. 
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In general, the study population demonstrated an adequate intake of energy, major 
macronutrients and micronutrients. The BMI and LBM produced a trend towards 
improvement. The viral load decreased significantly, while the MCV and MCHC increased 
significantly with supplementation. The physical appearance and the general well-being of 
the patients improved following supplementation. However, the supplement did not 
indicate a positive effect on the CD4+T-cell counts, possibly due to the short duration of 
supplementation, stage of HIV infection (late stage), low level of immune status, inter-
assay variation and degree of bioavailability of supplement. The reduction in the viral load 
is very important since median survival time is known to increase with reduction in the HIV 
viral load. Because of certain limitations (small sample size, short duration, late stage of 
the infection and inter-assay variation), further study is necessary to confirm the influence 
of the supplement. 
7.1 Recommendations 
It is recommended that: 
• Future study should recruit HIV-positive patients with a higher CD4+T-cell count as 
inclusion criterion because of increased chances of patients' drop out resulting from 
low CD4+T-cell count. 
• There is need to assess the dietary intakes at both baseline and end of study as 
this would give a better assessment of the nutritional status of the patients as the 
infection progresses. 
• Controls should be included in subsequent studies for the purpose of comparison 
and to be able to monitor the effect of the supplement more reliably and effectively. 
• There is the need for a larger prospective population-based study of both HIV-
positive patients and negative (control) individuals. 
• The duration of supplementation should be extended to six months or one year for 
possible better effects. 
• In subsequent studies, laboratory analysis of blood vitamins and minerals should be 
carried out before, during and after supplementation. This would assist in 
monitoring the possible effects of the supplement. 
• More research is needed in order to find out or define more clearly the health-risk 
posed by HIV infection and to establish meaningful criteria for the formulation of 
interventions with regards to the health and nutrition of HIV-infected persons. 
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• Consumption of alcohol should also be monitored in HIV-positive/AIDS patients 
since consumption of alcohol or related substance is known to have adverse effects 
on nutritional status. 
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APPENDIX A 
SOCIO-DEMOGRAPHIC QUESTIONNAIRE 
All information in this uestionnaire is confidential. 
Name: ______ _ 
Respondent number: 
Interviewer: ______ _ 
!TTl 1-3 
--cIJ 4-5 
DDMMYYY Y 
Birth Date: 
Interview Date: 
Age (years) if Birth Date unknown: _______ _ 
I i I I I I II 1'·,3 14-21 
22-23 
Address: __________ ~~-----
Tel No (H):______ (W): _____ _ 
How many years have you been living in an urban area (like Mangaung)? 
Encircle the appropriate answer: 
Language: 
1. Sotho 
2. Tswana 
3. English 
4. Afrikaans 
5. Other, 
specify ______ _ 
Number of children: (born):. ______ _ 
Number of children : (alive): ______ _ 
Do you smoke at all? 
1. Yes 
2. No 
If yes, how many cigarettes per day? 
Household composition: 
How many persons live in the house permanently (5-7 days per 
week)? ____ _ 
Number of children « 18 yrs) :. _____ _ 
Number of adults (? 18 yrs): ______ _ 
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Marital status of respondent: 0 40 
1. Unmarried 
2. Married 
3. Divorced 
4. Separated 
5. Widowed 
6. Living Together 
7. Traditional Marriage 
8. Other, 
specify 
What is your highest level of education? o 41 
1. None 
2 . Primary School 
3. Std 6-8 
4. Std 9-10 
5. Tertiary Education 
6. Don't Know 
Employment status of respondent 0 42 
1. Unemployed 
2. Self Employed 
3. Full time wage eamer (receive a salary) 
4. Other, specify (part-time, peace job 
etc.) 
5. Don't Know 
Husband/ partner's employment status 0 43 
1. Retired by choice 
2. Unemployed 
3. Self Employed 
4. Full time wage earner (receive a salary) 
5. Other, specify (part-time, peace job 
etc.) 
6. Not Applicable e.g. dead 
Who is the head of this household? 0 44 
1. Self 
2. Husband 
3. Child/ren 
4. Parent 
5. Grandparent 
6. Friend 
7. Other, specify 
203 
© Central University of Technology, Free State
Type of dwelling: 
1. Brick, Concrete 
2. Traditional mud 
3. Tin 
4. Plank, wood 
5. Other, specify ______ _ 
Number of rooms in house (excluding bathroom, toilet and 
kitchen, if separate)separate): 
Where do you get drinking water most of the time? 
1. Own tap 
2. Communal tap 
3. River, dam 
4. Borehole, well 
5. Other, specify ______ _ 
What type of toilet does this household have? 
1. Flush 
2. Pit 
3. Bucket, pot 
4. VIP 
5. Other, specify ______ _ 
What fuel is used for cooking most of the time? 
1. Electric 
2. Gas 
3. Paraffin 
4. Wood, Coal 
5. Sun 
6. Open fire 
Do you use a cast iron pot for cooking? 
1. Never 
2. ::: Once a week 
3. > Once a week 
4. Every day 
Does the home have a working: 
Refrigerator and/ or freezer 
1. Yes 
2. No 
Stove (Gas, Coal or electric) or Hot Plate 
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1. Yes 
2. No 
Primus or Paraffin Stove 
1. Yes 
2. No 
Microwave 
1. Yes 
2. No 
Radio and/or Television 
1. Yes 
2. No 
I How many people contribute to the total income? ____ _ 
I 
Household income per month (including wages, rent, sales of 
vegs, etc. State grants). 
1. None 
2. R100-R500 
3. R501-R1000 
4. R1001-R3000 
5. R3001-R5000 
6. Over R5000 
7. Don't know 
Is this more or less the income that you had over the past six 
months? 
1. Yes 
2. No 
If no, is it more or less? 
1. More 
2. Less 
How much money is spent on food weekly? 
1. RO-R50 
2. R51-R100 
3. R101-R150 
4. R151-R200 
5. R201-R250 
6. R251-R300 
7. R301-R350 
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8. R351-R400 
9. Over R 400 
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APPENDIX B: Anthropometry 
Name: ____________ __ 
Respondent number: 
Measurer (interviewer): ______________ _ 
Weight (kg):. ____________ __ 
Height (m): ______________ __ 
Circumferences (cm): 
Upper-arm: ___________ _ 
Waist: _____________ _ 
Hip: _ ______________ _ 
Bio-impedance: 
Age (yrs) : _____________ _ 
Elbow width (cm): _________ _ 
Bodystat count: ___________ _ 
Frame size 
1. Small 
2. Medium 
3. Large 
% Fat: _________ _ 
% Lean mass: ___________ _ 
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APPENDIX C 
QUANTITATIVE FOOD FREQUENCY QUESTIONNAIRE 
Name:----:---,,--_:-_____ _ 
Respondent number: 
Interviewer: __________ _ 
QUANTITATIVE FOOD FREQUENCY QUESTIONNAIRE 
Greeting 
1Tll1-3 
W 4-S 
Please think carefully about the food and drinks you have consumed during the past 6 
months. I will now go through a list of foods and drinks with you and I would like you to tell 
me: 
• if you eat these particular foods, 
• how the food is prepared , 
• how much of the food you eat at a time, and 
• how many times a day you eat it and if you do not eat it every day, how many times a 
week or a month it is eaten? 
To help you to describe the amount of a food, I will show you pictures or models of 
different amounts of the food. Please say which picture or model is the closest to the 
amount eaten, or if it is smaller, between sizes or bigger than the pictures or models. 
Amounts can also be reported as cups (c), tablespoons (T) or teaspoons (t). 
• THERE ARE NO RIGHT OR WRONG ANSWERS. 
• EVERYTHING YOU TELL ME IS CONFIDENTIAL. 
• IS THERE ANYTHING YOU WANT TO ASK NOW? 
• ARE YOU WILLING TO GO ON WITH THE QUESTIONS? 
• ENCIRCLE APPROPRIATE ANSWER 
Do you follow any special diet? YES NO 
(1) (2) 
If yes, please specify (encircle appropriate answer) 
1. Diabetic diet 
2. Slimming diet 
3. Allergies 
4. Other 
(Specify), ___________ _ 
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• Do you use salt in your food? 
• Are other, flavoured salts e.g. Aromat used in your 
food? 
Please 
specify 
• Do you use beef! chicken stock in your food? 
• Do you use any dietary supplements? 
• If yes, please specify the type (name), how often, and 
how much: 
Vitamins: 
Minerals: 
Protein: 
Energy: 
Other: 
EATING PATTERNS: (FREQUENCY OF EATING) 
YES 
(1) 
YES 
(1) 
YES 
(1) 
YES 
(1) 
NO DON'T 8 
(2) KNOW 
(3) 
NO DON'T 9 
(2) KNOW 
(3) 
NO DON'T 10 
(2) KNOW 
(3) 
NO DON'T 11 
(2) KNOW 
(3) 
12-
14 
15-
17 
18-
20 
21-
23 
24-
26 
PLEASE INDICATE WHICH OF THE FOLLOWING BEST DESCRIBES THE EATING 
PATTERN YOU USUALLY FOLLOW (MARK ONLY ONE): 
• l.More than three meals with eating between meals 
• 2.Three meals with eating between meals 
• 3.Three meals with no eating between meals 
• 4.Two meals with eating between meals 
• S.Two meals with no eating between meals 
• 6.0ne meal with eating between meals 
• 7.0ne meal with no eating between meals 
• 8.Nibble the whole day, no specific meals 
• 9.Others (Please specify): 
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DO YOU EAT BREAKFAST: 
• 1.Regularly (~4 times a week) 
• 2.Sometimes (1 - 3 times a week) 
• 3.Never 
HOW OFTEN DO YOU EAT AT THE FOLLOWING PLACES AWAY FROM 
HOME? 
Family l.Nev 2>once/ 3.Weekly 
er week 
Friends l.Nev 2.> 3.Weekly 
er once/week 
Cafe 1.Nev 2.> 3.weekly 
er once/week 
Restaurant l.Nev 2.> 3.Weekly 
, Fast food er once/week 
Other, l.Nev 2.> 3.Weekly 
specify er once/week 
Do you drink coffee with your meals? 
• 1. Yes 
• 2. No 
If yes, at which 
meals 
Breakfast 1. Yes 2. No 
Lunch 1. Yes 2. No 
Supper 1. Yes 2. No 
Snacks 1. Yes 2. No 
Do you drink tea (except Rooibos) with your 
meals? 
• 1. Yes 
• 2. No 
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4.Monthly 5.> once a 
month 
4.Monthly 5.> once a 
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4.Monthly 5.> once a 
month 
4.Monthly 5.> once a 
month 
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If yes, at which 
meals 
Breakfast 1. Yes 2.No 
Lunch 1. Yes 2. No 
Supper 1. Yes 2. No 
Snacks 1. Yes 2. No 
With how many meals per day do you eat meat, fish or poultry? 
• 1. One meal 
• 2. Two meals 
• 3. All meals 
• 4. None 
Do you eat fresh fruit and! or vegetables with the 
following meals? 
Breakfast 
Lunch 
Supper 
Snacks 
1. Yes 
1. Yes 
2. No 
2. No 
1. Yes 2. No 
1. Yes 2. No 
SUMMARY OF FOOD FREQUENCY QUESTIONNAIRE 
40 
41 
42 
43 
45 
46 
47 
48 
FOOD CALCULATIONS CODE AMOUNT PER DAY (g) 
(1-8) 
(9-
16) 
(17-
24) 
(25-
32) 
(33-
40) 
(41-
48) 
(49-
56) 
(57-
64) 
(65-
72) 
(73-
80) 
I (1-8) 
I (9-
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161 
(17-
24) 
(25-
32) 
(33-
40) 
(41-
48) 
(49-
56) 
(57-
64) 
(65-
72) 
(73-
80) 
(1-8) 
(9-
16) 
(17-
24) 
(25-
32) 
(33-
40) 
(41-
48) 
(49-
56) 
(57-
64) 
(65-
72) 
(73-
80) 
(1-8) 
(9-
16) 
(17-
24) 
(25-
32) 
(33-
40) 
(41-
48) 
I 
(49-
56) 
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(57-
64) 
(65-
72) 
(73-
80) 
(1-8 
(9-
16) 
(17-
24) 
(25-
32) 
(33-
40) 
(41-
48) 
(49-
56) 
(57-
64) 
(65-
72) 
(73-
80) 
FOOD DESCRIPTION AMOUNT TIMES EATEN 
USUALLY 
EATEN 
Per Per Per Seldom 
day week month Never 
Maize-meal Stiff (pap) 
porridge 
Maize-meal Soft (slappap) 
porridge 
Maize-meal Crumbly (phutu) 
porridge 
Sour porridge Specify ratio 
Mabella/Maize 
Mabella Stiff, coarse, fine 
porridge 
Mabella Soft, coarse, fine 
porridge 
Oats porridge Brand name: 
Breakfast Puffed Wheat, plain 
cereals 
Corn Flakes plain 
Weet Bix 
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Puffed Rice, sweet 
Specify types usually 
eaten 
Brand names of cereals 
available at home 
now: 
Milk on None 
porridge or Whole/fresh 
cereal : Sour 
Circle type 2% fat 
usually used Fat free/skimmed 
Milk blend 
Sov milk 
Condensed 
(whole sweet) 
Condensed (skim, 
sweet) 
Evaporated whole 
EvaDorated low fat 
Non-dairv creamer 
Is sugar None 
added to 
" porridge or White 
cereal? 
" (Tick box) Brown 
" Syrup 
" Honey 
" Sweetener: 
: tvDe 
Is fat added None 
to porridge or 
" cereal? Animal fat (butter) 
(Tick box) 
" Hard margarine 
" Soft margarine 
" Oil 
" Peanut Butter 
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Ii 
Samp/Maize Bought 
rice Self ground 
Samp and Specify ratio (1: 1) 
beans 
Samp and Specify ratio 
peanuts 
Rice: specify White 
brands Brown 
names: Sorqhum rice 
Stamped 
wheat 
Pastas Macaroni 
Spaghetti 
Spaghetti in tomato 
sauce 
Other: 
HOW MANY TIMES A WEEK DO YOU EAT PORRIDGE OR BREAKFAST CEREAL AT ANY 
TIME OF THE DAY (NOT ONLY BREAKFAST)? ____ _ 
FOOD DESCRIP- AMOUNT TIMES EATEN CODE AMOUNT 
TION USUALLY / 
EATEN DAY 
Per Per Per Selda 
day we mont m/ 
ek h Never 
Bread/Bread White 3210 
rolls : 
Bread slices: Brown 3211 
thin 
Medium, thick Whole 3212 
wheat 
Other breads Specify 
types e.g. 3214 
Raisin 3278 
Maize meal 3379 
Sweetcorn 3213 
Rye 
Other 
Pizza (specify Cheese, 3353 
toppings) tomato & 
Hot Dogs( onion 
specify 
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sausage) 
Hamburgers 
-(specify 
meat) 
Are any t he Butter 3479 
! 
following 
" 
3523 
spreads used Butro 3494 
on bread? 
" 
3495 
Fat spreads Animal fat 3484 
(Tick box) (beef 3496 
tallow) " 3516 
Lard 
" Hard 
margarine 
(brick) " 
Soft 
margarine 
(light) 
" Cooking 
Fat 
" 
, 
Peanut butter 3485 
Sweet Jam 3985 
spreads Syrup 3988 
Honey 3984 
Marmite/ 4030 
OXO/ 4029 
Bovril 4029 
Fish paste 3109 
Meat paste 2917 
Cheese Specify 
types : 2760 
Cottage 2725 
low-fat 2723 
cheese 2722 
Cream 
cheese 
I Gouda 
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Cheddar 
Other: 
--
-
I 
Cheese Low fat 4310 
spreads Full fat 2730 
Specify 
types 
Atchar 3117 ! 
Other 
spreads: 
(Specify 
tipes) 
--
Dumpling 3210 
Vetkoek 3257 I 
Provita 3235 ! Crackers 3331 
(refined) 3391 
Crackers 
(whole i wheat) 
Rusks Bran 3330 
Buttermilk 3329 
White 3364 
Boerebesku 3364 
Home-made: it, white 3380 
All-bran 3380 
Raisins 3215 
Buttermilk, 3255 
white 
Buttermilk, 
whole 
wheat 
Other 
Scones 3237 
Muffins Plain 3408 
Bran 3407 
HOW MANY TIMES A DA Y DO YOU EAT BREAD? ___ _ 
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DESCRIPTION AMOUN TIMES EATEN CO AMOUNT 
T DE / 
USUALL DAY 
Y 
EATEN 
Per Per Per Seldo 
day week mont m/ 
h Never 
Chicken Boiled: with skin 292 
without skin 6 
296 
3 
Do you eat Fried: in 301 
the batter/crumbs 8 
chicken Fried, but not 292 
with the coated 5 
skin? 
Yes • No Roasted/grilled 292 
• with skin 5 
without skin 
295 
0 
Chicken AOO 
bones 3 
stew 
Chicken 299 
heads, 9 
raw 
Chicken 300 
stew, with 5 
veg. & 
skin 
Chicken 299 
feet, raw 7 
Chicken Giblets 299 
offal 8 
Chicken Commercial 295 
pie Home-made 4 
295 
4 
Red meat: Fried/grilled: 290 
Beef with fat 8 
295 
without fat 9 
Stewed/bailed: 300 
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with fat 6 
290 
without fat 9 
Mince with 298 
tomato and onion 7 
Red meat: Fried/grilled: 292 
Mutton with fat 7 
293 
without fat 4 
Stewed/boiled: 304 , 
with fat 0 
291 
without fat 6 
Red meat: Fried/grilled: 293 
Pork with fat 0 
297 
without fat 7 
Stewed/boiled: 304 
with fat 6 
304 
I without fat 5 
Red meat: Fried/grilled: 428 
Goat with fat 1 
without fat 
Stewed/boiled: 428 
plain 1 
428 
with vea 2 
Offal: Intestines: 3003 
Specify boiled, nothing 
type: added 
"Vetderm" fried 3003 
Stewed with 
vegetables 
Liver 2955 
Kidney 2956 
Tripe "pens" 3003 
trotters, head 
Pluck (lungs, 3019 
heart. aullet) 
Specify 
vegetables 
used in 
meat 
stews 
. I ..• 
219 
© Central University of Technology, Free State
(only if not 
mentioned 
elsewhere) 
Wors I Fried 2931 
sausaqe 
Bacon 2906 
Cold meats Polony 2919 
Ham 2967 
Vienna's canned 2936 
Russian 2948 
Frankfutter 2937 
Other (specify) 
Canned Bully beef 2940 
meat 
Other (specify) 
Meat pie Bouqht 2939 
Canned 
fish: 
Pilchards In brine 3055 
In tomato sauce 3102 
Mashed with fried A005 
onion 
Sardines In oil 3087 
In tomato sauce 3087 
Tuna In oil 3093 
In brine 3054 
Mackerel 3113 
Salmon 3101 
Pickled 3076 
fish I curried 
Do you YES • NO • remove 
fish bones 
before 
eating 
canned fish 
Fish cakes Fried: 3080 
Specify oil/butter/margarine, 
canned or commercial 
other 
Salted 3077 
dried fish 
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Eggs Boiled/poached 2867 
Scrambled in: oil 2889 
2886 
butter 2887 
2869 
margarine 2868 
Fried in: oil 2877 
butter 2870 
margarine 2902 
bacon fat 
Curried 
HOW MANY TIMES A WEEK DO YOU EAT MEAT 
BEANS 
CHICKEN 
FISH ____ AND 
EGGS 
---? 
FOOD DESCRIPTION AMOUNT TI 
USUALLY 
EATEN 
Per Per 
day weel 
Cabbage Boiled nothing added 
Boiled with potato and onion and 
fat 
Fried in margarine (nothing added) 
Fried, in oil (nothing added) 
Boiled then fried with potato, onion 
Other: 
Spinach/morogo/imfin%ther Boiled, nothing added 
green leafy vegetables: Boiled fat added (margarine) 
List names Boiled with onion/tomato and fat 
-onion &potato (marqarine) 
- onion tomato & potato 
- with peanuts 
Other: 
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Tomato and onion Home made 
'gravy' /relish/chow without fat 
Canned 
Pumpkin Cooked in fat & suqar 
Specify type: Boiled, little sugar and fat 
Boiled 
Other: 
Carrots Boiled, sugar & fat 
Boiled nothinq added 
Boiled potato onion no fat 
Boiled potato onion marqarine 
Boiled, with sugar 
With potat%nion 
Raw, salad (orange juice) 
Chakalaka 
Other: 
Mealies/Sweet corn On cob 
Off cob -creamed sweet corn 
Off cob whole kernel 
Beetroot Cooked 
Salad (bought or home-made) 
FOOD DESCRIP AMOUNT TIMES EATEN CODE AMOUNl 
TION USUALLY /DAY 
EATEN 
Per Per Per Seldom 
day week month / 
Never 
Potatoes Boiled with 4155 
skin 
without skin 3737 
Baked in 3736 
skin(flesh and 3970 
skin) in skin 
(flesh only) 
Mashed - 3875 
skim milk, 
marqarine 
Mashed - 3876 
222 
© Central University of Technology, Free State
whole milk, 
margarine 
Roasted in 3878 
I beef fat 
French 3740 
fries/potato 
chips (oil) 
Salad 3928 
(mayonnaise 
and eqq) 
Other: 
! 
Sweet Boiled 3748 I potatoes wit 
h skin 
- 3903 I 
wit 
hout skin 
Baked 3748 I 
wit 
h skin 
- 3903 
wit 
hout skin 
Mashed 3903 
other: 
I 
Peas Green, frozen 4146 I Green, frozen 3720 
with sugar 3859 
With sugar 4149 
and butter 
Tinned peas 
Green Raw 3733 i 
peppers Cooked (stew 3865 
with oil) 
Brinjal/e Cooked 3700 
99 plant Fried in oil 3802 
Stew (oil, 3798 
onions, 
tomato) , 
Mushroo Raw 3842 , 
ms Sauteed in 3839 
brick 3841 
margarine 
Sauteed in oil 
Onions Sauteed in 3730 
223 
© Central University of Technology, Free State
sun oil 3844 
Sauteed in 
marqarine 
Salad Raw tomato 3750 i 
vegetable Lettuce 3723 
s Cucumber 3718 I 
Avocado's 3656 
Green Boiled, 3696 
Beans nothing 
added 
Cooked, 3792 
potato, onion, 
margarine 
Cooked, 3933 i 
potato, onion, 
no fat , 
Cauliflow Boiled 3716 
er ! 
Other 
vegetable 
Si specify 
If you fry Butter 3479 I 
veg or 
" 
3523 
add fat Butro 3494 
specify 
" 
3495 
type of Animal fat 3484 
fat (beef tallow) 3496 
usually 0 3524 
used Lard 3507 
" Hard 
margarine 
(brick) 
" Soft 
margarine 
(tub) 
" Soft 
margarine 
(light) 
" Sunflower oil 
" 
HOW MANY TIMES A WEEK DO YOU EAT VEGETABLES? _____ _ 
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FOOD DESCRIPTION AMOUN TIMES EATEN COD AMOU 
T E NT/D 
USUALL AY 
Y EATEN 
Pe Per Per Seldo 
r wee mont m/ 
da k h Never 
y ; 
Mayonnaise Mayonnaise: bought 3488 
/salad home- 3506 
dressing made 3503 
Cooked salad 3505 
dressing 3487 
Salad dressing low-oil 3509 
Salad dressing French 3507 
Oil: Olive 4280 
Sunflower 
Canola 
Apples Fresh 3532 
Canned, 4216 
unsweetened 
Pears Fresh 3582 I 
Canned in syrup 3583 ! 
Bananas 3540 
Oranges 3560 
Naartjie 3558 
Grapes 3550 
Peaches Fresh 3565 , 
Canned in syrup 3567 .. 
Apricots Fresh 3534 
! Canned, in syrup 3535 
Mangoes Fresh 3556 
Pawpaw Raw 3563 
Pineapple Raw 3581 i 
Canned (syrup) 3648 
Guavas Fresh 3551 
Canned (syrup) 3553 
Watermelon 3576 : 
Spanspek Orange flesh 3541 , 
Green flesh 3575 
Wild 
fruit/ berrie 
s 
(Specify 
types) 
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Dried fruit Raisins 3552 
(also as Prunes (raw) 3596 
snacks) Prunes (cooked with 3564 
sugar) 3568 
Peaches (raw) 3569 
Peach (cooked with 3600 
sugar) 3995 
Apples (raw) 
Dried fruit sweets 
Other 
-
Ot her fruit 
- --
--
-
- - --
- --
- -
-
--
-- --
- --
--
--
- --
-- --
- -- -- --
- --
-- --
-
--
-- --
- -- -- --
-
-- - --
- -- --
- - -- --
-- -
--
--
- --
HOW MANY TIMES A WEEK DO YOU EAT FRUITS? _____ _ 
WE NOW WILL ASK YOU QUESTIONS ABOUT WHAT YOU USUALLY DRINK 
BEVERAGE 
S 
DESCRIPTION AMOU 
NT 
USUAL 
LY 
226 
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TAKEN 
Per Per Per Seldo 
day wee mon m/ 
k th Never 
Water 404 
2 
Tea Ceylon 403 
I 
Rooibos 8 
405 
4 
Coffee 403 
7 
Sugar per White 398 I 
cup of tea Brown 9 
or coffee 400 
5 
Milk per Fresh/long life whole 271 
cup of tea 8 
or coffee 
What type of Fresh/long life 2% 277 
milk do you Goat 2 
put in tea 273 
and/or 8 I coffee? 
Fresh/long life/fat 277 ! free (skimmed) 5 
Whole milk powder, 283 
reconstituted 1 
Specify brand: 
Skimmed milk 271 , 
powder, reconstituted 9 
Specify brand : 
I 
Milk blend, 277 
reconstituted 1 
Specify brand: 
Whitener/non-dairy 275 
creamer 1 
Specify brand: 
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Condensed milk 271 
(whole) 4 
Condensed milk 274 
(skim) 4 
Evaporated milk 271 
(whole) 5 
Evaporated milk (Iow- 282 
fat) 7 
None 
Milk as Fresh/long life/whole 271 
such: Fresh/long Iife/2% 8 
What type Fresh/longlife/fat free 277 
of milk do (skimmed) 2 
you drink Goat 277 
as such? 5 
273 
8 
Sour / Maas 278 
7 
Buttermilk 271 
3 
BEVERAGE DEsCRIP AMOUNT TIMES TAKEN CODE AMOUN' 
5 TION USUALLY /DAY 
TAKEN 
Per Per Per Seldom 
day week mont / 
h Never 
Milk drinks Nestle 4287 
I Specify Nesquik __ 2735 
brands, Milo 2774 
Including 
milk 
-
supplement Flavoured 
s and type milk 
of milk 
-- I used Other 
Yoghurt Drinking 2756 i 
yoghurt 2732 
Thick 
yoghurt, 
plain, fruit 
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Squash SixO 3990 
Oros 3982 
Lecol with 3982 
sugar 3990 
-artificial 3982 
sweetener 
Kool Aid 
Other 
-- I 
Fruit juice Fresh/Liquifru 2866 I 
it/Ceres/ 
"Tropica"/ 2791 
mixtures with 
milk 
Fruit Average 2865 
syrups Guava syrup 2864 
Fizzy drinks Sweetened 3981 
Coke, Fanta Diet 3990 
Mageu/Mot 4056 
ogo 
Alcoholic Sorghum 4039 -, 
beverages beer 
such as Specify: 
Sorghum 
beer 
Other, Beer average 4031 
specify: Wine 4033 
Cider 4057 
-
-
-
-
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1- 1 1 I 1 1 I 
PLEASE INDICATE WHAT TYPES AND AMOUNTS OF SNACKS, PUDDINGS AND 
SWEETS YOU EAT: 
FOODS DESCRIPTION AMOU TIMES EATEN COD 
NT E 
USUA 
LLY 
EATE 
N 
Per Per Per Seldo , 
day wee mon m/ 
k th Never 
Potato 341 
crisps/ chip 7 
s 
Peanuts Roasted, unsalted 345 
Roasted, salted 2 
345 
8 
Cheese Average 326 
curls: Savoury 7 
Niknaks 341 
etc. 8 
Popcorn Plain (no salt and 333 
butter) 2 
Plain (salt and butter 
added) 335 
Sugar coated 9 
Raisins 423 
(seeds) 1 
Chocolates Milk 398 
Kit Kat 7 
Peppermint crisp 402 
Specify types and 4 
names 399 
7 
Candies Sugus, gums, hard 398 
sweets (specify) 6 
Peppermint 
400 
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4 
Sweets Toffees 399 
Hard boiled 1 
Fudge, caramels 398 
(specify) 6 
399 
1 
Biscuits/co Specify type 
okies Home made plain 323 
Shortbread, butter 3 
Commercial, plain 329 
Commercial with 6 
filling 321 
6 
321 
7 
Cakes & Chocolate, plain 341 
tarts 9 
Pancakes/ 334 
crumpets 4 
Koeksisters 323 
1 
Savouries Sausage rolls 293 
Samoosas - vegetable 9 
Samoosa - mutton 341 
Biscuits e.g. bacon 4 
kips 335 
Other: 5 
333 
1 
Pudding: 398 
jelly 3 
Baked Plain batter 342 
pudding 9 
Instant Skim milk 331 
pudding Whole milk 4 
326 
6 
Ice cream Commercial regular 348 
Commercial rich 3 
Soft serve 351 
Sorbet 9 
Ice lollies 351 
Chocolate coated 8 
individual ice creams 349 
(e.g. Magnum) 1 
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398 
2 
Custard Home made, whole 271 
milk 6 
Ultramel 271 
6 
Cream Fresh 352 
0/ 
348 
0 
Other 
puddings 
(Specify): 
HOW MANY TIMES A WEEK DO YOU EAT SNACK FOODS? _____ _ 
SAUCES / GRAVIES / CONDIMENTS 
FOODS DESCRIPT AMOU TIMES EATEN COD AMOUNT/DAY 
ION NT E 
USUA 
LLY 
EATE 
N 
Per Per Per Seldom 
day week mont / 
h Never 
Tomato 313 
Sauce 9 
Worcester 430 
sauce 9 I 
Chutney Fruit 316 
8 I 
Tomato 311 
4 
Pickles 386 
6 
Packet 315 
soups 8 
Beef/chick 402 
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I en stock 9 
Others: 
WILD BIRDS, ANIMALS, INSECTS OR FRUITS AND BERRIES (hunted or collected in rural 
areas or on farms: (specify) 
I I I I I I I 
• PLEASE MENTION ANY OTHER FOODS YOU EAT MORE THAN ONCE EVERY TWO 
WEEKS WHICH WE HAVE NOT TALKED ABOUT AND OR FOODS EATEN IN OTHER 
HOMES OR PLACES DURING THE PAST WEEK 
FOOD DESCRIPT AMOU TIMES EATEN COD AMOUNT/DAY 
ION NT E 
USUA 
LLY 
EATE 
N 
Per Per Per Seldom 
day week mont / 
h Never 
ARE THERE ANY FOODS THAT YOU EAT WHICH WE HAVEN'T TALKED ABOUT? 
PLEASE LIST THEM. 
" 
FOODS DESCRIPTION AMOU TIMES EATEN COD AMOUNT/ 
NT E DAY 
USUA 
LLY 
EATE 
N 
Per Per Per Seldo 
day wee mon m/ 
k th Never 
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THANK YOU FOR YOUR CO-OPERATION AND PATIENCE. 
GOOD BYE! 
ADAPTED FROM THE QUESTIONNAIRES OF THE THUSA STUDY (WITH 
ACKNOWLEDGEMENT TO THE RESEARCH GROUP OF PUCHO) AND THE 
NATIONAL FOOD CONSUMPTION SURVEY 
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APPENDIX D 
PHYSICAL EXAMINA TlON 
All information in this uestionnaire is confidential. 
Name: ____ __ _ 
Respondent number: 
Interviewer: ______ _ 
!Tll 1-3 
-W 4-5 
DDMMYYY Y 
I I I I I I II 1'-13 14-21 
22-23 
Birth Date: 
Interview Date: 
Age (years) if Birth Date unknown: _______ _ 
Address: 
Tel No (H)-: ---------;:-(W:-;c)-:~~~~~~~ __ _ 
SYSTEM YES NO 
1. EYES 
• JAUNDICE 
• DISCHARGE 
• INFECTION 
• PUPIL NORMAL 
2. EARS 
• PAIN 
• INFECTION 
• DISCHARGE 
• VERTIGO 
3. NOSE 
• PAIN 
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• ULCER 
• SWELLING 
4. MOUTH AND LIPS 
• PAIN 
• ULCER 
• SWELLING 
• CRACKED LIPS 
• CANDIDAS 
5. THROAT 
• PAIN 
• ULCER 
• INFECTION 
• CANDIDAS 
6. NECK 
• SWELLING 
# SUBMENTAL 
# JUGULAR 
# POSTERIOR TRIANGLE OF NECK 
# OCCIPITAL 
7. BREASTS 
• PAIN 
• LUMPS 
DISCHARGE 
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8. RESPIRATORY SYSTEM 
• COUGH 
• SHORTNESS OF BREATH/ DYSPNOEA 
• PAIN 
• HAEMOPTYSIS 
• TB 
• ABNORMAL BREATH SOUNDS 
9. CARDIOVASCULAR 
• SWELLING OF LEGS/ANKLES 
• OTHER EDEMA 
• SHORTNESS OF BREATH/DYSPNOEA 
• CYANOTIC 
• CLUB FINGERS 
10. BLOOD FORMING ORGANS 
• ENLARGEMENT OF SPLEEN 
• . GLANDS IN NECK 
• .. AXILLA 
• GROINS 
11. DIGESTIVE 
• MASS LOSS/MALNARISH 
• EATING WELL 
• NORMAL BOWEL MOVEMENTS 
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• STOOLS NORMAL 
• ABDOMINAL PAIN 
• NAUSENVOMITING 
• PAIN 
• LIVER ENLARGEMENT 
• SPLEEN ENLARGEMENT 
12. GENITO-URINARY 
• DYSURIA 
• DYSMENORRHOEA 
• VAGINAL DISCHARGE 
• URETHRAL DISCHARGE 
• STI 
• PENILE DISCHARGE 
• SWELLING OF SCROTUM 
13. LOCOMOTOR 
• PAIN 
• NEUROPATHY 
14. SKIN 
• RASHES 
• ULCERS 
• TUMORS 
15. CENTRAL NERVOUS 
• PARALYSIS 
• NORMAL STATE OF CONSCIOUSNESS 
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• NORMAL SENSORY SYSTEM 
16. VITAL SIGNS 
• TEMP: 
• BLOOD PRESSURE 
• RESP 
• PULSE 
17. TREATMENT: 
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APPENDIX E: Consent Form 
HIV/AIDS Nutrition Project 
Date: 
A. Patient information 
Surname: 
First name 
Male: --------------- Female: 
Date of birth: 
B. Patient's Consent 
Hereby I declare that I have been informed of the aims of this project (as printed at the 
back of this form) and that the following samples can be taken: 2 tubes of blood (purple 
stopper blood). I also understand that my information will be regarded as confidential, that 
my participation is voluntary and that I could withdraw at any time. 
Patient's signature Date 
c. Information sheet 
Several vitamins and minerals are critical for fighting HIV infection because they are 
required by the immune system and major organs to attack infectious pathogens. 
Research indicates that in the early period of HIV infection, weight gain or maintenance 
might be achieved through nutrition. Data on the prevalence of malnutrition, dietary intake 
and / or supplementation in HIV-infected persons in industrialized countries, is widely 
available. However, this information is often scarce in Africa where endemic malnutrition 
and lack of nutrition management are common . Therefore, study to evaluate the role of 
nutritional supplementation in HIV-positive patients becomes necessary, especially in a 
developing country such as South Africa. Africa's Solution was developed and this clinical 
trail is set up to investigate its efficiency on the immune system of HIV/AIDS patients with 
a suppressed immune system. 
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HIV/MIV VOEDINGSPROJEK 
Datum: 
A. Pasient inligting 
Vctn: -----------------------------------------------------
Vo II e N a m e -----------------------------------------------------
Mctnlik: Vroulik: 
Geboorte dcttum: -----------------------------
B. Pctsient Toestemming 
Hiermee verklctar ek dat ek ingelig is oor die doelwitle vctn die projek (soos uiteengesit op 
die agterblad) en die volgende monsters kan van my geneem word: 2 buise bloed (pers 
prop buise). Ek verstaan ook dat my pasient inligting konfidensieel hanteer sal word en dat 
my deelname vrywillig is en ek teen enige tyd kan ontlrek. 
Pasient handtekening Datum 
c. Inligtingstuk 
Verskeie vitamiene en minerale is krities vir die bevegtig van HIV infeksie, omdat hulle 
benodig word deur die immuunsisteem en die belangrikste organe om geinfekteerde 
patogene aan te val. Navorsers het aangedui dat gedurende die vroee fase van HIV 
infeksie gewigstoename en instandhouding verkry kan word deur voeding . Data oor die 
voedingsstatus, dieet inname en lof supplement aanvulling in HIV geinfekteerde persone 
in ontwikkelende lande is redelik maklik beskikbaar. Hierdie inligting is egter nie so maklik 
verkrygbaar in Afrika nie, waar wanvoeding en ondervoeding redelik algemeen is. Daarom 
het dit nodig geraak om die rol van 'n supplement aanvulling in HIV positiewe pasiente te 
evalueer, veral in ontwikkelende lande. "Africa's Solution" is ontwikkel en 'n kliniese studie 
is saamgestel om die invloed van die supplement aanvulling op die immuunsisteem te 
ondersoek in HIV/MIV positiewe pasiente met 'n onderdrukte immuunsisteem. 
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HIV I AIDS NUTRITION PROJECT 
Letsatsi: 
Hlahiso lesedi ya monkakarolo 
Sefane: 
Lebitso: 
Monna: Mosadi: 
Letsatsi la tswalo: 
Tumallano ya monka karolo 
Kaho ke paka hore ke tsibisitswe ka maikemisetso a projeke ena (kaha ho 
tlanyaditswe ka morae ha foromo ena) Ie hore ho ka etwa dipatlisiso tse latelang: 
ho nkuoa ha madi ka di dinnalete tse pedi (e Ie nywe ya sekwahelo se kgubedu, 
Ie enywe ka se perese). Kutlwisiso ya ka kehore ntho tsaka di tla amohelwa ka 
sephiring, Ie hore honka karolo haka ho bolela hore nka tlohela haro ho sebaka. 
Tshaeno ya monka karolo Lestatsi 
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